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Abstract
Copper is essential for life, but potentially toxic due to its ability to redox cycle and
displace metal cofactors. Therefore, ubiquitous protein networks exist to safely handle and
deliver copper. Copper is removed from the cell via an integral membrane P1B-ATPase,
characterised by its soluble metal-binding domains (MBDs) which receive copper from
Atx1-like copper chaperones in the cytoplasm. The mechanism of copper removal is un-
known. Low molecular weight thiol species (LMWT) may play a role in cellular copper
trafficking. The metallochaperone (CopZ) and soluble domains of the ATPase (CopAab)
from Bacillus subtilis each bind Cu(I) with high affinity/specificity and form higher-order
assemblies. Native electrospray ionisation mass spectrometry (ESI-MS) revealed forma-
tion of multiple copper-bound species with increasing Cu(I) level; cooperative formation of
Cu4(CopZ)2 and Cu6(CopAab)2 was observed. The affinity for Cu(I) of bacillithiol (BSH),
the primary LMWT in the B.subtilis cytoplasm, was determined to be β2 = 4.1 x 1017 M-2.
ESI-MS revealed reduced intensity of dimeric forms of CopZ and CopAab in the presence of
BSH (and other LMWT) due to copper competition; bacillithiolation of CopZ was observed.
Higher order copper-bound complexes were observed for metallochaperones from Strep-
tomyces lividans and Saccharomyces cerevisiae, and their decrease in the presence of
LMWT. Rapid and reversible copper transfer between CopZ and CopAab was observed
with similar rate constants at 25 ◦C for forward (247 ± 2.2 s-1) and reverse (258 ± 2.6
s-1) directions of transfer. The rate constant was independent of concentration, suggest-
ing the rate-limiting step is first-order, and likely to be protein complex formation. Kinetic
studies demonstrated that protein complex formation resulted in a 7-fold increase in the
rate of copper transfer; a copper-bound CopZ:CopAab complex was observed via ESI-MS.
Bidirectional copper transfer between CopZ and CopAab consistent with a regulatory role
for the MBDs.
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Chapter 1
Introduction
1.1 Copper as a Bioelement
Copper is the 29th element in the periodic table and its biochemical effects have been long
exploited by human society as it was used by the ancient Greeks, Aztecs and Egyptians
for medicinal purposes, such as sterilising wounds and drinking water [1]. Its other uses
include metallurgy, on its own and alloyed in bronze, and more recently its ductility and
conductivity have made it useful in wiring [2]. Copper has been identified as an essential
nutrient in the human diet [3], and copper deficiency is associated with anaemia through
its adverse effects on iron uptake in animals [4].
The bioavailability of copper can be traced back to the rise of photosynthetic cyanobac-
teria 2.5 billion years ago which oxygenated the Earth’s oceans and atmosphere, and dras-
tically altered the solubility and bioavailability of metals [5]. Prior to this, copper existed in
insoluble sulfides as Cu(I) and was not bioavailable; early biological processes on earth
requiring redox function primarily used water soluble ferrous iron [2]. Oxygenation of the
atmosphere led to the mass precipitation of iron in the oceans as it oxidised from Fe(II) to
Fe(III), making it largely unavailable for biological utilisation [6]. Conversely, other metal
ions including copper became more bioavailable as they were released from their sulfide
forms.
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Newly soluble copper was initially dangerous to early life, but the altered chemistry
caused by oxygenation eventually forced organisms to adapt to what metals were avail-
able [5]. Oxidative metabolism required a metal that could function at higher potentials
than those used for anaerobic metabolism [7]. Most copper enzymes work between +0.25
and +0.75 V, which is higher than the Fe(III)/Fe(II) potential [2]. The changes in metal util-
isation are evident in the relationship between copper usage and metabolism; though few
anaerobic organisms utilise copper, many aerobic organisms utilise copper because they
evolved ways to harness copper redox chemistry for metabolism without suffering any of
its deleterious effects [6].
Copper has two stable, naturally occurring isotopes, 63Cu and 65Cu, with 69% and 31%
abundance, respectively. Cu(II) has a 3d9 valence electron configuration and usually exists
in coordination number 4 (square planar), 5 (trigonal bipyramidal or square pyramidal) or 6.
Cu(I) has a full valence shell 3d10 and prefers coordination numbers 2, 3, or 4 (tetrahedral)
though coordination 5 does exist [8]. Cu(I) is a soft Lewis acid and has a tendency to
bind soft bases such as thiols, hydrides, alkyl groups, cyanide and phosphines. Cu(II) will
bind these ligands as well but, as an intermediate acid, it will form complexes with other
ligands such as sulfate and nitrate. Therefore, protein binding sites for copper dominated
by amino acids with side chains that are soft ligands containing nitrogen and sulfur donor
atoms: histidine, cysteine and methionine [6] (Figure 1.1.1).
This ligand set affords cuproproteins a variety of properties in terms of binding strength,
hydrophobicity and charge state. Deprotonation of the first nitrogen on the histidine imida-
zole ring generates a neutral nitrogen donor, and the second generates an anionic imida-
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Figure 1.1.1: Typical Cu(I) ligands. Based upon the coordination preferences
of Cu(I) as a soft Lewis acid, protein binding sites for Cu(I) usually feature ligands
from Cys, Met and/or His.
zolate that is able to bridge two metal ions. Cysteine can also bridge two metal centres via
an anionic thiolate that forms upon deprotonation, and can also oxidise to form disulfide
bonded cystine. The neutral sulfur donor on the thioether of methionine serves as the ac-
tive metal-binding site, which is not pH-dependent like histidine and cysteine. Methionine
is also more hydrophobic than histidine or cysteine which affects solvent accessibility [6].
The metal centre formed by these ligands can take on varied geometry and compo-
sition, determining its redox potential, which enables cuproproteins to keep copper in the
appropriate oxidation state. A larger reduction potential of the metal centre will favour keep-
ing copper in its Cu(I) state and a lower reduction potential will favour copper in its Cu(II)
state.The cytoplasm has a reduction potential of -0.29 V and is rich in thiolates [9] which,
as soft donors, can bind Cu(I) very tightly, ensuring that copper is only present in the cy-
toplasm safely as Cu(I) complexes and not as a free cation. The less toxic Cu(II) is more
abundant in aerobic environments such as the extracellular milieu [10].
Because redox-active copper is more reactive in its reduced state, it is potentially very
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toxic [5]. If ions were freely available in the cytoplasm, copper could undergo the production
of dangerous hydroxyl radicals via Fenton chemistry [1]:
Cu(I) +H2O2 −→ Cu(II) +OH− +OH• (1.1)
Cu(II) +O−2 −→ Cu(I) +O2 (1.2)
Thus redox cycling of copper leads to the net equation:
O−2 +H2O2 −→ O2 +OH• +OH− (1.3)
Hydroxyl radicals are very reactive and can damage many cellular molecules including pro-
teins, nucleic acids, and lipids. Copper toxicity can also occur through disruption of protein
structure through interactions with the polypeptide backbone, and can displace other metal
cofactors, interrupting enzyme function. Displacement of iron from iron-sulfur clusters has
been demonstrated in Escherichia coli for proteins in the branched-chain amino acid syn-
thesis pathway [11].
The copper ion’s reduction potentials enable its proteins to engage in a wide variety of
functions which are roughly grouped into broad classes: those that transport copper and
those that use copper as a cofactor [6]. Proteins involved in copper trafficking generally are
Cu(I)-binding proteins involved in maintenance of copper homeostasis within cells. These
proteins transfer copper to enzymatic or catalytic proteins as Cu(I), where copper is utilised
as a cofactor and cycled between the Cu(I) and Cu(II) oxidation states [12].
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1.2 Copper Homeostasis Across Biology
Cuproenzymes exploit the ability of copper to cycle between the oxidised Cu(II) and re-
duced Cu(I) forms, which serves a wide range of catalytic functions [8]. Copper has been
classed as a cofactor for several dozen enzymes in higher organisms and microbes [7],
which function in electron transfer, catalysis and oxygen transport.
In order to safely supply copper to metabolic enzymes, networks of copper trafficking
proteins carry out management of this essential yet potentially toxic metal [13]. It is believed
that half of a given cuproproteome is involved in copper trafficking [12] but mechanisms and
regulation of uptake, distribution and eﬄux are not fully characterised.
Though metabolic utilisation of copper in enzymes is more common in higher order
organisms, few organisms have been found which lack copper detoxification machinery
[7]. Below is an overview of copper proteins across biology: common cuproenzymes, the
proteins which comprise a typical copper trafficking network, and some of their structural
and functional features in eukaryotic and prokaryotic organisms.
Cuproenzymes
Cytochrome c oxidase
The most commonly occurring cuproprotein in biology is cytochrome c oxidase (CcO) [14].
CcO plays a central role in aerobic respiration as the terminal electron acceptor in the
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electron transport chain. CcO sits within the inner mitochondrial membrane and contains
four redox active metal sites, two heme sites (hemes a and a3) and two copper sites (CuA
and CuB) [12]. CcO translocates four protons across the mitochondrial membrane and
reduces molecular oxygen. The delivery of copper to cytochrome c oxidase is carried out
through the cooperative efforts of four proteins in humans and yeast. Cox17 is a cysteine-
rich protein which delivers copper to Sco1 and Sco2 and Cox11, all of which are anchored
to the inner mitochondrial membrane. These proteins then insert copper into the Cox1 and
Cox2 domains of CcO [15].
Copper/zinc superoxide dismutase
Copper/zinc superoxide dismutase (Cu/Zn-SOD) has become one of the best-characterised
copper-containing enzymes, as it has been linked with angiogenesis, cancer, and neurode-
generative disease [16]. Cu/Zn-SOD disproportionates superoxide to dioxygen and hydro-
gen peroxide, thus providing protection from oxidants which arise from the environment or
as a side effect of aerobic metabolism. Cu/Zn-SOD plays diverse roles in cell signaling and
serve as a virulence factor of pathogens, and carries out catalysis at a rate close to the dif-
fusion limit (∼ 109 M-1 s-1 [17]) and over quite a wide pH range (pH = 5 – 10). Homodimeric
Cu/Zn-SOD acquires copper in the cytosol and contains one copper and one zinc ion per
subunit. Copper is the enzymatically active metal, found at the end of a funnel-shaped
cavity formed by residues in loop VII [18]. Zinc interacts with this loop and with the copper
site (via a bridging histidine) to secure the redox active cofactor and stabilise the protein
fold.
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Copper trafficking proteins
Management and distribution of copper is largely handled by a few groups of proteins:
importers, chaperones, metallothioneins, and exporters. In addition, the copper traffick-
ing function of these proteins may be complemented by low molecular weight thiol (LMWT)
containing species in the cytoplasm, which play a complex role in vivo including modulation
of redox status [19] [20] [21]. LMWT thiol ligands have high affinity for soft metals including
Cu(I), and evidence suggests they may influence cytoplasmic copper levels [22] [23] [24].
Examples of LMWT are glutathione (GSH) in humans [25], mycothiol (MSH) in actino-
mycetes [26], and bacillithiol (BSH) in B.subtilis [27] (see Section 4.2.3).
Import proteins
Active uptake mechanisms are essential for importing copper in organisms which actively
utilise copper in their metabolic pathways. The use of cuproenzymes is rarer among
prokaryotes, and therefore in this domain fewer copper uptake proteins have been de-
fined [7]. The primary known mechanism of copper import into cells involves the eukary-
toic Ctr family of plasma membrane-associated high-affinity copper transport proteins. The
Ctr proteins were first identified in yeast (Ctr1), and their deletion results in defective mito-
chondrial oxidative phosphorylation [28]. Ctr proteins use a concentration gradient to drive
copper into the cell by way of a pore at the interface [6].
In other eukaryotes, Ctr1 analogs have been identified (hCtr1 in humans and mCtr1 in
mouse); in lower-order organisms, other copper import proteins have been identified, YcnJ
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in B. subtilis [29], HmtA in Pseudomonas aeruginosa [30]). In addition, other mechanisms
for copper uptake have been proposed including divalent metal transporter DMT1 (human)
[31] and methanobactins (bacteria) [32].
Copper chaperones
After being taken up into the cell, copper is transported as cargo by high-affinity chaperones
which deliver copper to the correct destination [33]. These proteins are often referred to
as the Atx1-like copper chaperones, after the first metallochaperone to be identified [34].
In addition to escorting cellular copper to its required target, it has been demonstrated that
Atx1-like chaperones may play a role in cellular copper storage [35] and gene regulation
[36].
Atx1-like chaperones are usually approximately 70 residues long comprising a con-
served βαββαβ motif, connected by loop regions with a MXCXXC binding motif [37]. Coor-
dination to the Cu(I) is digonal or trigonal [38] [39] with flexibility in the loop containing the
copper-binding site; this low-coordinate, flexible geometry helps facilitate transfer of copper
to another protein [6]. The copper-binding motif is surface-exposed with the two cysteines
located in the first loop and the beginning of the first α-helix. NMR data have demonstrated
a distorted linear coordination, with S-Cu-S bond angles of 115 – 120◦ [40] [41].
Metallothioneins
Metallothioneins (MTs) are small, intracellular metal-binding proteins found in bacteria,
plants, invertebrates and vertebrates, which display considerate diversity across biology.
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In vertebrates, MTs are frequently considered a binding reservoir for divalent metals, and
are ∼ 60 – 70 amino acids in length and contain up to 20 cysteines. The bacterial MTs
contain proteins which are neither homologous in sequence nor related by evolution to
the animal MTs [10]; these proteins are cysteine-rich but also contain aromatic residues
including His [42]. One bacterial copper-specific MT has been identified, MymT, from the
Gram-positive Mycobacterium tuberculosis [43], which has little homology to other MTs
and features a unique motif (CHCXXGXXYRCTC). Other prokaryotic MTs, in species from
the cyanobacterial genus Synechococcus, seem primarily to function in Zn2+ homeostasis,
whereas MT from other organisms may function in stress response and detoxification of
divalent metals. Though gene deletion has confirmed MymT functions in protection against
copper toxicity, overexpression of other MTs in bacteria has led to metal buildup rather than
detoxification. This, coupled with the fact that they are relatively rare in bacterial sequences,
makes their role in nature unclear [42].
Typically, MTs are investigated in vitro for their capacity to bind multiple divalent metal
ions. It has been demonstrated MT can provide essential metals Zn2+ and Cu+ to apo-
enzymes [44]. Their ability to bind multiple metals makes their potential role in vivo com-
plex. For example, MT may serve to sequester and donate zinc to metalloproteins for
which zinc is a cofactor, giving MT the potential to influence numerous cellular processes
including gene regulation, cell proliferation, differentation and apoptosis. In addition, zinc
is a regulator of glutathione (GSH) synthesis which links MT further with metal trafficking in
vivo [45]. The thiol ligands of GSH have a high affinity for Cu(I), making this one of several
ways that metallothionein could be linked to copper homeostasis.
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Membrane exporters
The P1B-type ATPases function with specificity towards soft Lewis acids including copper
(see Figure 8.1.1). P1B-type ATPases couple the energy released by dephosphorylation
of ATP with active transport of a Cu(I) ion across a transmembrane channel, which follows
the Albers-Post catalytic cycle. A crystal structure was solved of CopA from Legionella
pneumophilla [46], which provided the first complete atomic structure of a P1B-type ATPase.
From this, a three-step pathway for transmembrane copper transport was proposed, but
the full mechanism for copper transfer and eﬄux is not fully understood.
A distinct feature of P1B-type ATPases are soluble, cytoplasmic metal-binding domains
(MBDs) located at the N-terminal end. In addition, at the mouth of the transmembrane
channel is a metal-binding site (MBS), which in P1B-type ATPases is a CPC motif [47]. It
has been demonstrated that Cu(I) can be transferred from Atx1-like chaperones directly
to this MBS [48], suggesting that MBDs may not facilitate entrance of copper to the trans-
membrane channel.
Though the role of MBDs in cellular copper removal is unclear, copper transfer from the
Atx1-like copper chaperones to the MBDs has been demonstrated [49] [50] [51] [52]. Like
the copper chaperones, each MBD typically contains a ferredoxin-like fold with a conserved
CXXC motif [12] (see Chapter 5), and their interaction is facilitated by complementary struc-
tural elements (see Chapter 6). Both display an extremely high affinity for Cu(I), creating a
shallow thermodynamic gradient for copper transfer.
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Copper trafficking in eukaryotes
Copper trafficking networks vary across biology depending upon the complexity of the or-
ganism and the extent to which it utilises copper ions in its metabolism. For example,
active transport uptake mechanisms are crucial for species which actively utilise copper as
an enzymatic cofactor.
Homo sapiens
In humans, copper is a necessary cofactor for embryonic development and respiration
and, thus, is an essential component of the diet. Copper is absorbed by diffusion across
the mucosal membrane in the stomach and small intestine and excreted primarily via the
bile at a rate of ∼ 1 mg / day. Under normal circumstances, up to 75% is recycled among
the digestive tract and bodily fluids/tissues, especially the liver [15].
Copper uptake occurs via the hCtr1 transporter [53], from which it is bound to intra-
cellular copper chaperones, Atox1, CCS or Cox17. It is not clear how cytoplasmic copper
chaperones acquire Cu(I) from hCtr1 [54]. Atox1 delivers Cu(I) to ATP7A/B (see below),
CCS delivers Cu(I) in the cytoplasm to SOD1 and Cox 17 delivers Cu(I) to the mitrochon-
dria for insertion into cytochrome c oxidase (with the assistance of additional proteins) [55].
High-affinity copper binding by intracellular molecules such as albumin, ceruloplasmin and
transcuprein, GSH and metallothioneins have also been demonstrated [15].
Atox1 is a 68-residue Atx1-like copper chaperone in humans, featuring a surface-
exposed MXCXXC copper binding site in a ferredoxin-like fold. Atox1 has been shown
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to dimerise in vitro [56], with the Lys60 involved in hydrogen bonding at the dimer inter-
face [57]. Lys60 and Thr11 were found to participate in electrostatic networks that stabilize
the Cu-bound form and, in the apoform, determine the solvent exposure of the two Cys [58].
The copper chaperone Atox1 delivers copper to the secretory pathway and docks with
the P1B-type ATPases, ATP7B in the liver, or ATP7A in other cells [59]. Most enzymes
acquire copper from ATP7A/B in the Golgi. Deficient functioning of ATP7A and ATP7B are
associated with Menkes and Wilson disease, respectively. Menkes disease [60] results
in copper deficiency due to limited absorption of dietary copper; Wilson disease [61] is a
copper-overload disorder resulting in accumulation of copper in the liver and brain [13].
Saccharomyces cerevisiae
Copper uptake in yeast occurs primarily by way of Ctr1, which features three transmem-
brane helices which form a pore across which copper is transported [62] and is regulated
by Fre1/Fre2. A second Ctr protein, Ctr3, and low affinity Smf1 and Fet4 permeases also
participate in copper uptake [63]. The Ctr proteins act on reduced copper Cu(I) which
means a metalloreduction event takes place at or near the membrane before Cu import.
Copper then is delivered to one of three cytoplamic chaperones, Ccs1, Atx1 or Cox17
[64]. Ccs inserts copper into SOD in the cytoplasm, and Cox17 delivers copper at the
mitochondrial membrane to Sco1 and Cox11 for donation to the CuA and CuB sites, re-
spectively, of CcO. Atx1 delivers copper to the P-type ATPase Ccc2 at the Golgi apparatus
for incorporation into the iron transport protein Fet3. In addition, a varying quantity of cel-
lular copper exists bound to MTs, Cup1 and Crs5, whose expression are regulated by a
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copper-responsive transcription factor Ace1 [65].
Atx1 is a 73 amino acid, namesake protein of the cytosolic copper chaperone group
[34]. S. cerevisiae Atx1 was the first metallochaperone to be discovered [34] and solu-
tion structures of Cu(I)-bound and apo forms of Atx1 [41]. Yeast mutants deficient in Atx1
suffer from impaired iron uptake due to impaired copper supply to Fet3, whose activity is
required for iron importer Ftr1 [14]. Copper transfer and complex formation have been
observed in vitro for Atx1/Ccc2 [66] [67]. Ccc2 is an integral membrane copper ATPase,
with two cytoplasmic metal-binding domains that in typical fashion are structurally similar
to Atx1, each with a fold and MXCXXC copper binding motif [68]. Surface lysine residues
provide complementary electrostatic charge to the negative surface of Ccc2a [14], with
Lys65 important for Cu delivery to Ccc2. During copper transfer it seems that Atx1 un-
dergoes structural changes, where the cysteines move to become more solvent-exposed,
while Ccc2 structure changes very little [37].
Copper trafficking in prokaryotes
Prokaryotic copper-trafficking systems have been characterised in several species such
as Escherichia coli, Pseudomonas aeruginosa, and Enterococcus hirae. A distinction can
be made between prokaryotes which utilise copper for metabolism and those who simply
possess copper defense mechanisms. Though copper trafficking networks can be smaller
in some prokaryotes, these systems must meet metabolic and structural requirements. For
example, cyanobacteria utilise copper within the photosynthetic electron transport chain
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as a cofactor for plastocyanin, which is found in the thylakoid. In order for copper to be
transported across the thylakoid membrane, in cyanobacteria copper is available in the
cytoplasm [33].
In Gram-positive bacteria such as B. subtilis, ATPase membrane transporters are suffi-
cient to remove excess copper from the cytosol. But Gram-negative bacteria require mem-
brane transporters to remove copper from the cytoplasm, but also need a way to remove
excess copper from the periplasm. One example the CusCFBA operon in E. coli, which
encodes a protein system to export copper from the periplasm and is comprised of inner
membrane pump Cus A, periplasmic proteins CusB and CusF, and the outer membrane
pump CusC [69]. [70]
Streptomyces lividans
Recently, Atx1-like copper chaperones have been characterised from the species Strepto-
myces lividans. Streptomycetes are Gram-positive, aerobic, soil dwelling-bacteria [71].
The life cycle of Streptomyces involes germination of spores which form a network of
mycelium that grows into aerial hyphae. From there, cell division takes place and the hy-
phae mature into new spores. Copper is esssential for the development of spores into
aerial mycelium [72]. The twin-arginine translocation (Tat) pathway secretes a large num-
ber of proteins with a metal cofactor. When this pathway is deleted, limited if any aerial
mycelium are produced, but can be restored by copper supplementation, suggesting this
pathway secretes cuproproteins necessary for development [71].
S. lividans possesses multiple CopZ and PIB-type ATPase genes [73]. As is typical
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for copper eﬄux systems, they are upregulated through Cu(I) binding of copper sensitive
operon repressor (CsoR). In S. lividans, CsoR regulates a 3-loci regulon comprising two
copZA-like operons and its own csoR gene. Cu stress increases the transcript levels of the
copZ and copA genes, and eventually the csoR gene. Under the transcriptional control of
CsoR are CopZ-3079 and CopZ-1317, two Atx1-like proteins. Though copper transfer from
these CopZ proteins to the ATPase has not yet been demonstrated in vitro, unidirectional
Cu(I) transfer to CsoR has been demonstrated [74]. Transcription levels suggested that
CopZ-1317 contributes much less to Cu(I) resistance than does CopZ-3079, as during
copper stress, CopZ-1317 is less than 2% of transcription.
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1.3 Copper trafficking in Bacillus subtilis
Bacillus subtilis is a non-pathogenic, soil-dwelling bacterium capable of sporulation and
formation of biofilms, the genome sequence of which was published in 1997 [75]. It is
one of the best-characterised bacteria, with the transcriptome, proteome, secretome and
metabolome all available [76]. It has been important to humans for over 1000 years, dating
back its use in fermentation of soybeans in Japan [76]. Today B. subtilis is primarily used
as an enzyme factory in biotechnology. As a member of the Bacillales, the only order of
phylum Firmicutes which use copper as a cofactor in metabolism [7], B. subtilis requires
the machinery to prevent copper toxicity and regulate copper homeostasis.
B. subtilis imports copper ions across the membrane by way of an uptake pump YcnJ,
encoded by the ycnJ gene. In copper-limiting conditions, the ycnJ gene has been shown to
be upregulated, and ΔycnJ mutants have shown reduced growth. The ycnK gene encodes
for a transcriptional regulator YcnK, which forms a dimer and acts in response to elevated
copper as a repressor for the ycnJ gene [77].
The copper eﬄux system in B. subtilis is encoded by the copZA operon, and comprises
an Atx1-like chaperone CopZ and P1B-type ATPase CopA to shuttle excess copper out of
the cell [78]. The copZA operon is transcriptionally regulated by a CsoR-like regulator [79]
encoded upstream of the copZA operon. In the presence of elevated copper levels (but
not other metals), the operon is derepressed [29], and mutation of this operon has been
demonstrated to increase copper sensitivity [78].
CopZ binds copper with high affinity to keep cytosolic levels of copper at extremely
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low concentrations [77]. The CopZ protein is 69 amino acid residues long and contains
a typical βαββαβ fold; its solution structure was published in 2001 [40]. CopA, predicted
to possess eight transmembrane domains, transports copper across the cell membrane
using energy generated by ATP hydrolysis. CopA contains two soluble MBDs (CopAa and
CopAb), that are similar in structure to CopZ, containing two βαββαβ domains connected
by a short dipeptide linker [80].
Copper binding to CopZ and to a soluble protein containing the CopA N-terminal do-
mains (denoted CopAab) has been studied. CopZ dimerises upon binding Cu(I) to form
Cu(CopZ)2 complex which binds up to 3 additional Cu(I) ions to form Cu4(CopZ)2 [35]. The
high-resolution crystal structure of Cu4(CopZ)2 indicates a tetranuclear Cu(I) cluster at the
interface of the two CopZ monomers [81]. CopAab has been shown to bind multiple Cu(I)
ions, likely leading to the formation of Cu4(CopAab)2 [80]. This dimeric species is lumi-
nescent and loss of signal above 2 Cu / protein suggests this dimeric species may bind
additional Cu(I) ions.
Binding of Cu(I) has also been characterised to the individual soluble MBDs (Co-
pAa and CopAb). CopAb binds Cu(I) with high affinity, and dimerises above a level of 1
Cu/protein, generating a weakly luminescent Cu(I) cluster [82]. CopAa too binds with high
affinity and was demonstrated by analytical ultracentrifugation to form a tetramer upon
binding of copper [83]. However, CopAa could not accommodate high copper loadings
and demonstrated instability upon addition of copper >1 / protein; this instability was not
observed in a mixture of CopAa/CopAb.
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1.3.1 Aims of the project
B. subtilis CopZ and CopAab have been demonstrated to interact in vivo, with copper trans-
fer rapid and reversible [84]. CopZ and CopAab, as well as proteins from other organisms,
have been shown to bind multiple Cu(I) ions, but spectroscopic studies have been unable to
resolve the mixture of species which forms with changing Cu(I) levels. Among other func-
tions, LMWT may play a role in cellular metal trafficking and have been shown to affect
association state of CopZ [52]. Therefore, the aims of the project are:
• Employ native electrospray ionisation mass spectrometry (ESI-MS) to analyse the
Bacillus subtilis copper trafficking system.
• Compare the copper-binding behaviour of a mixture of CopAa and CopAb to the
protein containing both domains CopAab.
• Explore the influence of BSH upon copper-binding behaviour of copper trafficking
proteins, via spectroscopy and native ESI-MS.
• Examine the formation of higher order complexes by chaperones from from S. lividans
and S. cerevisiae.
• Examine the mechanism and kinetics of copper transfer between CopZ and CopAab
via stopped flow and UV-visible absorbance.
• Purify integral membrane protein CopA.
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Chapter 2
Materials and Methods
2.1 Molecular Biology
Escherichia coli strains JM109 and BL21(DE3) were used for protein expression and grown
at 37 ◦C in Lysogeny Broth (LB) broth [85] or on LB plates supplemented with 1% (w/v) agar
(LBA). Ampicillin was used at a concentration of 100 μg/mL where appropriate. Plasmid
DNA was isolated from 5 mL or 40 mL cultures of E. coli using a plasmid prep kit (Qiagen)
which follows the alkaline lysis method [86]. E. coli cells were made competent by the
CaCl2 method [87], and stored at -80 ◦C. Transformation of E. coli cells with plasmid DNA
was carried out using the heat shock method [88]. Here, 1 μg of plasmid DNA was added
to 0.2 mL aliquots of competent cells and incubated on ice for 30 min. The cells were
heat shocked at 42 ◦C for 90 s and returned to ice for 10 min. Then 0.8 mL LB broth at
37 ◦C was added and cells were incubated at 37 ◦C for 45 min. Cells were pelleted by
centrifugation for 10 min at 5000 × g. Finally, 0.8 mL of the supernatant was removed
and the pellets resuspended in the remaining 0.2 mL before plating on LBA plates with
ampicillin and overnight incubation at 37 ◦C.
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2.2 Expression Constructs and Protein Purification
2.2.1 CopZ
The CopZ expression vector was constructed previously by Dr Margaret Kihlken by insert-
ing the copZ (yvgY ) gene into a pAlterEx-1 expression vector creating plasmid pMKNC6
for the overproduction under control of the T7 promotor, of wild-type CopZ [89] with the
sequence as listed in Figure 2.2.1.
Figure 2.2.1: Sequence encoded by pMKNC6 Primary sequence of CopZ, as
produced using pMKNC6 and the isotopically averaged molecular mass of the
sequence
WT-CopZ was produced by inoculating 2.5 L (5 × 500 mL) of LB with ampicillin at 100
μg/mL, with 5 mL of overnight culture of E. coli JM109 containing pMKNC6. These cultures
were incubated at 37 ◦C, 200 rev/min until the OD600nm reached 0.4 – 0.6, at which point
IPTG (Formedium) was added to a final concentration of 0.5 mM and the cultures incubated
at at 37 ◦C, 200 rev/min, for a further 4.5 hr. Cells were harvested by centrifugation at 5000
× g for 20 min at 4◦C and resuspended in 100 mL of 100 mM HEPES, pH 7.0. Lysozyme
(Sigma) was added to a final concentration of 0.1 mg/mL and the cells incubated at 30
◦C for 15 min at 100 rev/min. DNAse I and RNAse A (Sigma) were each added to a
final concentration of 6 μg/mL. The cells were sonicated while on ice for 2 × 8 min 20
s using a Status US200 ultrasonicator (Novara) in pulse mode (0.2 s per s) set at 50%
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power. The lysate was centrifuged at 39,000 × g for 20 min at 4 ◦C. The supernatant
was taken slowly to 75 ◦C with gentle stirring, held for 15 min and placed on ice for a
further 15 min. The suspension was centrifuged at 39,000 × g for 20 min at 4◦C. DTT
(dithiothreitol) (Formedium) was added to the supernatant to a final concentration of 15
mM, and the solution passed through a 0.45 μm filter (Sartorius). The protein solution was
then applied to 2× 5 mL HiTrap DEAE anion exchange column (GE Healthcare) previously
equilibrated with 10 column volumes (CV) Buffer A (100 mM HEPES, 15 mM DTT, pH 7.0).
The column was subsequently washed with a further 10 CV Buffer A before eluting with a 10
CV gradient of 0 to 1 M NaCl in the same buffer, with CopZ eluting at a concentration of ∼
300 mM NaCl. To remove contaminating nucleic acids, (NH4)2SO4 was added to fractions
containing CopZ (determined by SDS-PAGE analysis), to a final concentration of 3 M. The
protein solution was then loaded onto a 15 mL phenyl-sepharose hydrophobic interaction
chromatography (HIC) column (GE Healthcare), previously equilibrated with 5 CV 100 mM
HEPES, 100 mM NaCl, 3 M (NH4)2SO4, 15 mM DTT, pH 7.0. The column was washed with
20 CV binding buffer before applying a 100 mL gradient of 3 – 0 M (NH4)2SO4, with CopZ
eluting at approximately 2.4 M (NH4)2SO4. Fractions containing CopZ (as determined by
SDS-PAGE analysis) were buffer exchanged into 100 mM HEPES, 100 mM NaCl, pH 7.0
and concentrated to <2.5 mL, using an centrifugal ultrafiltration unit (Vivaspin; Millipore)
at 8000 × g and 4◦C. The protein solution was passed through a 0.45 μm filter (Sartorius)
and DTT added to a final concentration of 15 mM before applying to the Sephacryl S-100
gel filtration column, equilibrated in 100 mM HEPES, 100 mM NaCl, pH 7.0. Fractions
containing CopZ (as determined by SDS-PAGE analysis) were concentrated to <10 mL
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using centrifugal ultrafiltration unit as above, before aliquoting and flash freezing.
2.2.2 His6CopZ
The His6-tagged CopZ plasmid was constructed previously by Dr Margaret Kihlken, where
the copZ (yvgY ) gene was inserted into a pET21a (Promega) expression vector, generating
plasmid pMKNC3, which produces a protein fused to a C-terminal His6tag. Overexpression
of this plasmid in E. coli produces a protein with the sequence in Figure 2.2.2.
Figure 2.2.2: Sequence encoded by pMKNC3 Primary sequence of His6CopZ,
as produced using pMKNC3 and the isotopically averaged molecular mass of the
sequence
His6-CopZ was produced by inoculating 2.5 L (5× 500 mL) of LB with ampicillin at 100
μg/mL with 5 × 5 mL of overnight culture of E. coli BL21(DE3) containing pMKNC3. The
cultures were then incubated at 37 ◦C, 200 rev/min until the OD600nm reached 0.4 – 0.6,
when IPTG (Formedium) was added to a final concentration of 0.5 mM and the cultures
were incubated with shaking for a further 4.5 hr. Cells were harvested by centrifugation at
5000 × g for 20 min at 4◦C and resuspended in 100 mL Buffer A (20 mM Tris-HCl, 0.5 M
NaCl, 5 mM imidazole, pH 7.5). Lysozyme (Sigma) was added to a final concentration of
0.1 mg/mL and the cells incubated at 30 ◦C for 15 min at 100 rev/min. DNAse I and RNAse
A (Sigma) were added to a final concentration of 6 μg/mL. The cells were sonicated while
on ice, for 2 × 8 min 20 s using a Status US200 ultrasonicator (Novara) in pulse mode
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(0.2 s per s) set at 50% power. The lysate was centrifuged at 39,000 × g for 20 min at
4◦C. DTT (Formedium) was added to the supernatant to a final concentration of 15 mM
and the solution passed through a 0.45 μm filter (Sartorius) before loading onto 2 × 5 mL
HiTrap affinity column (GE Healthcare) charged with Ni2+, according to the manufacurer’s
instructions. The column was subsequently washed with 10 column volumes (CV) Buffer
A, and then 25 CV Buffer B (20 mM Tris-HCl, 3 M NaCl, 50 mM imidazole, pH 7.5) to
remove nucleic acid contamination. After reequilibrating in Buffer A, a 10 CV gradient from
0.05 to 1 M imidazole was applied, with His6-tagged CopZ eluting at a concentration of
∼ 300 mM imidazole. Fractions containing CopZ (determined by SDS-PAGE) were buffer
exchanged into 100 mM HEPES, 100 mM NaCl, pH 7.5 using an centrifugal ultrafiltration
unit (Vivaspin; Millipore), and concentrated to a final volume <10 mL before aliquoting and
flash freezing.
2.2.3 CopAab
Construction of the CopAab expression vector was carried out by Dr Margaret Kihlken and
Dr Chloe Singleton. The 473 bp fragment of the copA encoding the two soluble domains
of CopA was isolated and inserted into pET21a (Promega) expression vector, creating
plasmid pCSNC1 [80]. Overexpression of this plasmid in E. coli produces the protein with
sequence in Figure 2.2.3.
CopAab was produced by inoculating 2.5 L (5 × 500 mL) of LB with ampicillin at 100
μg/mL with 5 mL of overnight culture of E. coli BL21(DE3) containing pCSNC1. These cul-
tures were incubated at 37 ◦C, 200 rev/min until the OD600nm reached 0.4 – 0.6, at which
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Figure 2.2.3: Sequence encoded by pCSNC1 Primary sequence of CopAab,
as produced using pCSNC1 and the isotopically averaged molecular mass of the
sequence.
point IPTG (Formedium) was added to a final concentration of 0.5 mM and the cultures in-
cubated at at 37 ◦C, 200 rev/min, for a further 4 hr. Cells were harvested by centrifugation
at 5000 × g for 20 min at 4◦C and resuspended in 100 mL of 100 mM HEPES, pH 7.0.
Lysozyme (Sigma) was added to a final concentration of 0.1 mg/mL and the cells incubated
at 30 ◦C for 15 min at 100 rev/min. DNAse I and RNAse A (Sigma) were each added to
a final concentration of 6 μg/mL. The cells were sonicated while on ice for 2 × 8 min 20
s using a Status US200 ultrasonicator (Novara) in pulse mode (0.2 s per s) set at 50%
power. The lysate was centrifuged at 39,000 × g for 20 min at 4◦C. The supernatant was
taken slowly to 75 ◦C with gentle stirring, held for 15 min and placed on ice for a further 15
min. The suspension was centrifuged at 39,000 × g for 20 min at 4◦C. DTT (Formedium)
was added to the supernatant to a final concentration of 15 mM, and the solution passed
through a 0.45 μm filter (Sartorius). The protein solution was then applied to 2 × 5 mL
HiTrap DEAE anion exchange column (GE Healthcare) previously equilibrated with 10 col-
umn volumes (CV) Buffer A (100 mM HEPES, 15 mM DTT, pH 7.0). The column was then
washed with a further 10 CV Buffer A before eluting with a 10 CV gradient of 0 to 1 M
NaCl in the same buffer, with CopAab eluting at a concentration of ∼170 mM NaCl. To re-
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move contaminating nucleic acids, (NH4)2SO4 was added to fractions containing CopAab
(determined by SDS-PAGE analysis), to a final concentration of 3 M. The protein solution
was then loaded onto a 15 mL phenyl-sepharose hydrophobic interaction chromatography
(HIC) column (GE Healthcare), previously equilibrated with 5 CV 100 mM HEPES, 100 mM
NaCl, 3 M (NH4)2SO4, 15 mM DTT, pH 7.0. The column was washed with 20 CV binding
buffer before applying a 100 mL gradient of 3 – 0 M (NH4)2SO4. Fractions containing Co-
pAab (as determined by SDS-PAGE analysis) were buffer exchanged into 100 mM HEPES,
100 mM NaCl, pH 7.0 and concentrated to <2.5 mL, using an centrifugal ultrafiltration unit
(Vivaspin; Millipore) at 8000 × g and 4◦C. The protein solution was passed through a 0.45
μm filter (Sartorius) and DTT added to a final concentration of 15 mM before applying to the
Sephacryl S-100 gel filtration column, equilibrated in 100 mM HEPES, 100 mM NaCl, pH
7.0. Fractions containing CopAab (as determined by SDS-PAGE analysis) were combined
and dialysed against 100 mM HEPES 1 mM EDTA, pH 7.0 to remove any traces of bound
metal ions. CopAab was then dialysed against EDTA-free buffer concentrated to <10 mL
using an centrifugal ultrafiltration unit as above, before aliquoting and flash freezing.
2.2.4 CopAa
Cloning of the CopAa expression vector was carried out by Dr Chloe Singleton, where
the fragment of the copA gene encoding the first soluble domain of CopA was cloned into
pET21a (Promega), generating pCSNC2 [83]. Overexpression of this plasmid in E. coli
produces a 72-residue protein with the sequence in Figure 2.2.4.
E. coli BL21(DE3) containing pCSNC2 cultures were used to inoculate, typically, 5 ×
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Figure 2.2.4: Sequence encoded by pCSNC2. Primary sequence of CopAa,
as produced using pCSNC2 and the isotopically averaged molecular mass of the
sequence.
500 mL of Lysogeny Broth media with ampicillin at 100 μg/mL in 2 L flasks, followed by
incubation at 37 ◦C 200 rev/min until OD600nm reached 0.6. IPTG was added to a final
concentration of 0.4 mM and the cultures were incubated for a further 3 h. Cells were
harvested by centrifuging at 5,000 × g at 4◦C for 20 min. Cell pellets were resuspended in
100 mM HEPES, pH 7.0 containing lysozyme (Sigma) at a concentration of 0.1 mg/mL, and
incubated at 30 ◦C for 15 min with gentle shaking. RNase A (Sigma) and DNAse I (Sigma)
were added to a final concentration of 6 μg/mL, before sonicating cells for 2 × 8 min 20
s using a Status US200 ultrasonicator (Novara) in pulse mode (0.2 s per s) set at 50%
power. The lysate was centrifuged at 39,000 × g for 20 min at 4◦C and the supernatant
heated slowly to 50 ◦C, stirred continuously for 15 min, and placed on ice for a further
15 min. The suspension was centrifuged at 39,000 × g for 20 min at 4◦C. Dithiothreitol
(Formedium) was added at a final concentration 5 mM to the supernatant, which was filtered
at 0.45 μM (Satorius) before applying to 2 × 5 mL HiTrap Q anion-exchange column (GE
Healthcare), where the protein was eluted using a 0 –1 M NaCl gradient, with CopAa eluting
at approximately 550 mM NaCl. To fractions containing CopAa (determined by SDS-PAGE
analysis), bulk precipitation was carried out to separate protein from contaminating nucleic
acid, by adding (NH4)2SO4 to a particular concentration (% w:v), incubating 1 hour at 4◦C
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with gentle stirring, then centrifuging at 39,000 × g for 20 min at 4◦C. The first cut at 60%
w:v led to precipitation of contaminating proteins, with the majority of CopAa located in
the supernatant. The second and third cuts at 80% w:v and 90% w:v (NH4)2SO4 resulted
in the majority of protein including CopAa in the pellet, with contaminating nucleic acid
washed away in the supernatant. Semi-pure CopAa was concentrated to<2.5 mL, using an
centrifugal ultrafiltration unit (Vivaspin; Millipore) at 8000 × g and 4◦C. The protein solution
was passed through a 0.45 μm filter (Sartorius) and DTT added to a final concentration of
15 mM before applying to a Sephacryl S-100 gel filtration column, equilibrated in 100 mM
HEPES, 100 mM NaCl, pH 7.0. Fractions containing CopAa (as determined by SDS-PAGE
analysis) were combined, aliquoted and flash frozen.
2.2.5 CopAb
Cloning of the CopAb expression vector was carried out by Dr Chloe Singleton, where the
fragment of the copA gene encoding the second soluble domain of CopA was cloned into
pET21a (Promega), generating pCSNC3 [82]. Overexpression of this plasmid in E. coli
BL21(DE3) produces a 74-residue protein with the sequence in Figure 2.2.5.
Figure 2.2.5: Sequence encoded by pCSNC3. Primary sequence of CopAb,
as produced using pCSNC3 and the isotopically averaged molecular mass of the
sequence.
E. coli BL21(DE3) cultures containing pCSNC3 cultures containing ampicillin at 100
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μg/mL, were used to inoculate 5 × 500 mL of Lysogeny Broth media in 2 L flasks, followed
by incubation at 37 ◦C and 200 rpm until OD600nm reached 0.4 – 0.6, when IPTG was
added to a final concentration of 0.4 mM and the cultures were incubated for a further 3
hr. Cells were harvested by centrifuging at 5,000 × g at 4◦C for 20 min. Cell pellets were
resuspended in 100 mM HEPES, pH 7.0 containing lysozyme (Sigma) at a concentration
of 0.1 mg/mL, and incubated at 30 ◦C for 15 min with gentle shaking. RNase A (Sigma)
and DNAse I (Sigma) were added to a final concentration of 6 μg/mL, before sonicating
cells for 2 × 8 min 20 s using a Status US200 ultrasonicator (Novara) in pulse mode (0.2
s per s) set at 50% power. The lysate was centrifuged at 39,000 × g for 20 min at 4◦C
and the supernatant heated slowly to 75 ◦C, stirred continuously for 15 min, and placed on
ice for a further 15 min. The suspension was centrifuged at 39,000 × g for 20 min at 4◦C.
Dithiothreitol (Formedium) was added at a final concentration 15 mM to the supernatant,
and filtered at 0.45 μM (Satorius) before applying to 2 × 5 mL HiTrap Q anion-exchange
column (GE Healthcare), where the protein was eluted using a 0 –1 M NaCl gradient, with
CopAb eluting at approximately 500 mM NaCl. To remove contaminating nucleic acids,
(NH4)2SO4 was added to fractions containing CopAab (determined by SDS-PAGE analy-
sis), to a final concentration of 3 M, and centrifuged at 39,000 × g for 20 min at 4◦C. The
protein solution was then loaded onto a 15 mL phenyl-sepharose hydrophobic interaction
chromatography (HIC) column (GE Healthcare), previously equilibrated with 5 CV 100 mM
HEPES, 100 mM NaCl, 3 M (NH4)2SO4, 15 mM DTT, pH 7.0. The column was washed with
20 CV binding buffer before applying a 100 mL gradient of 3 – 0 M (NH4)2SO4. Fractions
containing CopAb (as determined by SDS-PAGE analysis) were buffer exchanged into 100
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mM HEPES, 100 mM NaCl, pH 7.0 and concentrated to < 2.5 mL, using an centrifugal ul-
trafiltration unit (Vivaspin; Millipore) at 8000 × g and 4◦C. The protein solution was passed
through a 0.45 μm filter (Sartorius) and DTT added to a final concentration of 15 mM before
applying to the Sephacryl S-100 gel filtration column, equilibrated in 100 mM HEPES, 100
mM NaCl, 15 mM DTT, pH 7.0. Fractions containing CopAb (as determined by SDS-PAGE
analysis) were buffer exchanged and concentrated, as above, to< 10 mL, before aliquoting
and flash freezing.
2.3 Protein Isolation and Chromatography
2.3.1 Anion Exchange Chromatography
Ion exchange chromatography separates proteins based upon their charge, which is con-
trolled by selecting the appropriate buffer pH. The pH at which a protein has no net charge
is its isoelectric point (pI), dictated by the number of charged functional groups. In order to
facilitate good recovery, it is desirable to operate >1.0 pH units away from the protein’s pI
to ensure it has sufficiently strong interaction with the ion exchange resin.
Anion exchange resins are coated in positively charged functional groups to bind neg-
atively charged proteins, with varied functional groups available for varied tightness of the
binding. The stationary phases used here consisted of cross-linked agarose bound to ei-
ther the weak exchanger, diethyl-aminoethyl (DEAE), or the strong exchanger quaternary
amonnium (Q), the structures of which are shown in Figure 2.3.1.
After passing a protein solution through an anion exchange column to bind negatively
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Figure 2.3.1: Anion exchange chromatography resin. Structures of the anion
exchange chromatography resins used in purification of B. subtilis copper traffick-
ing proteins.
charged proteins, a salt gradient is applied to elute the proteins gradually. As the ionic
charge of the mobile phase in increased, the salt ions compete with bound proteins for the
positively charged resin functional groups, and proteins will elute in order of the strength
of their interaction with the resin (i.e., the most weakly bound proteins elute first).
2.3.2 Immobilised Metal Affinity Chromatography
IMAC was developed [90] based upon the affinity observed between divalent metal ions
and histidine residues in solution, but immobilised to allow protein fractionation. Nitrilotri-
acetic acid (NTA) is the chelating ligand used to affix the Ni2+ to agarose [91]. Modern
microbiology and recombinant protein purification enabled the addition of oligohistidine ex-
tensions to known protein sequences, allowing their selective binding to the IMAC resin.
NTA is a tetradentate ligand for the Ni2+, leaving two valencies available for histidine im-
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idazole. This ratio has been demonstrated to be optimal for higher protein recovery with
minimal metal ion leaching [91].
Figure 2.3.2: Ni2+-NTA IMAC resin. Structural representation of a hypothetical
His6-tagged protein bound to Ni2+-NTA IMAC resin, used in purification of recom-
binant proteins such as His6-CopZ.
Clarified protein solution is passed through an Ni2+ IMAC column to selectively bind
hexa-histidine tagged proteins, with a small amount of imidazole in the mobile phase to pre-
vent non-specific binding with the aim of only the hexahistidine protein being immobilised.
Then a gradient of imidazole is applied to elute the proteins gradually as the imidazole
molecules compete for the NTA chelating ligand, hopefully eluting only the hexa-histidine
tagged protein.
2.3.3 Size Exclusion Chromatography
Size exclusion chromatography separates proteins based upon size, by filtering them through
a stationary phase that has a porosity defined to separate a particular size range. These
porous beads are packed into a column, which will have two parameters to define its use:
the volume excluding the matrix pores (void volume, V0) and the combined volume inside
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and outside the pores (total volume, Vt). The matrix should be selected with a fractionation
range such that it elutes after the V0 but within Vt [92].
Proteins elute in order of decreasing size, as larger molecules can only access the void
volume and thus take less time to traverse the column, whereas smaller molecules diffuse
into the matrix pores, causing them to elute later. For a particular protein or molecule,
its elution volume, Ve, will be affected by its shape (hydrodynamic volume) and molecular
weight. Overall, the Ve will be determined by its partition coefficient, Kav, the portion of
stationary phase it can access. This can be defined as [93]:
Ve = V0 +Kav(Vt − V0) (2.1)
which can be rearranged to give
Kav = (Ve − V0)/(Vt − V0) (2.2)
To maximise resolution, gel filtration is carried out with a small sample volume, usually 1 –
5 % of the total bed volume. Typically, SEC is carried out at moderate ionic strength (0.1 –
0.2 M) to disrupt weak electrostatic protein-matrix interactions [92].
2.4 Nucleic acid removal
Purification of B. subtilis copper trafficking proteins typically involved a step involving a high
salt wash devoted to removal of contaminating nucleic acid fragments. For His-tagged
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proteins, this was carried out with the protein bound to the Ni2+ IMAC column, but proteins
lacking a His-tag required a different approach to allow separation of nucleic acid from
protein: hydrophobic interaction chromatography (HIC) for proteins soluble at high ionic
strength; ammonium sulfate bulk precipitation for proteins insoluble at high ionic strength.
2.4.1 Hydrophobic Interaction Chromatography
Hydrophobic interaction chromatography (HIC) separates proteins based upon their hy-
drophobicity. Liquid water molecules form ordered clusters arising from intramolecular hy-
drophobic interactions. The order of this structure is disrupted at the interface with another
phase or hydrophobic molecule, where water orients itself to form a sharp interface with
the hydrophobic portion. For a water-soluble protein, hydrophobic side chains are typically
driven to the protein interior upon folding, but the minimal energy state typically will be a
thermodynamic compromise based upon the solution, relaxing the fold in some regions to
expose hydrophobic patches. HIC capitalises upon this, using a high ionic strength buffer
to enhance the interaction between the hydrophobic protein surfaces and the hydrophobic
resin. Water molecules are attracted away from the protein, enhancing protein interaction
with the hydrophobic resin.
HIC is useful after ion exchange chromatography when the sample is already in high
salt buffer. The Phenyl-Sepharose HP contains a hydrophobic aryl group attached to a
Sepharose matrix, comprised of crosslinked agarose. The solution containing the isolated
protein of interest is passed through a 15 mL Phenyl-Sepharose HP column to bind the
protein. After washing with high salt binding buffer to separate protein from contaminating
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nucleic acid, the ionic strength is decreased to elute the purified protein.
2.4.2 Bulk precipitation
Protein precipitation techniques involve altering the ionic strength of solution containing
protein(s) of interest, to decrease its solubility and separate it from the other solution com-
ponents. The ability of a particular salt to salt out is described by the Hofmeister series,
which arranges ions in order of chaotropic nature, the ability to disrupt the hydrogen bond-
ing network in solution. This type of precipitation is reversible as the protein is not pre-
cipitated through denaturation but, rather, is dehydrated due to salt ions competing for the
solvating water molecules. Though ammonium sulfate produces relatively higher precipi-
tation effects, it also promotes protein-protein interactions. Several rounds of precipitation
enabled separation of the dehydrated protein from soluble nucleic acid. A protein’s solu-
bility curve is defined by Equation 2.3.
logS = β −Ks(Γ/2) (2.3)
Here, because the constants β and Ks are characteristic of the protein, the solubility (S) of
the protein in mg/mL of solvent is controlled through alteration of Γ/ 2, the ionic strength [94].
2.5 SDS-PAGE
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) utilises an elec-
tric field to separate macromolecules in order to estimate their relative molecular mass,
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by moving them through a polyacrlyamide gel containing sodium dodecyl sulfate (SDS).
The anionic SDS will unfold protein, creating an unstructured linear chain, and imparts
a negative charge based upon protein size. Therefore all proteins in a mixture will con-
tain a roughly uniform charge-to-mass ratio, and are thus resolved by size as they migrate
through the polyacrylamide, by way of attraction to the positively charged electrode.
SDS-PAGE gels were prepared using a Hoefer SE-250 gel electrophoresis assembly.
Typically 8 × 7 cm gels were prepared at 20% acrylamide for proteins of interest <10
kDa; otherwise 15% polyacrylamide gels were used. Cell suspensions or purified protein
samples were mixed 50:50 with concentrated sample buffer (4% SDS, 20% glycerol, 100
mM Tris/HCl pH 6.8, 0.2% bromophenol blue in deionised water). DTT was added to a final
concentration of 300 mM immediately before heating cells at 100 ◦C for 10 min. Between
12 μL and 15 μL of each sample was then loaded, along with PageRulerTM Unstained Low
Range Protein Ladder (3.4 to 100 kDa), and gels run for ∼45 min at 180 V, using a Consort
E844 power source. Gels were then soaked in staining solution (40% v/v methanol, 10%
v/v acetic acid, 0.1% Coomassie Brilliant BlueTM) for 30 min, then soaked in destaining
solution (40% v/v methanol, 10% v/v acetic acid) for 2 × 1 hour, or until bands were clearly
visible.
2.6 Metal Ion Additions
Prior to the addition of Cu+, proteins were treated with 15 mM DTT in an anaerobic glove
box (Faircrest, O2 <2ppm), after which DTT was removed by buffer exchange using a PD-
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10 desalting column (GE Healthcare). Copper was added as a solution of Cu(I) prepared
from Cu(I)Cl, in 1 M NaCl, 100 mM HCl under anaerobic conditions. Additions of metal
ions during titrations were made using a microsyringe (Hamilton) into a septum-sealed
quartz cuvette. Control experiments where Cu(I) was titrated into buffer alone resulted in
no change of the spectroscopic properties of the buffer, therefore observed changes were
due to Cu(I)-binding to the protein or copper chelator.
2.7 UV-Visible Spectroscopy
UV-visible spectroscopy is carried out by measuring the energy absorbed by a sample from
light in the UV (240 – 400 nm) and visible (400 – 800 nm) wavelength range. Wavelength
and energy are related by the equation:
E = h(c/λ) (2.4)
where h is Planck’s constant and c is the velocity of light in vacuum. Photon energy between
200 and 780 nm allows excitation of outer valence electrons and selected inner shell d-d
transitions. Typically, bonding orbitals are fully populated and transitions between ground
and excited states are accommodated by electrons jumping to anti-bonding orbitals [95].
For proteins, these pi → pi* transitions are observed in the aromatic sidechains of Tyr, Trp
and Phe which absorb light in the near-UV region (240 – 300 nm) [96].
Absorbance is a dimensionless quantity representing the proportion of incident light
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intensity (Io) that is transmitted through the sample (I), and is defined by the equation:
A = log(Io/I) (2.5)
The absorbance measured by a UV-vis spectrometer is used to determine protein concen-
tration according to the Beer-Lambert Law:
A = εcL (2.6)
where A is absorbance, ε is molar extinction coefficient (units M-1 cm-1), c is protein concen-
tration (units M), L is cell path length (units cm). Each chromophoric residue contributes to
the molar extinction coefficient of a protein, but this value is dependent on the protein fold
and must be determined experimentally. Here, the molar extinction coefficients reported
for each protein have been determined experimentally previously [97]. In order to ensure
accuracy of this value, it is essential that the protein is effectively purified as contaminants
or other proteins would contribute to the absorbance. Removal of nucleic acid contamina-
tion with high-salt wash steps during purification was essential, as pyrimidine and purine
ring systems experience their own pi → pi* transitions that create overlapping absorbance
at 260 nm [95]. Also, disulfide bonds formed between two cysteine residues also give rise
to an absorbance band near 260 nm and, so, protein concentrations were calculated after
reduction of disulfide bonds using dithiothreitol.
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2.8 Circular Dichroism
Circular dichroism spectroscopy is a technique that measures the difference in absorption
by chiral molecules of left- and right-handed circularly polarised light (L-CPL and R-CPL,
respectively). Chiral molecules exist as isomers which form non super-imposable mirror
images, called enantiomers. Most amino acids, and thus proteins, are chiral.
CD occurs at wavelengths absorbed by a chiral molecule, using a polarimeter to mea-
sure the rotation of the linearly polarised wave upon travelling through the sample. Light
is passed through two monochromators, whose optics ensure light is monochromated and
linearised, before passing through a modulator.
When the resultant, circularly polarised light is passed through an optically active sam-
ple, the L-CPL and R-CPL will be absorbed to different degrees. Thus, the light becomes
elliptically polarised and thus magnitude of circular dichroism is expressed as molar ellip-
ticity [θ] (angle whose tangent is ratio of minor and major ellipse axes) or (here) as the
absorption difference, ∆:
∆(λ) = L(λ)− R(λ) (2.7)
where R and L are extinction coefficients of right- and left-handed components of light of
wavelength λ, and the units of ∆ are M-1cm-1 [98].
CD spectra of proteins are not the sum of the individual residues but depend upon
the overall protein structure, with individual elements displaying their own CD behaviour.
The far-UV spectra (<250 nm) are dominated by amide chromophores and denote ele-
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ments of secondary structure. The near-UV spectra (250 –350 nm) are dominated by pi→
pi* transitions of aromatic residues and denote ligand-binding, tertiary structure and pro-
tein folding [99]. Here, CD spectra have been recorded to establish the range of ligand
concentration over which protein conformational changes have taken place. Previous CD
spectroscopical studies have established the near-UV fingerprint of CopZ over a range of
Cu(I) / protein ratios, establishing the signal changes at (+) 265 nm and (-) 335 nm to arise
from ligand-metal charge transfer bands.
2.9 Stopped Flow UV-Visible Spectroscopy
Stopped flow rapid reaction kinetics enables rapid sample mixing and monitoring of spectral
changes with time. The stopped flow design comprises two sample syringes from which
the flow is controlled by a drive ram. When a shot is fired, a predetermined volume of each
sample is combined in a mixing chamber and driven through to an observation cell. Filling
of the subsequent stop syringe determines when flow is stopped, which simultaneously
triggers data acquisition. This enables reactions to be monitored at a controlled tempera-
ture with an extremely short dead time (< 2 ms). In order to monitor absorbance changes
associated with bidirectional copper transfer between CopZ and CopAab, samples of apo-
protein and its copper-loaded partner were loaded into the sample syringes and several
shots fired to establish a baseline before spectral acquisition. For data collection, the tem-
perature of the syringe chamber was controlled and equilibrated, and three individual shots
were averaged for each experiment.
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2.10 Layout and Function of ESI-TOF Mass Spectrometer
The ESI mass spectrometer comprises the stages: ion source, transfer, mass analyser,
and TOF/detector. A schematic of the Bruker microToF Q III ESI-MS instrument used in
this work is presented in Figure 2.11.1 [100]. After the sample is introduced to the ESI
source, by way of a continuous flow system into the spray chamber, charged analyte ions
are generated. The ion cloud is focused into a stable trajectory and guided by applied volt-
ages at progressively decreasing pressure through the subsequent stages. The transfer
stage (funnels/hexapole) focuses the ion beam and mass analysers (quadrupole/collision
cell) sort and separate ions according to their m/z ratio, with selected ions passed to the
TOF/detector where their abundance is measured as an electric signal, from which a mass
spectrum is generated.
Figure 2.10.1: ESIMS schematic Representation of the stages comprising the
Bruker micrOTOF Q III ESI-MS. The sample is introduced through the spray cham-
ber, with resulting gas-phase analytes focused in the funnels and hexapole, and
guided through the mass analysers, then to the TOF/detector which generates a
mass spectrum. Figure adapted from [100].
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2.10.1 The Ion Source and Electrospray Ionisation
Electrospray ionisation requires the generation of small charged droplets due to the pres-
ence of an electric field. The process of electrospray ionisation is depicted in Figure 2.11.2
and can be described in terms of three steps: production of charged droplets, solvent evap-
oration and final droplet ionisation, whereby the gas phase ion is formed.
The ESI process takes place when a dilute (∼ 1 – 15 μM) liquid sample passes at low
flow rate (∼ 1 – 5 μL / min) through a nebulizer needle into the spray chamber. Volatilisation
of the sample is aided by a sheath of nebuliser gas (N2) that flows around the tip of the
needle. Ionisation takes place in one of two modes, defined by the polarity applied which
creates electron flow, either to or from the capillary. Though it is common for charge to be
applied to the needle, the Bruker microToFQ III generates an electric field by applying a
high voltage to the capillary and spray shield. In positive mode, solvent oxidation occurs
and positively charged ions are selected due to the charge differential applied between
the needle and capillary; in negative mode, the opposite occurs, selecting for negatively
charged ions. Polar solvents are amenable to these redox processes; when water is used,
for example, the reactions in Equations 2.8 – 2.10 will take place [101].
2H2O −→ O2 + 4H+ + 4e− (2.8)
2H2O −→ H2O2 + 2H+ + 2e− (2.9)
H2O −→ HO∗ +H+ + e− (2.10)
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The process of charged droplet formation in positive mode, for example, would begin
when accumulation of positive charges would cause the solution to be repelled from the
capillary needle and drift toward the outlet (also influenced by flow). As the fluid meniscus
is drawn outward from the capillary tip a cone shape, called the Taylor cone [102], is formed
and the high field strength and turbulence in this region causes a fine stream of liquid to
be ejected. This stream easily breaks up into droplets of approximately 3 μm in diameter
which are subjected to further evaporation by the stream of nebulisation gas flown coaxially
around the spray needle.
Figure 2.10.2: Mechanism of electrospray ionisation. Representation of the
ESI process that takes place upon introduction of liquid sample into the spray
needle. Applied voltage between the spray needle and capillary assists with ioni-
sation and draws the gas-phase analyte ions into instrument. Drying gas (N2) that
flows countercurrent to the ion path prevents entry of uncharged components.
The potential energy is minimised within these charged droplets by arrangement of
positive charges on the droplet surface. These positive charges also help drive the flow
57
of ions toward the counterelectrode i.e., the heated, charged capillary at the entrance to
the mass analyser. Opposing forces in the droplet are surface tension which tries to re-
tain spherical shape and Coulomb repulsion between like charges which tries to break
down spherical shape. Solvent evaporation occurs rapidly between the spray needle and
capillary, decreasing the droplets’ size. As the droplet shrinks, the surface charges en-
croach upon each other until the Rayleigh limit is reached, beyond which further expansion
is facilitated by Coulombic repulsion and the droplets disburse into smaller droplets. The
offspring droplets typically hold about 2% of the mass and 15% of the charge of the parent
droplet [101] so, in addition to being smaller, the offspring droplets also feature a decreased
ratio of mass-to-charge. Successive cycles of evaporation and expansion result in forma-
tion of a nanodroplets with high charge, which undergoes a final step of desolvation to form
the charged analyte. The typical lifetime of a droplet is < 10 ms, dependent upon factors
including ion spray voltage, solvent, nebuliser gas flow and temperature.
The ions generated via ESI-MS are produced by addition (or removal) of a charged
atom/molecule (such as H+ or NH4+) and are therefore termed quasi-molecular ions; a true
molecular ion would occur through removal or addition of an electron [103]. The mecha-
nism by which charged gas-phase analytes form from the evaporated nanodroplets is under
debate, with two proposed models: the charge residue model (CRM) and the ion evapora-
tion model (IEM). In the charged residue model (CRM) [104], the final product of repeated
solvent evaporation and Coulomb fission is a final droplet sufficiently small to contain only
one analyte molecule which, upon complete desolvation, is coated with surface charges to
become the gas phase charged analyte. The ion evaporation model (IEM) [105] states that,
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as the droplet radius shrinks, the condensing surface charge generates an electric field,
which eventually is large enough to eject solvated analytes which then acquire charge as
they are emitted through the droplet surface. Generally speaking, evidence supports CRM
for larger biomolecules and IEM for small inorganic and organic ions [101].
Next the ion beam enters the ion transfer stage, where transmission is maximised
via separation of analyte ions from drying gas and solvent before transfer to the mass
analyser stage. The gas-phase charged ions are drawn into the ion transfer stages through
a charged orifice plate (spray shield) mounted in front of a metal coated glass capillary.
Heated drying gas (N2) flows from behind the spray shield, countercurrent to the ion beam,
to assist with drying (and thus generation of gas-phase analyte) and removal of uncharged
material. Curtain gas is used in the opposite direction to the ion beam flow path to ensure
only charged gas-phase ions enter the capillary [106]. A charge differential of 400 – 500 V
between the spray shield and capillary helps to focus the beam through the capillary which
exits into the tandem funnel section.
The funnels are at low pressure (∼4 mbar) and comprised of successive, spaced
rings with progressively decreasing inner diameters that generate the funnel-shaped void
through which the ions are transmitted. Beam scattering is reduced through decreased
pressure and an applied RF potential to overcome space-charge effects (repulsive force
of a dense, like-charged ion beam) [107]. A DC potential applied to the first and last rings
guides the beam toward the funnel exit. Altering the DC potential of funnel 1 affects the
acceleration of ions into funnel 2, which is manipulated to carry out in-source collision
induced dissociation (isCID) [100].
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The gas-phase charged analytes then enter a hexapole, where the pressure is lowered
to ∼ 10-4 mbar. The purpose of this stage is to effectively transport and focus the ion into
the analytical quadrupole. Again, the ion beam is aligned and focused onto the hexapole
axis by an applied RF voltage and a focusing lens at the end of the stage. Also at the end
of the stage is a gate lens which inhibits cross-talk by ”pulsing” ions through into the mass
analyser stage [100].
2.10.2 Quadrupole Mass Analysers
Prior to entering the TOF/detector stage, ions pass through the low pressure Q-q stage
comprising an analytical quadrupole and a second quadrupole (collision cell) [100]. During
MS operation, the analytical quadrupole acts as an ion guide which transmits a broad range
of masses, with low collision cell energy to avoid fragmentation. During MS/MS operation,
the analytical quadrupole acts as a mass filter to isolate a single mass, or a range of ion
masses, which can be fragmented by elevated collision cell energy [101].
The analytical quadrupole contains four rods in a square configuration that generates
a path in the + z-direction. An oscillating electric potential containing DC (U) and AC (V)
components, equal in magnitude but opposite in sign, is applied to opposing rod pairs:
φ0 = U − V cos(ωt) and − φ0 = −U + V cos(ωt) (2.11)
This oscillating field will constantly subject ions within the quadrupole to an alternating
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attractive force toward the x- and y-axis. Ion motion along the z-axis is unaffected, with
a separate electric potential driving acceleration through the quadrupole. The oscillating
potential focuses the trajectory of the ions toward the centre of the quadrupole, with ions
subjected to the net force:
F = [(x2 − y2)/r20] [U + V cos(ωt)] (2.12)
Therefore for particular values of U, V, ω, within a quadrupole of radius r0, an ion’s position,
defined by x and y, will be confined within the four rods and pass through the quadrupole
(stable ion trajectory). For other values, the ion strikes one of the rods and is lost (unstable
trajectory) [108]. A stable ion trajectory can be defined by mathematical solutions to Equa-
tion 2.12, shown in Equations 2.13 and 2.14. These have been adapted from the Mathieu
functions [109], originally derived to describe the vibrations of elliptical membranes:
qu = qx = −qy = 4zeV
mω2r20
or V = qu(m/z)
ω2r20
4e
(2.13)
au = ax = −ay = 8zeU
mω2r20
or U = au(m/z)
ω2r20
8e
(2.14)
Here, e is the magnitude of the electron charge, U is the DC potential, V is the RF potential;
for a given quadrupole, r0 and ω are constant.
A plot of these equations (Figure 2.10.3) defines regions of stability for different ions
i.e., combinations of U and V which do not let x and y reach or exceed r0. Comparing
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Figure 2.10.3: Regions of ion stability within a quadrupole The solutions to
Eqn 2.13 and 2.14 overlap to generate triangular regions of stability for ions of
different masses, as a function of U (DC voltage) and V (RF/AC voltage). The
line on the plot marks the hypothetical relationship between U and V. Hypothetical
masses (m) separated by 1 mass unit are labelled, where m1 < m2 < m3. For
MS only mode, U = 0 and broad ion transmission occurs. For MS/MS mode,
appropriate combinations of U and V enable particular ions to be selected and
transmitted to the collision cell.
the Eqn 2.13 and 2.14 illustrates that U and V have a linear relationship. Therefore a
quadrupole must be operated along this line for multiple ion detection. Due to the stability
diagram shapes, increasing the slope of this line leads to greater instrumental resolution;
the line drawn in Fig 2.10.3 illustrates mass detection at unit resolution. Therefore, in
MS/MS mode, when both DC and AC components are present, resolution and selection of
particular m/z values is possible [110].
During MS mode, the analytical quadrupole is set to RF only (U = 0) and, for low values
of V, broad mass transmission is observed. Increasing V will establish a threshold mass,
below which transmission through the quadrupole is not possible. For example in Figure
2.10.3, when U = 0, V can be selected such that all ions with masses equal or lower than
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m1 will have an unstable trajectory, and all those above m1 will have a stable trajectory and
be transmitted through the quadrupole.
After ions exit the analytical quadrupole, they enter the collision cell where pressure
is elevated slightly ( ∼10-4 vs ∼10-2 mbar), due to the presence of neutral N2 collision
gas [100]. Acceleration of ions into this stage at increased pressure leads to fragmentation,
but also increases the risk of ion loss due to molecular collision. This is compensated by
a lens at the entrance to focus the ion beam, and the RF field of the collision cell (also a
quadrupole) leads to dissipation of energy, and focuses parent and fragment ions. Because
arrival times to the detector are used to measure m/z values, ions must begin their journey
in the TOF/detector stage simultaneously, which is controlled at the end of the collision cell.
Here, during fragmentation, a transfer lens blocks transmission, while a gate lens allows
transmission. This arrangement enables adjustment of the time frame for ion accumulation
before transfer to the TOF/detector stage.
2.10.3 Time-of-Flight/Detector
The TOF/detector stage comprises three parts: orthogonal acceleration stage, reflector
and detector. Orthogonal acceleration takes place in a region containing stacked elec-
trodes, and occurs in two parts. First, incoming ion flow fills the pulsing region; ions which
pass through are excluded from analysis. Second, voltage pulses periodically deflect the
ion population upward toward the reflector. Before pulsing another ion packet upward, the
previous packet would have reached the reflector.
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The accelerated ions reach the deflector plate (an electrode) and are subjected to fur-
ther pulsed voltage, after which they are accelerated to the TOF analyser. Due to slight
variation in initial ion velocity and position within the accelerator, the final kinetic energy is
variable. An advantage of orthogonal acceleration is improved resolution, as ion penetra-
tion into the reflector aids in normalising the final kinetic energy.
Detection takes place by way of a microchannel plate collector, comprising a solid
core assembly with millions of microchannels, small pores 5 - 10 μm in diameter. Each
of them functions as an independent electron multiplier, where the ion signal is converted
and amplified into an electrical signal. This arrangement minimises saturation and occurs
rapidly (<1 ns) to improve resolution.
The mass spectra generated feature intensity on the y-axis and mass-to-charge (m/z)
ratio on the x-axis. The m/z value defines each ion measured in the detector, and is calcu-
lated by time-of-flight, acceleration voltage and length of the drift region. Determination of
m/z occurs in the field-free drift region based upon the precise time it takes to impact the
detector. Drift time is measured after ions are accelerated upward to a fixed kinetic energy
(several thousand electron-volts), when they assume different velocities depending upon
their m/z ratio.
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Chapter 3
Electrospray Ionisation Mass Spectrometry for Proteins
3.1 Introduction
The development of ”soft” electrospray ionisation (ESI) [111] was a pivotal advancement for
biomolecular mass spectrometry, as it allowed transfer of intact proteins to the gas phase
[112], enabling investigation of biomolecular assemblies up to several hundred kilodaltons
with high resolution and mass accuracy [113].
Subjecting proteins to the ESI process (Chapter 2.10) involves imparting charge via
addition or removal of a proton, generating ”quasi-molecular ions” (rather than true ions
generated via addition/removal of an electron). This is accomplished by nebulisation of
the sample in the presence of applied voltage and, though fragmentation is unlikely due
to low internal energy, molecular changes take place during the few millisecond lifetime of
the charged analyte droplet [114]. Evaporating solvent causes change in forces which bal-
ance the tertiary structure of a protein: loss of hydrophobic interactions, and enhancement
(typically) of electrostatic interactions [112], collapse of side chains, which alternately could
form stabilising hydrogren bonds with carbonyl groups [115]. The final desolvation step is
rapid (nano/picosecond range) and generates the final ”dried off” gas-phase analyte [116].
ESI-MS, like other biophysical techniques, has strengths and limitations; its interpreta-
tion requires caution and understanding of potential discrepancies between solution- and
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gas-phase observations. For example, the possibility exists that distorted equilibrium would
arise during ionisation due to radical concentration changes within the analyte droplet [113].
Another possibility is non-specific association between species in the ”final” droplet, which
do not represent an intial association in solution [117]. Thus, ESI-MS spectra should be
interpreted among a wider body of evidence. However, it has been observed that only a
small percentage of gas-phase ions result from ion-molecule interactions [118] and it has
been suggested that final desolvation occurs on a nanosecond timescale with no changes
in protein structure [119]. Non-specific final droplet interactions are likely weak and would
readily dissociate after desolvation, and can be overcome by working at low concentrations,
using solutions of high purity [120]. In addition, there is strong evidence in favour of agree-
ment between gas- and solution-phase data, for example in heat shock proteins [121],
αβ-crystallin [122], and in myoglobin and β-lactoglobulin [123].
The versatility and high sensitivity of ESI-MS makes it a powerful approach to bio-
chemical analysis. Experiments can be carried out on a short timescale using only pico-
molar amounts of protein, as opposed to the millimolar concentrations required for nuclear
magnetic resonance (NMR) or isothermal titration calorimetry (ITC) [124]. Though other
techniques such as surface plasmon resonance and fluorescence spectroscopy rival ESI-
MS in terms of sensitivity, these techniques often require modification of analyte via im-
mobilisation or tagging [113], whereas ESI-MS depends only upon the intrinsic property of
mass.
ESI-MS also can be coupled to an high-performance liquid chromatography (HPLC).
Insertion of this separation stage prior to ESI-MS allows mixtures of proteins to be resolved.
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The proteins could then be subjected to a ”top-down” analysis, where the proteins are intact
during ESI and subsequently fragmented in the mass spectrometer [116]. This approach
could also be applied in a ”bottom-up” approach, where an enzymatically cleaved protein
is separated in the HPLC, then introduced via ESI, and the fragmented peptides analysed,
or potentially fragmented further, in the MS. HPLC typically involves analysis under dena-
turing conditions, where sample purity and protein identity can be confirmed, ionisation is
encouraged (due to the increased surface area and acidified solvent), and ligand binding
is inhibited due to abolition of the ”native” protein fold and related binding sites [125].
Native ESI-MS describes experiments using volatile buffer which, coupled with the
gentle ionisation of the ESI process, enables weak, non-covalent interactions to be main-
tained. This facilitates the investigation of unfragmented analytes and their complexes,
which can be investigated under near-physiological conditions. Direct infusion of the sam-
ple into the ESI source allows a mixture of analytes to be investigated simultaneously.
The m/z and mass spectra enable identification of the analyte of interest, mass shifts as-
sociated with adduct formation, and ligand binding, and can also provide structural and
conformational information [125].
Here, ESI-MS has been utilised in analysing unfragmented copper trafficking proteins,
assessing: multimer formation, ligand binding, stoichiometry and distribution of protein
species in a mixture. This chapter contains information about the steps taken to interpret
these mass spectra and to optimise parameters during data acquisition.
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3.2 Evaluation of Protein Mass Spectra
3.2.1 Spectrum Deconvolution
Applying the ESI process to a protein sample in volatile buffer will generate gas-phase ions
which typically acquire multiple charges. In addition to varying with mass, conformation and
primary sequence, there will be fluctuation in the availability of surface-exposed sites for
ionisation, even within a sample. Thus the number of charges a given protein acquires will
vary and the resulting m/z spectrum will contain multiple peaks.
Each protein species appears as an envelope of ion peaks in the m/z spectrum, sepa-
rated by one charge, which must be resolved to obtain the neutral mass spectrum (Figure
3.2.1). This is advantageous because, even for large macromolecular assemblies, the
resulting range of mass-to-charge (m/z) ratios, are consolidated onto a scale typically ac-
commodated by mass analysers.
Figure 3.2.1: Mass spectrum before and after deconvolution The ESI-MS
generates a mass spectrum that plots relative intensity against mass to charge
ratio (left) where multiply charged species will appear as a grouping of peaks.
The process of deconvolution converts this to a mass spectrum displaying the
neutral parent mass (right).
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This group of peaks will display a roughly Gaussian distribution, with a sequential
charge state distribution i.e., there is no jump in the number of charges between peaks.
Using Figure 3.2.1 as an example, acquired in positive ion mode, simple calculations can
be made to resolve these peaks (deconvolution) [126]. In order to calculate the parent
mass Mr, the number of charges (n1 and n2) on two neighboring peaks, m/z1 (higher) and
m/z2 (lower) can be defined as:
n2 = n1 + 1 (3.1)
Using mH for the mass of a proton and assuming all charges n arise due to protonation,
m/z1 and m/z2 can be defined by:
m
z1
=
(Mr + n1mH)
n1
(3.2)
m
z2
=
(Mr + n2mH)
n2
(3.3)
inserting the expression for n2 from Eqn 3.1 into Eqn. 3.3. and using simultaneous equa-
tions to derive an expression for n1:
n1 =
(m/z2 −mH)
(m/z1 −m/z2) (3.4)
Subsequently, the value of Mr can be determined by rearranging Eqn 3.2 and inserting the
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determined value of n for the particular value of m/z1:
Mr = n1(m/z1 −mH) (3.5)
In Figure 3.2.1, without knowing Mr, the above method of charge deconvolution can be
applied (Eqn 3.4), for example, to the neighbouring m/z values 918.0 (m/z2) and 1049.0
(m/z1), with charges n2 and n1, respectively, to determine the parent neutral mass Mr.
Accordingly:
n1 = (m/z2 −mH)/(m/z1 −m/z2) = (918− 1)/(1049− 918) = 7
Therefore using this value for n1, Mr can be calculated from Eqn 3.5:
Mr = n1(m/z1 −mH) = 7(1049− 1) = 7336
This straightforward, arithmetic method works well for single compounds or mixtures
where peak envelopes do not overlap. However, in many cases manual assignment would
be too difficult and, therefore, an automated method is typically used, with software equipped
with the capability for charge deconvolution; here, the algorithm used is Maximum Entropy
Charge Deconvolution [127]. This utilises all spectral data to generate parent spectra, and
was designed to overcome the noise occurring in native mass spectra, and reduce arte-
facts arising from overlapping peak envelopes [128]. This allows automatic generation of
a neutral parent mass spectrum from charge state envelopes which appear in the mass
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spectrum.
The mass spectrum before and after deconvolution is scaled in percent relative inten-
sity, which enables spectra from different experiments to be compared on a universal scale.
The raw MS data results as ions are summed as they pass the microchannel plate detector
(see Chapter 2), generating absolute counts of individual ions. However, depending upon
the length of experiment and number of species in solution, the total counts and maximum
value of total count will be variable. Therefore these values are typically normalised to the
highest absolute count, which becomes 100% relative intensity. Percentages which are
normalised to the most intense peak will ”weight” species differently compared to the case
where percentages represent a propotion of total molecules present.
ESI-MS charge deconvolution generates a neutral mass based upon the number of
observed charges (protons in positive ion mode) on each m/z peak. Depending upon
the protein’s initial charge in solution, the number of additional protons acquired may not
equal the observed charge state. Thus, though the mass spectrum prior to deconvolution
indicates the number of protons bound in the gas phase, the neutral mass does not re-
port on solution phase characteristics such as charge or number of protons retained by
side chains [129]. Furthermore, in the case of a protein with a metal ion bound, the posi-
tively charged ion will offset the number of protons bound to achieve the observed charge
state [106]. Here, it has been assumed that the charge state observed is attributable to
protonation, except where mass shifts such as those due to Cu+ are observed.
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3.2.2 Exact Mass Analysis
Confirming the exact mass of the protein of interest is essential in order to identify it and
monitor mass shifts. The reported mass for a protein is usually its isotopically averaged
neutral mass, with the mass contribution of each element weighted according to its natural
abundance. For example, the mass of carbon is 12.011 due to the natural abundance of
12C = 98.9% and 13C = 1.1%, but the proportion of carbon-13 in a protein structure might
vary slightly from 1 out of every 100 carbon atoms. Therefore, a protein sample will contain
a mixed population of molecules that, in a mass spectrum, is displayed as a cluster of peaks
(Figure 3.2.2), or envelope, centred upon the isotopically averaged mass.
Figure 3.2.2: CopZ isotopic distribution observed by ESI-MS. Because the
isotopic composition of a protein will vary from molecule to molecule, the mass of
the most intense peak (most abundant isotopomer) could vary from spectrum to
spectrum. Thus the species mass is taken from the peak centroid.
The most intense peak in the mass envelope is greater than the protein’s monoiso-
topic mass, reflecting the increased likelihood of heavier isotopes being included in the
molecular structure for larger molecules such as proteins. With increased protein mass,
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the resolution of these isotopomers decreases as the likelihood of individual chemical for-
mulas approaches unity, resulting in a more smoothed mass spectrum peak, centred on
the averaged neutral mass. For peptides and smaller proteins, such as CopZ (Mr = 7338.1
Da), resolution of isotopic peaks is possible. Figure 3.2.2 illustrates the overlaid mass
spectra expected and acquired of CopZ, illustrating the isotopic resolution compared to
that predicted based upon its sequence.
3.2.3 Charge State Distribution
The soft ionisation and high resolution of ESI-TOF-MS affords studies of intact proteins,
where the identity of proteins and their complexes can be confirmed after the multiply
charged mass spectrum is deconvoluted to provide the neutral mass spectrum. In addition
to reporting on species’ masses, interpretation of the mass spectrum prior to deconvolution
provides additional insight, as the degree of protonation reports on the protein conforma-
tion. A higher charge state (greater value of z) corresponds to more sites available for
protonation reflecting the higher surface area of denatured or less folded proteins [106]. In
addition, a protein with many different charge states could indicate variability in surface ac-
cessibility arising if the protein has a less regular, unfolded structure. In short, more tightly
folded proteins tend to have lower net charges (lower values of z) and lower distribution
of charge states (fewer peaks in the m/z spectrum). Figure 3.2.3 shows the charge state
distribution arising from folded and unfolded protein in the mass spectrum of a sample of
CopAab under different conditions.
The presence of denaturing solvent increases the number of peaks present and shifts
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Figure 3.2.3: Mass spectra depicts folded and unfolded protein. Mass spec-
tra recorded of CopAab: A) LCMS, denaturing, depicting entirely unfolded protein
B) native, in AmmOAc + MeOH depicting partially unfolded protein C) native 0 Cu
/ protein, depicting folded protein D) native 4 Cu / protein + acetic acid, depicting
partially folded protein, some with Cu(I) bound E) native 4 Cu / protein depict-
ing folded protein with Cu(I) bound. The spectra illustrate that a single protein or
mixtures of different protein species (here, monomer/dimer) in the neutral mass
spectrum can be observed as multiple peak envelopes (separated or overlapping)
prior to deconvolution. In addition, the monomer only spectra (A – C) illustrate that
denaturing solvent leads to less folded protein, observed by a shift in m/z values.
For simplicity, here, peaks not annotated.
the peak envelope, reflecting protein being in a less folded state (3.2.3A – C); this can
arise from denaturation or other structural changes. Variations in solution phase conditions
can partially destabilise the protein, allowing binding domain or mechanistic information
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to be interpreted [122]. For example, the Cd binding behaviour of α and β domains of
human metallothionein was tested at variable pH where changes in charge state distribution
illustrated structural and cadmium-binding changes [130]. Shifts in charge state distribution
and numbers of peaks can be used to denote multiple conformations/states of the same
protein, leading to multiple peak envelopes, for example, if a protein forms multimers (see
Figure 3.2.4).
Figure 3.2.4: Multiple overlapped charge state envelopes observed for Atx1
upon Cu(I) binding. Atx1 from S. cerevisiae in the presence of Cu(I) forms
monomer (M), dimer (D) and trimer (T), denoted by the multiple overelapping
peak envelopes which appear in the mass spectrum. The charge envelope of
each species has a quasi-Gaussian distribution and the charge states are se-
quential. Overlapped charge states are even numbered, and are grouped by mul-
tiples of the oligomeric state. Depending upon the degree of envelope shift, the
odd-numbered charge states tend not to overlap.
Here, because the relative surface area to mass changes upon multimer formation,
the degree of protonation will increase, but not linearly. For example, dimerisation will not
lead to a doubling of the charge state [131] [132]. Because multimers do not increase their
charge state directly in proportion to the number of protomers involved, the m/z ratio does
not shift as a multiple of the mass increase, resulting in staggered peak envelopes.
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3.3 Adapting ESI-MS method parameters
The goal of subjecting a protein to ESI under native solution conditions is to generate gas-
phase analytes which are merely ”dried off”, mimicking as closely as possible the solution
phase situation [119]. In order to achieve this goal, the method must be adapted to ensure
thorough but gentle ionisation of a pure sample, and adjust the parameters on the ESI-MS
instrument to appropriately visualise the species present in the sample.
To ensure sufficient sample quality requires high purity, removal of ion suppressants
and contaminants, removal of detergents and plasticisers, and limited salt concentration
to prevent ion suppression and mass shifts caused by adduct formation. In addition, a
decreased amount of analyte can actually increase sensitivity, and can be achieved by
either lowering sample concentration or flow rate [106].
Ultimately, optimisation of parameters in each stage of analysis must be customised
for a protein’s stability and gas-phase behaviour, as well as the experimental aims. When
analysing the copper trafficking proteins, once pure sample was generated for ESI-MS,
the proteins ionised well, with adjusting parameters to visualise the different species rep-
resenting the major experimental challenge.
3.3.1 Source and Transfer Stages
Parameters in the ESI-MS source affect volatilisation and flow of ions into the transfer stage,
ensuring maximal ionisation and transmission. Aerosol formation and solvent evaporation
can be influenced by the nebulisation gas pressure, and the flow rate and temperature
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of drying gas. Ionisation efficiency can be increased by adjusting the electrospray nee-
dle voltage and voltage gradient between needle and shield/capillary. However, here a
balancing act is required where maximal ionisation takes place without thermally induced
protein denaturation or “in-source decay” caused by high energy collisions [106]. For cop-
per trafficking proteins, these parameters were adjusted slightly to minimise appearance
of denatured protein with no major loss of ionisation intensity.
Figure 3.3.1: In-source collision induced dissociation (isCID). The process
of isCID is carried out when voltages are adjusted within the transfer funnels,
causing collision of analyte with neutral gas. Here, the effect of this process is
shown for copper-loaded CopZ when the voltages are set at: A) 0 eV, B) 20 eV
C) 40 eV, D) 60 eV, E) 80 eV. Spectral changes illustrate breakdown of dimeric
protein species (m/z = 1675).
The first low pressure region containing the transfer funnels is the location of in-source
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collision induced dissociation (isCID), where gas-phase analyte is accelerated against inert
gas. This leads to increased internal energy which can be used to fragment a complex
into subunits, remove salt/solvent from the analyte of interest, or potentially break covalent
bonds resulting in a fragmented protein [133]. The effect of isCID upon CopZ is shown in
Figure 3.3.1, where increasing between 0 – 80 V first led to increased overall ionisation (0
– 35 V), which is likely a result of improved focusing of the ion beam through the funnels
and increased throughput into the Q-q stage. Subsequently (35 – 80 V), a decrease in
intensity of the m/z = 1675 peak was observed.
In order to maximise transmission but prevent multimer breakdown, experiments using
CopZ were carried with this parameter at 35 eV. For CopAab, increased ion intensity did not
result from increased isCID voltage and therefore was set to zero in CopAab experiments.
3.3.2 Q-q Stage
The Q-q stage enables selection or enhancement of regions of interest of the mass spec-
trum, leading to improved resolution and signal intensity, and allowing changes in the an-
alytes of interest to be visualised [134].
As described in Section 2.10.2, Collision RF (CRF) voltage is the AC component of
the oscillating electric potential applied within a quadrupole which establishes the threshold
for mass transmission. Increasing the CRF voltage results in an unstable trajectory for
lower m/z ions. Figure 3.3.2 illustrates the effect upon the mass spectrum of copper-
loaded CopZ of CRF voltage. Optimisation was carried out at multiple copper loadings to
ensure sufficient peak intensities of the overlapping monomeric/dimeric peak envelopes
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Figure 3.3.2: Effect upon mass spectrum of CRF voltage. Within the mass
spectrum of CopZ (prepared at 2 Cu / protein) when all other parameters held
constant, higher charge state peaks are suppressed with increased values of CRF
voltage: A) 600 V, B)1600 V, C) 2400 V, D) 3200 V. The maximum possible value
of CRF is 3800 V.
was attained as the copper level was changed, which established the experimental CRF
voltage value of 2200 V. This also enabled exclusion of the higher charge state peaks,
which represent unfolded protein that cannot bind metal, in order only to allocate intensity
of folded protein to the deconvoluted mass spectra.
When a single value of CRF voltage does not enable multiple regions of the spectrum
to be observed, its value can be fluctuated using the stepping function. This divides the
acquisition time (weighted as %) between multiple values in order to visualise all species of
interest. Figure 3.3.3 illustrates the effect of the stepping function upon the mass spectra
of copper-loaded CopAab, and shows how stepping can be used to create a combined
spectrum focused on different spectral regions. In order to effectively visualise all species
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Figure 3.3.3: Stepping of CRF Voltage. During acquisition, increasing the
CRF voltage leads to increased intensity of a progressively decreasing charge
state. The stepping function allows this parameter to be fluctated within an exper-
iment, and different regions of the spectrum can be observed together. A) 650 V
monomeric peaks dominant; B) 2200 V, better resolution of the dimeric peaks; C)
stepping: 90% at 2000 V, 10% at 3600 V, similar to previous; D) stepping: 75%
at 2000 V, 25% at 3600 V, marked increase in dimer, decrease in monomer; E)
3600 V, near removal of monomer
together, stepping parameters were tested for multiple copper loadings of the protein, with
the assistance of the automated tuning in the software.
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Chapter 4
Studies Of Cu(I) Binding To CopZ
4.1 Introduction
The copper chaperone from Bacillus subtilis, CopZ, is a 69-amino acid residue protein con-
taining a ferredoxin-like βαββαβ fold in both apo- and Cu(I)-bound forms [40]. Its conserved
MXCXXC Cu(I)-binding motif provides thiolate coordination to the Cu(I) at the end of loop
1, and binds Cu(I) with extraordinarily high affinity, β2 ∼ 1022 M-2 [84]. The solution struc-
ture (see Figure 7.1.2) of apo- and Cu-bound CopZ indicate a monomeric species with the
Cu(I) ion bound by the two cysteines and a third ligand, likely the sulfur from dithiothreitol
(DTT) [40]. In addition to a CopZ monomer with a single Cu(I) ion bound, in the absence
of low molecular weight thiols (LMWT) such as DTT (see below), CopZ has been demon-
strated in vitro to dimerise upon binding Cu(I), coordinating between one and four Cu(I)
ions [89]. A crystal structure of CopZ revealed a tetranuclear copper cluster coordinated
at the dimer interface (Figure 4.1.1), with mixed trigonal and digonal Cu(I) coordination by
Cys-13, Cys-16 and His-15 from each monomer [81]. Currently, the exact physiological
relevance of the different forms of CopZ is unclear.
Also thought to be involved in managing cellular copper are non-proteinaceous cyto-
plasmic LMWT found across biology, such as glutathione (GSH) in eukaryotes [25] [135],
mycothiol (MSH) in actinomycetes [26] [136], as well as coenzyme A and cysteine [137].
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Figure 4.1.1: Crystal structure of Cu4(CopZ)2. Ribbon diagram derived from
the crystal structure of CopZ solved at 1.5 A˚ resolution [81], depicting two CopZ
monomers coordinating a tetranuclear Cu(I) cluster. Cysteine sulfurs are shown
in yellow, copper ions shown in orange.
In 2009, it was discovered that low G+C Gram-positive bacteria (Firmicutes) such as Bacil-
lus subtilis contains a distinct LMWT, bacillithiol (BSH), which is the α-anomeric glycoside
of L-cysteinyl-D-glucosamine with L-malic acid [27]. LMWTs are known to bind Cu(I) with
reasonably high affinities (∼ 10-14 M for DTT) [138], or form heterocomplexes, as observed
via NMR for CopZ, where a DTT-Cu-CopZ species was observed [40]. Through competi-
tion for Cu(I), LMWT and copper trafficking proteins may function in concert to ensure the
cellular free copper concentration is virtually zero.
Previous in vitro studies clearly have revealed multiple Cu-bound forms of dimerised
CopZ in the absence of LMWTs, while in the presence of LMWTs the copper-binding capac-
ity of dimerised CopZ and other metallochaperone dimers [139] [52] was reduced. How-
ever, it is unknown exactly what effect this has on the CopZ speciation as spectroscopic
techniques do not allow resolution of individual species within a mixture.
In order to monitor the individual species formed as CopZ responds to a fluctuation
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in levels of copper in the absence and presence of LMWT, electrospray ionisation time-of-
flight mass spectrometry (ESI-TOF-MS) was employed (see Chapter 3 for methods opti-
misation). ESI-MS has been used to characterise the metal-binding stoichiometry of other
metalloproteins including metallothionein [140] and SlyD [134], along with copper chap-
erones CopZ Enterococcus hirae [141] and porcine Cox17 [142]. Knowing the relative
affinities of BSH and CopZ for Cu(I), and the species which form in a mixture of CopZ,
Cu(I), and BSH, provides insight into the cooperative role of BSH and CopZ in managing
cytoplasmic Cu(I) in B. subtilis.
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4.2 Materials and Methods
4.2.1 CopZ Sample Preparation For ESI-MS
CopZ was prepared as described in Section 2.2.1. Mass spectrometry samples of CopZ
were prepared by first adding 15 mM DTT (Formedium) and removing reductant by passage
down a G25 Sephadex column (PD10, GE Healthcare) in an anaerobic glovebox (Faircrest
Engineering, O2 concentration < 2 ppm) using 20 mM ammonium acetate, pH 7.4 (Sigma)
as the elution buffer. Protein concentrations were calculated using an extinction coefficient,
ε276 nm, of 1450 M-1 cm-1 [89]. UV-visible absorbance spectra were recorded on a Jasco V-
550 spectrophotometer. To prepare Cu(I)-bound CopZ samples, a deoxygenated solution
of Cu(I)Cl prepared in 100 mM HCl and 1 M NaCl was added to anaerobic, reduced CopZ
using a microsyringe (Hamilton) in an anaerobic glovebox. Unbound Cu(I) was removed by
passage of the sample down a G25 Sephadex column (PD10, GE Healthcare) equilibrated
with 20 mM ammonium acetate pH 7.4. The protein sample was diluted with the same
buffer to a working sample concentration of 15 μM.
4.2.2 Electrospray Ionisation Mass Spectrometry
Mass spectra were acquired using a Bruker micrOTOF-QIII electrospray ionisation (ESI)
time-of-flight (TOF) mass spectrometer (Bruker Daltonics, Coventry, UK), in positive ion
mode. The ESI-TOF was calibrated in the m/z range 300–2200 using ESI-L Low Concen-
tration Tuning Mix (Agilent Technologies, San Diego, CA). Native protein samples were
introduced to the ESI source via a syringe pump (Cole-Parmer) at 5 μL/min, and data ac-
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quired for 3 min, with ion scans between 50 – 3000 m/z. MS acquisition was controlled
using Bruker oTOF Control software, with parameters as follows: dry gas flow 4 L/min,
nebuliser gas pressure 0.4 Bar, dry gas 130 ◦C, capillary voltage 4500 V, offset 500 V,
isCID energy 35 eV, collision RF 2200 Vpp. LC-MS experiments were performed using
an UltiMate 3000 HPLC system (Dionex, Sunnvale, CA, USA). A 1 μL injection volume
of protein in 2% acetonitrile was applied to a ProSwift R© reversed phase RP-1S column
(4.6 × 50 mm, Dionex) at 25 ◦C. Gradient elution was performed at a flow rate of 200
μL/min using solvents A (0.1% formic acid) and B (acetonitrile, 0.1% formic acid), with the
following chromatographic method: isocratic wash (2% B, 0–2 min), linear gradient from
2–100% B (2–12 min), followed by an isocratic wash (100% B, 12–14 min) and column
re-equilibration (2% B, 14–15 min). MS acquisition parameters were as follows: dry gas
flow 8 L/min, nebuliser gas pressure 0.8 Bar, dry gas 240 ◦C, capillary voltage 4500 V,
offset 500 V, collision RF 650 Vpp. Processing and analysis of MS experimental data was
carried out using Compass DataAnalysis version 4.1 (Bruker Daltonik, Bremen, Germany).
The spectra were deconvoluted using the ESI Compass version 1.3 Maximum Entropy de-
convolution algorithm over a mass range of 7000–16000 Da. Overlapping peak envelopes
were deconvoluted manually. Exact masses were determined from peak centroids, with 3-
point Gaussian smoothing applied to mass spectra of samples containing BSH and GSH.
4.2.3 Preparation Of CopZ Samples For Thiols ESI-MS
For ESI-MS experiments, CopZ was purified and prepared as described in section 2.2.1.
ESI-MS experiments were carried out in 20 mM ammonium acetate, pH 7.4; CD and UV
85
experiments were carried out in 100 mM MOPS, 100 mM NaCl, pH 7.5. Thiol experiments
were carried out using GSH (Sigma), DTT (Formedium) or BSH (synthesised as described
previously [27]) (Figure 4.2.1), prepared anaerobically using deoxygenated LC-MS grade
water (HiPerSolv, VWR)). Protein solutions were prepared using aliquots of 1.0 Cu(I) per
CopZ, prepared as above, where thiol solution was added to yield ratios of 5, 10, or 25 thiol
per protein.
Figure 4.2.1: Structures of LMWT compounds used in ESI-MS experiments.
Structures of LMWT used in ESI-MS experiments: glutathione (GSH), the eukary-
otic analog of bacillithiol; dithiothreitol (DTT), a common in vitro reducing agent;
bacillithiol (BSH), the cytoplasmic LMWT found in B. subtilis.
4.2.4 Determination of Cu(I)-BSH binding affinity
BSH was synthesised as described previously [143], and dissolved under anaerobic con-
ditions using deoxygenated LC-MS grade water (HiPerSolv, VWR). The affinity of BSH
for Cu(I) was determined through competition experiments with bathocuproine disulfonate
(BCS), a Cu(I) chelator which forms a 2:1 complex, [Cu(BCS)2]3-, that exhibits an absorp-
tion band at 483 nm with ε483nm = 13,300 M-1 cm-1 [144].
For the titration, 2.5 μL additions of 60 mM BSH were made in an anaerobic glove box
to a 8.95 μM Cu(BCS)2 solution in 100 mM MOPS, 100 mM NaCl, pH 7.5, containing 2
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μM dithionite or ascorbate to scavenge trace oxygen and ensure copper existed solely as
reduced Cu(I). After each BSH addition, in a septum-sealed cuvette, samples were left to
equilibrate for 10 min before spectra were recorded. The A483nm values were used to cal-
culate changes in concentration of [Cu(BCS)2]-3 (as copper was transferred to Cu(BSH)2),
from which the concentrations of Cu(BSH)2, free BSH and free BCS could be determined.
Kex =
β2(BSH)
β2(BCS)
=
[CuBSH2][BCS
2−]2
[Cu(BCS)3−2 ][BSH]2
(4.1)
β2(BSH) = Kexβ2(BCS) (4.2)
The affinity of BSH for Cu(I) was calculated using Eqn 4.1 and 4.2, [84] and assuming
that BSH forms a 2:1 complex with Cu(I), as would be expected for a monothiol low molecu-
lar weight species. Here, Kex is the exchange equilibrium constant for competition between
BSH and BCS. The overall formation constant for Cu(BCS)2, β2, is a well-established way
to define affinity of stepwise complex formation [145] (log β2 = 19.8 [144]). The acid-base
properties of BSH indicate that Cu(I)-binding is likely to be pH-dependent [143] and so the
value determined here is an apparent β2 formation constant at pH 7.5.
4.2.5 Spectroscopic Methods
UV-visible absorbance spectra were recorded on a Jasco V-550 spectrophotometer as de-
scribed in Chapter 2. Near-UV CD spectra were recorded using a Jasco J-810 spectropo-
larimeter with a slit width of 2 nm. Intensity is expressed as Δε in units of M-1 cm-1. Prior
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to all Cu(I) addition experiments, CopZ was reduced with excess DTT under anaerobic
conditions and buffer exchanged to remove DTT. Protein concentrations were calculated
using an extinction coefficient, ε276 nm, of 1450 M-1 cm-1 [89], before anaerobic addition of
BSH. Additions of Cu(I) to CopZ were made using a microsyringe (Hamilton) to a 1 cm
pathlength septum-sealed cell.
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4.3 Results: ESI-MS Studies Of Cu(I) Binding To CopZ
4.3.1 LCMS of B. subtilis CopZ
The mass spectra under denaturing conditions of CopZ, (apo- and at 1 Cu / protein), before
and after deconvolution, are shown in Figure 4.3.1. Prior to deconvolution, the mass spec-
tra displayed an envelope of multiply charged molecular ions with m/z values corresponding
to [M+nH]n+/n, where M is the molecular mass and n the number of protons carried by the
protein (see Chap 3). Under denaturing conditions, the m/z spectra of apo-CopZ and 1 Cu
/ CopZ both displayed six peaks with charges +5, +6, +7, +8, +9 (Figure 4.3.1A and B).
Figure 4.3.1: Charge state analysis of CopZ via LCMS The mass spectra be-
fore and after deconvolution of: A) apo-CopZ B) 1.0 Cu / CopZ, obtained under
denaturing conditions of LCMS. The m/z spectra are shown on the left with the
charge state of each peak labelled; monomer and dimer regions of the corre-
sponding mass spectra are shown on the right, the protein species labelled and
the symbol () = acetonitrile adduct.
Deconvolution of the peaks in the spectrum of apo-CopZ gave a molecular mass of
7338.1 Da, in agreement with the predicted mass of CopZ (7338.1 Da). Deconvolution of
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the peaks in the spectrum of CopZ at 1 Cu / protein yielded a peak with a molecular mass
of 7337.0 Da, in reasonable agreement with the predicted mass. Despite the fact that the
sample was prepared with Cu(I), no peaks corresponding to copper-bound species were
observed under denaturing conditions.
4.3.2 Native ESI-MS of B. subtilis CopZ
To investigate the Cu(I)-dependent speciation of CopZ and, in particular, the formation of
dimeric CopZ, native MS spectra at 0, 0.5, 1.0, 1.5 and 2.0 Cu(I) per protein were recorded,
following the approach outlined in Chapter 3. The m/z spectrum of apo-CopZ (Figure
4.3.2A) displayed a peak envelope containing only three major peaks with charges +4, +5
and +6. Compared to the denatured spectra, this spectrum displayed fewer major peaks
with the peak envelope shifted toward higher m/z values, reflecting differences under native
conditions, where the protein is folded. Fewer charges were a result of the decreased
surface area of folded protein, and fewer major peaks resulted from a more tightly folded
structure [146].
The mass spectra obtained with progressively increasing proportions of Cu(I) / protein
(Fig 4.3.2 B – E) displayed a similar set of charged species together with an additional peak
envelope with charges +8 and +9. This clearly represented a second form of the protein.
The progressive changes in peak distribution in the mass spectra illustrated the changes
which occurred in CopZ speciation. The monomer peak envelope displayed no change in
charge state distribution upon copper binding. This suggests that CopZ was folded with no
major structural rearrangements before and after copper binding occurs.
90
Figure 4.3.2: Mass spectra for CopZ at varied Cu(I) levels. Native m/z spec-
tra acquired of CopZ, reconstituted with: A) 0 Cu/CopZ, B) 0.5 Cu/CopZ, C) 1.0
Cu/CopZ, D) 1.5 Cu/CopZ and E) 2.0 Cu/CopZ. The charge states are labelled,
with +4, +5, +6 corresponding to the monomer peak envelope, and +8, +9 to the
dimer peak envelope. Shifts in peak envelope intensities as Cu(I) level increased
reflect the progression toward increased proportion of dimeric species.
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4.3.3 Cooperative Formation Of Cu4(CopZ)2 Detected By ESI-MS
The mass spectra after deconvolution at 0, 0.5, 1.0, 1.5 and 2.0 Cu(I) per protein are
presented in Figure 4.3.3. Under native conditions, these spectra illustrated the ability of
CopZ to bind Cu(I), and revealed the metalloforms present in the samples at each copper
loading. The apo-CopZ spectrum contained predominantly CopZ with a small proportion of
disulfide-bonded (CopZ)2. The native mass spectra also contained sodium adduct peaks of
low intensity which, compared to the mass spectra generated under denaturing conditions
of LCMS (Figure 4.3.1A and B), illustrated one of the issues arising when directly infusing
protein samples in aqueous buffer.
At 0.5 Cu / CopZ (Figure 4.2.3B), the predominant species is CuCopZ, with a substan-
tial portion of CopZ and low-intensity dimer peaks also observed. At 1.0 Cu(I) per CopZ
(Figure 4.3.3C) a more diverse mixture of metalloforms was observed with a noteworthy
increase in the dimer peak envelope, but the majority of peak intensity was still associated
with the monomer peaks.
As the copper loading was increased further to 1.5 and 2.0 equivalents of Cu(I) per
CopZ (Figure 4.3.3C and D), a continued progression toward increased dimer and de-
creased monomer peak intensities was observed, with the predominant copper-bound
peak being Cu4(CopZ)2. However, at all copper loadings, a high proportion of apo-CopZ
was present.
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Figure 4.3.3: Deconvoluted mass spectra for CopZ at varied Cu(I) levels.
Native mass spectra acquired of CopZ in 20 mM ammonium acetate, pH 7.4, re-
constituted with: A) 0 Cu/CopZ, B) 0.5 Cu/CopZ, C) 1.0 Cu/CopZ, D) 1.5 Cu/CopZ
and E) 2.0 Cu/CopZ. The protein species are labelled and symbols used as fol-
lowed: (♦) = Na adduct, (+) = loss of H2O (•) = ACN adduct. Peak shifts as
Cu(I) level increased reflect a progression toward dominant copper-bound species
Cu4(CopZ)2.
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The relative intensities and exact masses of observed species are shown in Table 4.1.
The exact masses were mostly within 1 Da of the predicted mass, with the most significant
departures being for low-intensity peaks, when the peak centroids were likely influenced
by neighbouring sodium adducts.
Table 4.1: Species observed via ESI-MS for CopZ at varied Cu(I) levels. Observed
masses and relative intensities of species in native mass spectra of CopZ prepared at 0.5,
1.0, 1.5 and 2.0 Cu / protein.
Species Pred (Da) 0.5 Cu / CopZ 1.0 Cu / CopZ 1.5 Cu / CopZ 2.0 Cu / CopZ
CopZ 7336.1 71.7% 7336.5 100% 7336.3 100% 7336.3 100% 7336.1
CuCopZ 7399.7 100% 7400.7 27.4% 7400.0 13.9% 7399.0 18.2% 7398.0
(CopZ)2 14672.2 2.6% 14672.3 12.0% 14672.8 13.9% 14673.1 10.4% 14672.6
Cu(CopZ)2 14735.7 0% – 2.6% 14735.6 1.4% 14735.1 1.6% 14735.1
Cu2(CopZ)2 14799.2 7.1% 14802.0 3.7% 14801.2 0% – 0% –
Cu3(CopZ)2 14862.7 11.5% 14864.1 24.3% 14864.6 11.7% 14864.3 8.8% 14864.2
Cu4(CopZ)2 14926.2 4.8% 14924.4 39.7% 14927.2 85.1% 14927.0 83.9% 14926.9
In order to more clearly visualise this species distribution of CopZ, bar graphs are
shown in Figure 4.3.4, illustrating the species present at each copper loading. Above 1.0
Cu/CopZ, the relative amount of monomer species was significantly reduced, accompanied
by predominance of the tetra-copper species which indicated cooperative binding of Cu(I)
to the CopZ dimer and relatively low amounts of the Cu2(CopZ)2 and Cu3(CopZ)2 species.
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Figure 4.3.4: Species distribution via ESI-MS for CopZ at varied Cu(I) lev-
els. Bar graph representation of species CopZ mass spectra prepared at Cu
/ protein ratio as labelled. Bars represent the CopZ species observed at each
copper loading, with relative intensity from three experiments averaged and nor-
malised to the greatest total ionisation intensity. Species represented in the follow-
ing colours: Red, apo-CopZ; Blue, CuCopZ; Magenta, CopZ2; Cyan, Cu(CopZ)2;
Orange, Cu2(CopZ)2; Green, Cu3(CopZ)2; Yellow, Cu4(CopZ)2.
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4.4 Results: Cu(I) binding to CopZ In The Presence Of LMWT
4.4.1 Determination Of The Affinity Of Bacillithiol For Cu(I)
Affinities associated with Cu(I)-binding to thiolate ligands can be obtained through competi-
tion experiments with a high affinity Cu(I) ligand, such as bathocuproine disulfonate (BCS).
BCS forms a coloured complex with Cu(I), Cu(BCS)23-, that displays an Amax at 483 nm,
which enables its concentration to be monitored during competition with BSH. Previously,
a similar approach was used to determine the binding affinities of Cu(I) for both CopZ and
the soluble domains of its cognate membrane protein, CopAab [84] [147].
Figure 4.4.1: Competition for Cu(I) between BCS and BSH monitored by UV-
vis. Overlaid absorbance spectra from competition assay where BSH was titrated
into sample containing 8.95 μM Cu(BCS)23-, 2 μM sodium dithionite. Decrease in
A483 as BSH is titrated into solution indicates transfer of Cu(I) from BCS to BSH.
Inset: plot of A483 against BSH / Cu(I) ratio.
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By analogy with other LMWTs, it was expected that BSH would bind Cu(I) in a 2:1
ratio to form Cu(BSH)2. The UV-visible absorbance spectra recorded during titration of
BSH into the solution containing Cu(BCS)23- illustrated a steady decrease in A483 nm as
shown in Figure 4.4.1, which indicated the transfer of copper from BCS to BSH. Because
titrations of BSH alone into the same buffer did not exhibit absorbance in this region (data
not shown), absorbance changes were attributed to loss of Cu(I) from Cu(BCS)23- . Data
were analysed according to Eqn 4.1 and Eqn 4.2, giving an apparent formation constant
at pH 7.5 of β2(BSH) = 4.1 ± 1.5 × 1017 M-2 (see Table 4.2).
Table 4.2: Calculation of BSH Affinity for Cu(I). After titration of BSH into a solution con-
taining [Cu(BCS)2]-3, the A483nm values were used to calculate changes in concentration
of [Cu(BCS)2]-3 (as copper was transferred to Cu(BSH)2). From this, the concentrations
of Cu(BSH)2, free BSH and free BCS could be determined. The starting concentrations
were: [BCS]T = 23.7 μM, [Cu]T = 9.88 μM.
BSH/Cu(I) [BSH]T [Cu(BSH)2] [Cu(BCS)2]3- β2, BSH x 1017 β2, BSH, AVG (M-2)
0 0 0 8.95
24 240 6.74 3.14 8.03
36 359 7.34 2.52 5.40
48 477 7.82 2.02 4.38
61 595 8.09 1.73 3.57
73 713 8.31 1.49 3.07
85 830 8.38 1.40 2.44
97 947 8.49 1.28 2.12
4.1 ± 1.5 x 1017
During this experiment, as BSH is titrated in excess of copper, the ratio of free BSH to
Cu(BSH)2 decreases. Because the total proportion of BSH that binds copper decreases,
there appears to be a decreasing trend across the β2 values throughout the experiment
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(see Equation 4.1). Previous examples of this type of competition assay using BCS have
not been found to be influenced by formation of ternary complexes or intial formation of the
1:1 complex [148]. In addition, the variation observed here appears to be small and thus
the reported formation constant is the average of these values.
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4.4.2 Bacillithiol Reduces Number of CopZ Cu(I)-binding Phases
Previous spectroscopic studies of the effects of the LMWTs DTT, cysteine and GSH re-
vealed that, though initial Cu(I)-binding behaviour was not perturbed, the formation of
higher order Cu(I)-bound forms of dimeric CopZ is inhibited [89] [52]. These studies pre-
dated the discovery of BSH as the major LMWT in the B. subtilis cytoplasm [27]. To in-
vestigate the effects of BSH on Cu(I)-binding to CopZ, similar methods to those previously
employed were used. UV-visible spectra arising from additions of 0 – 2 Cu / CopZ in the
presence of 20-fold excess BSH are shown in Figure 4.4.2A, along with a plot of ΔA265nm
against increasing Cu / protein ratio Figure 4.4.2B.
Addition of Cu(I) ions led to a gradual essentially linear increase with respect to Cu(I)
in A265nm. Cu(I)-binding in the absence of LMWTs has been well-characterised, consisting
of a series of distinct binding phases with break points at ∼0.5, 1.0, 1.5 and 2.0 Cu(I) per
protein [89]. Clearly, here, multiphasic Cu(I) binding to CopZ was not observed in the pres-
ence of excess BSH. However, because Cu(I) bound to LMWT gives rise to absorbance
in this spectral range, absorbance does not discriminate between protein-associated and
non-protein-associated copper. CD spectroscopy, which provides more discriminating in-
formation about Cu(I)-binding to the protein was therefore used.
CD spectra of CopZ in the presence of 20-fold excess BSH resulting from anaerobic
additions of Cu(I) in the range of 0 – 2 Cu / protein are shown in Figure 4.4.3A, and Figure
4.4.3B shows plots of ΔΔε values at 265 nm, 290 nm and 335 nm as a function of Cu(I)
added.
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Figure 4.4.2: Cu(I) titration into CopZ, in the presence of BSH, monitored by
UV-vis. Titration of Cu(I) into 35 μM CopZ in 100 mM MOPS, 100 mM NaCl, pH
7.5, and 20-fold excess BSH monitored by UV-visible absorbance, presented as:
A) Overlaid spectra B) ΔA265nm against the Cu(I)/CopZ ratio.
The initial Cu-free spectrum of CopZ with BSH was consistent with the previously
reported spectrum of apo-CopZ with only a very shallow signal around 276 nm, due to
its two tyrosine residues. Thus, CD intensity changes were attributed to Cu(I) ions bound
at chiral centres within the protein. Initially, additions of Cu(I) gave rise to signal intensity
changes at (+)265 nm and (-)295 nm, due to ligand-metal charge transfer bands. A plot of
intensity versus Cu(I) depicted binding in the range from 0 – 0.7 Cu(I)/CopZ, after which
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Figure 4.4.3: Cu(I) titration into CopZ, in the presence of BSH, monitored
by CD. Titration of Cu(I) into 35 μM CopZ in 100 mM MOPS, 100 mM NaCl, pH
7.5, and 20-fold excess BSH monitored by CD, presented as: A) Overlaid spectra
with colour scheme as follows: Red, initial copper-free spectrum; Blue, 0.7 Cu /
protein; Black, 2 Cu / protein. B) ΔΔε against the Cu(I)/CopZ ratio.
there were only minor changes in intensity at (-)265 nm, (+)295 nm and (-)335 nm, in each
case levelling off at ∼ 2 Cu(I)/CopZ. Intensity at 335 nm was previously attributed to spin
forbidden 3d – 4s metal cluster-centred transitions arising due to Cu(I)–Cu(I) interactions
in multinuclear Cu(I) complexes [149] [150]. This behaviour was broadly similar to that
previously observed for Cu(I)-binding to CopZ in the presence of the same excess of GSH
and cysteine [52].
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4.4.3 DTT and GSH Inhibit Higher Order Cu(I)-Forms Of CopZ
Native MS affords the opportunity to gain high resolution insight into the effects of LMWTs
on Cu(I)-binding. Therefore mass spectra were recorded of CopZ prepared with 1 Cu /
protein and progressively increasing concentrations of DTT, GSH and BSH (see Section
4.2.3).
Figure 4.4.4: Mass spectra for 1 Cu/CopZ with varied DTT levels. Native m/z
and mass spectra acquired of CopZ in 20 mM ammonium acetate, pH 7.4, recon-
stituted with 1 Cu / protein in the presence of A) 5 DTT/CopZ, B) 10 DTT/CopZ,
C) 25 DTT/CopZ. The m/z spectra on the left with charge states labelled; on the
right, monomer and dimer regions of the mass spectra expanded, with the pro-
tein species labelled. Peaks shift as DTT level increases, illustrating decreased
dimerised CopZ species, favouring CuCopZ.
The mass spectra of 1 Cu / CopZ in the presence of DTT, before and after deconvolu-
tion, are shown in Figure 4.4.4. The spectra at all DTT loadings (5, 10 and 25 per CopZ)
contained a monomer CopZ envelope (charge states +4, +5 +6) and a small amount of
dimer envelope. In addition to the charge states observed in the absence of DTT (+8, +9),
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these contained an additional peak at +7, suggesting that DTT causes a reduction in the
number of charges on the CopZ dimer, perhaps resulting in a slightly more tightly folded
conformation of CopZ dimer.
The species present in the mass spectrum can be seen in the deconvoluted spec-
tra and in Table 4.3. The deconvoluted spectra illustrated that at 5 DTT/protein (Figure
4.4.4A), the peaks corresponding to dimer CopZ species, Cu3(CopZ)2 (14864.7 Da) and
Cu4(CopZ)2 (14925.0 Da) were significantly decreased in intensity compared to spectra
in the absence of the thiol (Figure 4.2.3B), with a corresponding increase in the CuCopZ
peak (7400.4 Da) which was the most prominent copper-bound species, and apo-CopZ
(7336.6 Da) the second most abundant (89% relative intensity).
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Table 4.3: Species observed via ESI-MS for 1 Cu/CopZ at varied DTT levels. Ex-
act masses and relative intensities of species observed in native mass spectra of CopZ
prepared at 1.0 Cu / protein in the presence of DTT (5, 10 and 25 / protein).
Species Pred (Da) 5 DTT / CopZ 10 DTT / CopZ 25 DTT / CopZ
CopZ 7336.1 87.3% 7336.6 47.3% 7336.9 36.0% 7337.6
CuCopZ 7399.7 100% 7400.7 100% 7400.7 100% 7400.7
(CopZ)2 14672.2 12.0% 14673.0 8.0% 14673.0 8.2% 14673.0
Cu(CopZ)2 14735.7 <3% – <3% – 3.5% 14738.2
Cu2(CopZ)2 14799.2 7.9% 14802.0 6.2% 14801.9 11.6% 14801.3
Cu3(CopZ)2 14862.7 3.0% 14864.7 <3% – 3.2% 14863.4
Cu4(CopZ)2 14926.2 0% – 0% – 0% –
At 10 DTT/protein and 25 DTT/protein (Figures 4.4.4B and C), the intensity of dimeric
CopZ peaks were further reduced, and the most prominent peak was that of CuCopZ
(7400.8 Da), while the relative intensity of the apo-CopZ monomer (7337.0 Da) decreased
to 55% and 37% at 10 and 25 DTT/protein, respectively. This suggested the presence of
DTT had a stabilising effect on the CuCopZ species. Also with increasing DTT levels, the
intensity of Cu2(CopZ)2 increased slightly, perhaps due to increased stability of CuCopZ
which facilitated the formation of this dimeric species.
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The mass spectra of 1 Cu / CopZ in the presence of GSH, before and after deconvo-
lution, are shown in Figure 4.4.5. The effect upon the mass spectra of GSH can be seen
where, as for DTT, near elimination of the dimer envelope is observed at the final level of 25
GSH / protein. The charge state distribution was similar to that found in the mass spectra in
the absence of thiol but, in the presence of GSH a great deal of adduct formation occurred,
with additional peak envelopes at 25 GSH / protein due to clusters of GSH, which obtained
multiple charges and overlapped with the CopZ peak envelope.
Figure 4.4.5: Mass spectra for 1 Cu/CopZ at varied GSH levels. Native
mass spectra of CopZ at 1 Cu / protein, after addition of A) 5 GSH/CopZ, B)
10 GSH/CopZ, C) 25 GSH/CopZ. Mass spectra on the left with charge states la-
belled; on the right, monomer and dimer regions of the mass spectra expanded,
with the protein species labelled. GSH ionises readily, leading to peak clusters
which affect relative protein ionisation and therefore the deconvoluted mass spec-
tra contain a lower signal-to-noise, particularly at high thiol ratio.
These effects can be seen after deconvolution and by the relative intensities and ob-
served masses in Table 4.4 where CopZ species contained a much higher proportion
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of sodium adducts than observed previously. At 5 GSH / CopZ (Figure 4.4.4A), there
was a slight increase in relative intensity of CuCopZ (7400.5 Da), relative to the dimerised
Cu3(CopZ)2 (14864.1 Da) and Cu4(CopZ)2 (14926.2 Da). Further reduction in intensity of
dimerised species was observed at 10 GSH / CopZ (Figure 4.4.4B), and finally at 25 GSH
/ CopZ (Figure 4.4.4C), the intensity of dimerised species was minimal (<10%), where
the most intense Cu-bound species was CuCopZ. In addition, peaks corresponding to the
addition of a glutathione molecule (+306.3 Da) were observed for CuCopZ (see below).
Furthermore, the intensity of the monomeric CuCopZ species also decreased relative to
the apo-CopZ peak, suggesting that these thiols might have competed with CopZ for Cu(I).
Table 4.4: Species observed via ESI-MS for 1 Cu(I)/CopZ at varied GSH levels. Exact
masses and relative intensities of species observed in mass spectra of CopZ at 1.0 Cu /
protein containing GSH (5, 10 and 25 per protein).
Species Pred (Da) 5 GSH / CopZ 10 GSH / CopZ 25 GSH / CopZ
CopZ 7336.1 100% 7336.8 100% 7336.7 100% 7336.2
CuCopZ 7399.7 50.5% 7400.5 57.7% 7400.2 34.0% 7400.7
CopZ-GSH 7643.4 0% – <3% – 36.8% 7643.1
CuCopZ-GSH 7707.0 0% – 0% – 20.0% 7706.7
(CopZ)2 14672.2 11.8% 14673.5 9.9% 14672.9 5.9% 14674.6
Cu(CopZ)2 14735.7 0% – 0% – <3% –
Cu2(CopZ)2 14799.2 10.6% 14799.7 8.8% 14799.3 6.5% 14799.3
Cu3(CopZ)2 14862.7 41.6% 14864.1 16.6% 14863.9 6.9% 14864.8
Cu4(CopZ)2 14926.2 38.7% 14926.9 28.2% 14926.2 0% –
(CopZ)2-GSH 14979.5 0% – 0% – 7.8% 14980.7
Cu3(CopZ)2-GSH 15170.2 0% – 0% – <3% –
Cu4(CopZ)2-GSH 15233.7 0% – 0% – <3% –
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4.4.4 BSH Inhibits Higher Order Cu(I)-Forms Of CopZ
In order to examine the effect of the physiological LMWT upon Cu-bound CopZ species
distribution, mass spectra were recorded of CopZ prepared at 1 Cu / protein in the presence
of 5, 10 and 25 BSH / protein. The mass spectra, prior to deconvolution are presented in
Figure 4.4.6A – C.
Upon addition of 5 BSH / protein, the mass spectrum featured fairly similar intensities
of CopZ peaks, compared to the thiol-free spectrum (Figure 4.3.2C). In addition, addi-
tional peaks corresponding to BSH adducts were observed. The mass spectrum at 10
BSH/protein revealed slightly reduced dimer peak intensity. In addition to appearing as
adducts of CopZ, BSH also appeared on its own and, at 25 BSH/CopZ, these clusters
overlapped with the CopZ peak envelope. A detailed view of the overlapped species is
annotated in Figure 4.4.6D.
Despite the presence of many additional peaks in the m/z spectrum, the monomer and
dimer charge states were still observed, as well as the trend where an increased proportion
of BSH resulted in less intense peaks in the dimer envelope. The relative proportion of
monomer/dimer peaks was hard to discern in the stacked mass spectra due to the overall
decrease in protein peak intensity as BSH increased. This presumably arose due to BSH
acting as an ion suppressant at higher concentration (25 BSH / protein = 250 μM BSH).
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Figure 4.4.6: Mass spectra for 1 Cu/CopZ with varied BSH levels. Na-
tive m/z acquired of CopZ reconstituted with 1 Cu / protein, in the presence of:
A) 5 BSH/CopZ, B) 10 BSH/CopZ, C) 25 BSH/CopZ. D) expanded view of 25
thiol/protein centred on m/z = 1220, where BSH peak clusters overlap with CopZ
monomer peaks (+6 charge state). BSH ionises readily, affecting signal-to-noise.
The intensity of charge states +8 and +9 (CopZ dimer peaks) decreases with in-
creasing BSH.
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After deconvolution, the monomer region (Figure 4.4.7) and the dimer region (Figure
4.4.8) of the mass spectra revealed additional information about the changes that oc-
curred with increasing ratio of BSH/protein. The relative intensity of monomeric CuCopZ
increased, and the predominant species in each spectrum was apo-CopZ. Also present
were sodiated CopZ species and BSH adducts (+397.3 Da), CopZ-BSH and CuCopZ-
BSH. Though the BSH adducts of apo-CopZ were likely disulfide-bonded, for CuCopZ, the
cysteine thiols would be involved in copper coordination, suggesting that BSH served as an
additional Cu(I) ligand, as observed in the solution structure in the presence of LMWT [40].
Figure 4.4.7: Deconvoluted mass spectra for 1 Cu/CopZ at varied BSH lev-
els, monomer. Native mass spectra acquired for CopZ reconstituted with 1 Cu /
protein, in the presence of A) 5 BSH/CopZ, B) 10 BSH/CopZ, C) 25 BSH/CopZ.
Monomer region of the mass spectra expanded, with the protein species labelled
and symbols used as followed: () = Na+ adduct, (+) = loss of H2O. Peaks shift as
thiol level increases, illustrating increased monomer peaks, favouring CuCopZ.
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Alongside the increase in relative intensity of CuCopZ, a decrease was observed in
peak intensity of dimer species, Cu3(CopZ)2 and Cu4(CopZ)2. However, this decrease was
not to the extent observed above for DTT and GSH. BSH adducts were again observed
which were likely to be involved in copper coordination for these higher order species.
Figure 4.4.8: Deconvoluted mass spectra for 1 Cu/CopZ at varied BSH lev-
els, dimer. Native mass spectra acquired for CopZ reconstituted with 1 Cu /
protein, in the presence of A) 5 BSH/CopZ, B) 10 BSH/CopZ, C) 25 BSH/CopZ.
Dimer region of the mass spectra, with the protein species labelled and symbol ()
= Na+ adduct. Peaks shift as thiol level increases, illustrating decreased dimerised
CopZ species.
In addition, with increasing BSH level, the proportion of bacillithiolated protein in-
creased, which may imply BSH exhibited a stabilising effect on the higher order species.
These relative proportions are presented in Table 4.5.
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Table 4.5: Proportion of BSH adducts observed for CopZ species. Results from ESI-
MS experiments where CopZ was reconstituted with 1 Cu / protein, in the presence of
three different ratios of BSH:CopZ. These values, representing the proportion of each
species’ BSH adduct relative to the total observed intensity of that particular species il-
lustrate that the proportion of each species’ BSH adduct increases as you progress from 5
10, 25 BSH/CopZ.
Species 5 BSH / CopZ 10 BSH / CopZ 25 BSH / CopZ
CopZ-BSH 8% ± 1% 13% ± 1% 18% ± 1%
CuCopZ-BSH 14% ± 3% 23% ± 1% 24% ± 7%
Cu3(CopZ)2-BSH 22% ± 2% 35% ± 1% 39% ± 3%
Cu4(CopZ)2-BSH 27% ± 1% 38% ± 4% 35% ± 21%
Table 4.6 contains the relative intensities and observed masses of species observed
above. The masses were mostly in reasonable agreement with their predicted mass. As
BSH is increased, the intensity of CuCopZ increased, accompanied by decreased intensity
of the dimerised species. In addition, with increasing BSH, progressively fewer Cu(I) ions
were coordinated by the dominant dimeric species, Cu3(CopZ)2 at 5 and 10 BSH/CopZ,
followed by Cu2(CopZ)2 at 25 BSH/CopZ.
Table 4.6: Species observed via ESI-MS of 1 Cu/CopZ at varied BSH levels. Exact
masses and relative intensities of species observed in native mass spectra of CopZ pre-
pared at 1.0 Cu / protein in the presence of 5, 10 and 25 BSH per protein.
Species Pred (Da) 5 BSH / CopZ 10 BSH / CopZ 25 BSH / CopZ
CopZ 7336.1 100% 7336.2 100% 7336.3 100% 7336.2
CuCopZ 7399.7 28.5% 7400.4 44.2% 7400.5 47.3% 7400.3
CopZ-BSH 7734.3 8.9% 7734.3 15.3% 7734.5 22.5% 7734.7
CuCopZ-BSH 7797.9 4.6% 7798.5 12.9% 7798.6 14.2% 7798.6
(CopZ)2 14672.2 13.5% 14673.2 17.6% 14674.1 28.4% 14674.3
Cu2(CopZ)2 14799.2 7.5% 14800.0 14.4% 14800.8 23.2% 14800.2
Cu3(CopZ)2 14862.7 32.7% 14864.5 25.9% 14864.8 19.3% 14864.5
Cu4(CopZ)2 14926.2 27.2% 14926.7 12.8% 14925.7 11.5% 14926.0
(CopZ)2-BSH 15070.6 0% – 0% – 0% –
Cu2(CopZ)2-BSH 15197.7 0% – 0% – 5.2% 15198.6
Cu3(CopZ)2-BSH 15262.3 9.2% 15262.3 13.6% 15262.8 12.5% 15265.8
Cu4(CopZ)2-BSH 15324.8 10.0% 15325.1 7.8% 15322.0 6.3% 15323.9
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4.4.5 Glutathionylation, Bacillithiolation and CopZ-thiol Complex Formation
In order to aid the comparison of the relative distribution of CopZ species when 1 Cu /
CopZ was loaded progressively increasing proportions of LMWT, bar graph representaions
of the mass spectra peaks are presented in Figure 4.4.9. These bar graphs more clearly
represent the overall trend observed: with an increase in thiol the major copper-bound
species becomes CuCopZ accompanied by a decrease in dimerised species, though a
more substantial amount of dimer remains at 25 BSH / protein compared to GSH and DTT.
Also, in some cases, thiolation or thiol coordination was observed; this is indicated by a
darker shaded bar beside each species.
Experiments conducted in the presence of GSH and BSH resulted in the observation
of thiol adducts of CopZ, whereas in the presence of DTT no such adducts were observed.
For apo-CopZ species, these adducts correspond to glutathionylation (+306.3 Da) or bacil-
lithiolation (+397.3 Da), whereby a mixed disulfide forms between a Cys residue of CopZ
and the LMWT. For Cu(I)-bound forms of CopZ, the adducts are unlikely to be mixed disul-
fides, as the Cys side chains are involved in coordination of the metal (as demonstrated
through previous crystal structures and EXAFS studies [81] [38]). The extent to which these
species were observed was different for GSH and BSH, with significantly more adducts ob-
served with the physiologically relevant BSH.
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Figure 4.4.9: Species distribution observed via ESI-MS for 1 Cu / CopZ at
varied thiol levels. Relative proportion of CopZ species in ESI-MS experiments
of CopZ reconstituted with 1 Cu / protein in the presence of: A) 5 thiol/CopZ, B)
10 thiol/CopZ, C) 25 thiol/CopZ, according to the following colour code: Red, apo-
CopZ; Blue, CuCopZ; Magenta, CopZ2; Cyan, Cu(CopZ)2; Orange, Cu2(CopZ)2;
Green, Cu3(CopZ)2; Yellow, Cu4(CopZ)2. The darker portion represents the pro-
portion of species containing a thiol adduct. With increasing thiol proportion, the
intensity of dimerised CopZ peaks decrease, favoring CuCopZ; also the propor-
tion of BSH/GSH adducts increases.
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4.5 Discussion
Cu(I)-binding to B. subtilis CopZ has been previously shown to be complex. Initial bind-
ing of Cu(I) results in dimerisation of CopZ to form a Cu(CopZ)2 species, which has the
capacity to bind three further Cu(I) ions at the monomer-monomer interface [84]. While
spectroscopic studies have revealed the different phases of Cu(I)-binding, and X-ray crys-
tallography has provided a high resolution structure of the Cu4(CopZ)2 species [81], none
of these techniques provided detailed information about the nature of the range of species
present under different conditions of copper loading. Here it is illustrated that native MS
can provide detailed, high resolution information about the distribution of CopZ and its
metallo-forms that exist at different stoichiometric ratios of Cu(I) in solution.
No Cu(I)-bound CopZ species were observed when the Cu-loaded CopZ sample was
subjected to the denaturing conditions of LCMS. Here, both the increased number of charge
states and greater average charge state reflect the unfolding of the protein in acidified
solvent, disrupting the Cu-binding site.
Under native conditions, apo-CopZ was, or was close to, the most abundant species
even in copper-loaded samples. This despite the fact that previous equilibrium sedimen-
tation and gel filtration revealed that CopZ exists predominately as a dimer in the pres-
ence of copper [89]. For a loading of 0.5 Cu/CopZ, this can be understood because so-
lution studies previously showed that CuCopZ recruits a second CopZ molecule to form
the dimeric species Cu(CopZ)2 [89]. However, the association constant for the binding of
the second CopZ is not high (estimated to be ∼105 M-1) [84] and so it is not surprising
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that the Cu(CopZ)2 species was observed only at low intensity in the mass spectrum, with
apo-CopZ and CuCopZ the major species, resulting from dissociation of the Cu(CopZ)2
species. At higher levels of Cu(I), the appearance of apo-CopZ may in part be a con-
sequence of the cooperative formation of the Cu4(CopZ)2 species. However, even at a
loading of 2 Cu/CopZ, which should saturate the formation of the Cu4(CopZ)2 species, sig-
nificant amounts of apo-CopZ were observed. Although unexpected because electrostatic
interactions are normally strengthened in the gas phase, the data appear to suggest that
the Cu(I)-CopZ interaction does not efficiently survive the ionisation process.
Though it has been demonstrated that apo-CopZ exhibits reduced thermal and chem-
ical stability [151], no change in ESI-MS charge state distribution was observed between
apo-CopZ and Cu-loaded CopZ. This indicates that no major protein conformational change
occurs upon addition of copper, and the reduced charge state distribution compared to de-
natured CopZ indicates that both apo-CopZ and Cu(I)-bound CopZ remain folded upon
ionisation. Addition of higher amounts of Cu resulted in the emergence of a dimer peak
envelope with charges +8, +9, centered upon higher m/z values than the monomer or dena-
tured protein peak envelopes. This change in charge state behaviour is consistent with the
well characterised relationship between protein association state and charge state [152].
At low Cu(I) loadings (0.5 Cu/CopZ), the major Cu(I)-bound species detected in the
mass spectrum was CuCopZ, at higher levels of Cu(I) (≥1 Cu/CopZ), several dimeric forms
of CopZ were readily detected. This is consistent with previous solution studies which
showed that binding of≥ 1 Cu(I) at the monomer-monomer interface stabilised the complex
significantly [89]. Cu2(CopZ)2, Cu3(CopZ)2 and Cu4(CopZ)2 species were all detected, with
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Cu3(CopZ)2 marginally the most abundant of these dimeric species at 1 Cu / CopZ.
At Cu(I)-loadings above 1 per CopZ, the major Cu(I)-bound form of CopZ was Cu4(CopZ)2,
at the expense of the other dimeric forms. This demonstrates a cooperativity of Cu(I)-
binding to the dimeric form of CopZ, indicating that the arrangement of four Cu(I) ions in
a cluster at the monomer interface is a particularly thermodynamically stable form. This
is consistent with previous structural studies, in which the structure of Cu4(CopZ)2 was
solved, but from crystallisation solutions containing a 1:1 ratio of Cu:CopZ (i.e., the Cu2(CopZ)2
species was the intended structural target of that study) [81]. E. hirae CopZ was previously
studied by native MS [141], with a similar narrow charge state distribution observed for
both apo- and Cu(I)-bound protein. In that case, although dimeric CopZ was detected in
solution it was not observed by MS.
An especially diverse mixture was observed at 1.0 Cu/CopZ, where the increased
number of species reflects the point of transition from monomeric CuCopZ to dimeric
Cu4(CopZ)2. This transitionary Cu(I)-binding behaviour accounts, at least in part, for rela-
tively large error bars in the 1.0 Cu/CopZ bar graphs (Figure 4.2.4), where slight variation
of Cu(I) concentration between experiments has a significant effect on the equilibrium distri-
bution of Cu(I)-bound CopZ species. Overall, the data demonstrate the distribution of met-
alloforms which exist as the major Cu(I)-bound species shifts from CuCopZ to Cu4(CopZ)2.
Previous spectroscopic and bioanalytical studies of the effect of LMWTs showed that
DTT, GSH and Cys interfere with Cu(I)-binding to CopZ, inhibiting the formation of higher
order Cu(I)-bound forms of the CopZ dimeric forms [89] [52], but the specific CopZ species
which arose could not be identified. In addition, these studies pre-dated the discovery of
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BSH, the recently discovered physiological LMWT in B. subtilis [27]. Therefore, it was de-
sirable to continue previous spectroscopic studies using the physiologically relevant BSH,
and probe the specific distribution via ESI-MS of CopZ species in the presence of LMWTs.
Data presented in this chapter generally agree with the observations from previous
spectrocopy studies i.e., that the initial binding phase of Cu(I) to CopZ in the presence
of LMWT is similar to that in the absence of thiol but, with subsequent Cu(I) additions, a
significant departure from thiol-free behaviour was observed. Furthermore, the native MS
data revealed more detail about the effects of thiols, demonstrating the decreased relative
proportion of higher order dimerised CopZ in the presence of LMWT.
This was the case in the ESI-MS experiments in the presence of DTT, which severely
inhibited the formation of higher order Cu(I)-bound forms of CopZ. However, because the in-
tial species formed upon copper-binding, Cu(CopZ)2, was not detected at significant abun-
dance in the spectrum, the effect of DTT (and other thiols) on the formation of this species
cannot be discerned. In addition, though DTT and DTT adducts of CuCopZ were not ob-
served, perhaps the capability of DTT to serve as an additional ligand for the CuCopZ
monomer species [40] is reflected by the increased proportion of CuCopZ with increasing
DTT levels.
The effects of BSH, along with GSH, were similar but less severe, with a marked
decrease in the abundance of dimer observed only at the highest ratio of GSH. The data are
consistent with previous investigations which indicated the presence of thiols (particularly
GSH and Cys) does not appreciably disrupt the initial binding of Cu(I) to CopZ, but does
inhibit the formation of higher order Cu(I)-bound CopZ species [52]. Here, however, in the
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presence of GSH and BSH, dimeric CopZ species persisted even at the highest ratios of
thiol to protein tested here.
It is likely that, at higher levels of Cu(I), LMWTs may compete for Cu(I) because step-
wise binding of Cu(I) to Cu(CopZ)2 is weaker than the initial binding step [89]. Because
of the high Cu(I)-binding affinities involved, competition effects would most likely occur
through the formation of transient hetero-complexes in which Cu(I) is at least temporar-
ily coordinated by both CopZ and a LMWT. For GSH and particularly BSH, it was found
that such hetero-complexes are stable and can be readily detected. Interestingly, in ad-
dition to hetero-complexes formed between BSH and CuCopZ, BSH adducts of all the
dimeric species were readily observed, suggesting that Cu(I) bound in clusters at the CopZ
monomer-monomer interface can accommodate BSH coordination as well.
The high affinity of BSH for Cu(I), determined here as β2 = 4.1 ± 1.5 × 1017 M-2,
is consistent with a potential role in buffering Cu(I) levels in the cell. GSH was unable
to compete with BCS for Cu(I) [138], suggesting that BSH has a higher affinity for Cu(I).
This affinity, however, is ∼3 orders of magnitude lower than that of CopZ [84], and so it
is unlikely that BSH alone buffers Cu(I). Consistent with this, B. subtilis cells lacking BSH
were recently found to be unaffected in their overall sensitivity to Cu(I) stress compared to
wild-type cells under equivalent conditions, but the expression of copZA was found to be
elevated [23]. These data suggest that BSH is not an essential component of the copper
trafficking pathways of B. subtilis, but are consistent with BSH playing a role in copper-
buffering. Perhaps the observation of BSH adducts of Cu(I)-bound CopZ species indicates
that BSH could function together with CopZ (and possibly CopA) via the formation of hetero-
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complexes to buffer Cu(I) levels. Interestingly, BSH was recently found to be a major buffer
of the cytoplasmic zinc pool in B. subtilis [23] in which a dedicated Zn(II) chaperone has
not been identified.
Also, apo-CopZ was observed as a BSH adduct; this is the S-bacillithiolated form of
the protein. Bacillithiolation of proteins in B. subtilis is known to occur as a reversible,
protective response against over-oxidation of functionally important Cys residues resulting
from oxidative stress. Bacillithiolation is known to protect proteins such as redox-sensor
OhrR [153] and the methionine synthase MetE [154]. Though it is not clear what the oxida-
tive driving force is in our experiments, a potential source could be a small amount of O2
introduced during acquisition, or the ionisation process itself. Regardless, the ease with
which these species are observed, even at relatively low ratios of BSH to protein, suggests
that this would be a physiologically important process for the protection of CopZ.
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Chapter 5
Studies of Cu(I) Binding to CopAab
5.1 Introduction
Translocation of Cu(I) across the Bacillus subtilis cell membrane takes place by way of
CopA, the integral membrane P-type ATPase CopA. The P-type ATPase protein family
typically contain a central core of transmembrane helices, multiple soluble cytoplasmic
domains (MBDs), an actuator domain (A-domain) and an ATP-binding domain (ATP-BD),
comprising two distinct sub-domains involved in nucleotide-binding (N) and phosphoryla-
tion (P) [47]. The P-type ATPases are further divided into subclasses based upon several
structural features [155]. The P1B-type ATPases contain an additional two helices in the
transmembrane core. The P1B1-type ATPase subclass also is distinguished by possession
of a CPC transmembrane metal-binding motif (TMBS) located in helix 4, and one or more
soluble MBDs at the N- and, sometimes, C-termini.
The two N-terminal cytoplasmic MBDs in B.sutbilis CopA, CopAab, possess the same
βαββαβ fold as the Atx1-like metallochaperone CopZ. Each individual domain, CopAa and
CopAb, contains a conserved MXCXXC copper binding motif with two solvent-exposed cys-
teines located between the end of the first loop and the beginning of the first α-helix [156].
Cu(I) is not bound by the CopAab from the cytoplasm directly but, rather, by interaction
with CopZ which helps to ensure specific transfer of copper, as the CXXC motif is capable
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of binding other metals, such as zinc [157].
The exact role of MBDs in ATPase function is unclear, though it has been demonstrated
they are required for copper transfer activity [158] [159], and interaction between MBD
and the catalytic domains suggest they play a regulatory role [160]. In the absence of
copper, one MBD interacts with one of the catalytic domains and is released upon copper
binding [161]. Though Cu(I) binding to the MBDs is required for catalytic activation, it seems
that copper-bound to the MBD at the start of the catalytic cycle remains bound, while Cu(I)
bound to the TMBS is extruded across the membrane [162].
Cu(I) binding to CopAab has been characterised previously [147], with CopAab shown
to undergo Cu(I)-mediated dimerisation above 1 Cu / protein and accommodate multiple
Cu(I) ions. Copper binding by CopAab at a ratio of 2 Cu / protein was observed via lu-
minescence, predicted to be Cu4CopAab2. However, luminescence quenching beyond a
raio of 2:1 suggests that dimeric CopAab may be able to bind additional Cu(I) ions [163].
CopAab binds Cu(I) with high affinity, leading to dimerisation at 1 Cu / protein. Data from
AUC and SEC suggested that a small portion of dimer (¡5%) is present at 1 Cu / protein
and by 2 Cu / protein the association state is fully dimeric. [80].
In addition, Cu(I) binding to CopAa [83] and CopAb [82] has been characterised pre-
viously. Solution-phase studies demonstrated continual binding of Cu(I) by CopAa and
CopAb between 0 and 2 Cu / protein.SEC and AUC data suggested the association state
of CopAa is tetramer/monomer equilibrium at 0.5 Cu / protein, tetramer/dimer at 1 Cu /
protein and a dimer at 2 Cu / protein. The association state of CopAb observed via AUC
to be monomeric at 0.5 Cu / protein and dimeric at 1.0 and 2.0 Cu / protein.
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Though apo-CopAa was observed to be folded (CD) and stable over 48 hours ob-
served (NMR) [164], instability was observed upon copper binding, which did not occur
when copper was bound by CopAab or CopAb [82]. In addition, instability was not ob-
served in a mixed sample (CopAa/Ab) suggesting their physical connection may influence
the stability and potentially structure and function of the protein in vivo.
The regulation of Cu(I) levels could be influenced by cytoplasmic low molecular weight
thiol-containing species (LMWT). For example, it has been demonstrated that glutathione
may serve as a copper-binding intermediate between the eukaryotic importer Ctr1 and
cytoplasmic chaperones [165]. Though this influence upon Ctr1 may not be the same as
in Cu(I) transfer to a Cu(I) export protein, a role in metal trafficking has been suggested for
the cytoplasmic LMWT in B. subtilis, bacillithiol (BSH). Therefore understanding of Cu(I)-
binding to B. subtilis CopAab, in the presence of LMWT, may help to further elucidate the
role these domains play in Cu(I) export.
Despite previous studies characterising Cu(I) binding to CopAab, the nature of species
and mixtures of species which form as Cu(I) levels fluctuate is unknown. In addition, the
influence of LMWT upon Cu(I) binding by CopAab is not clear, nor is the influence of the
two domain linker upon binding of Cu(I) by CopAab. In order to investigate these end-
points, native ESI-MS of CopAab in the absence and presence of LMWT was carried out,
in addition to an experiment monitoring Cu(I) binding to a mixture of individual domains
CopAa and CopAb by LCMS and ICP-AES.
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5.2 Materials And Methods
5.2.1 ESI-MS Of CopAab
Mass spectrometry samples of CopAab were prepared using protein aliquots purified as
described in section 2.2.3. ESI-MS samples of CopAab were prepared by first adding 15
mM DTT (Formedium) and removing reductant by passage down a G25 Sephadex col-
umn (PD10, GE Healthcare) in an anaerobic glovebox (Faircrest Engineering, O2 con-
centration < 2 ppm) using 20 mM ammonium acetate (Sigma), pH 7.4, as the elution
buffer. Protein concentrations were calculated using an extinction coefficient, ε276nm, of
5800 M-1 cm-1 [147], before anaerobic addition of Cu(I) using a microsyringe (Hamilton).
UV-visible absorbance spectra were recorded on a Jasco V-550 spectrophotometer. To
prepare Cu(I)-bound CopAab samples, a deoxygenated solution of Cu(I)Cl prepared in
100 mM HCl (Sigma), 1 M NaCl was added to anaerobic, reduced CopAab using a mi-
crosyringe (Hamilton) in an anaerobic glovebox. Unbound Cu(I) was removed by passage
of the sample down a G25 Sephadex column (PD10, GE Healthcare) equilibrated with 20
mM ammonium acetate, pH 7.4. The protein sample was diluted with 20 mM ammonium
acetate to a working sample concentration of 5 μM. Thiol experiments were carried out
using dithiothreitol (DTT) (Formedium) or BSH (synthesised as described previously [143];
for structures see Section 4.2.3) prepared anaerobically using deoxygenated LC-MS grade
water (HiPerSolv, VWR). Solutions of CopAab were prepared at 4.0 Cu(I) / protein (as de-
scribed above), where thiol solution was added to yield ratios of 1, 5, 10, or 25 thiol per
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protein.
Mass spectra were acquired using a Bruker micrOTOF-QIII electrospray ionisation
(ESI) time-of-flight (TOF) mass spectrometer (Bruker Daltonics, Coventry, UK), in positive
ion mode. The ESI-TOF was calibrated in the m/z range 300 – 2200 using ESI-L Low
Concentration Tuning Mix (Agilent Technologies, San Diego, CA). Native protein samples
were introduced to the ESI source at 4 ◦C via a syringe pump (Cole-Parmer) at 5 μL/min,
and data acquired for 2 min, with ions scanned between 500 – 3000 m/z. MS acquisi-
tion was controlled using Bruker oTOF Control software, with parameters as follows: dry
gas flow 5 L/min, nebuliser gas pressure 0.8 Bar, dry gas 180 ◦C, capillary voltage 4500
V, offset 500 V, isCID energy 0 eV, quadrupole RF stepping set at 2000 Vpp (25%) and
3200 Vpp (75%). Processing and analysis of MS experimental data was carried out us-
ing Compass DataAnalysis version 4.1 (Bruker Daltonik, Bremen, Germany). The spectra
were deconvoluted using the ESI Compass version 1.3 Maximum Entropy deconvolution
algorithm over a mass range of 15000 – 35000 Da. Exact masses were determined from
peak centroids, with 3-point Gaussian smoothing applied only to spectra acquired in the
presence of BSH.
5.2.2 Cu(I) Binding to CopAa/Ab Mixture
Samples were prepared under anaerobic conditions containing 100 μM of each CopAa
and CopAb (prepared as described in Sections 2.2.4 and 2.2.5) in 100 mM MOPS, 100
mM NaCl, pH 7.5, at 0, 0.5, 1.0 and 2.0 Cu(I) per domain. Each 500 μL sample was
loaded onto a Superdex G75 10/300 GL column (GE Healthcare), with a total column vol-
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ume (Vt) of 24 mL and a void volume (V0) of 7.6 mL, as determined using blue dextran.
The column was equilibrated and operated using thoroughly deoxygenated buffer at a flow
rate of 0.3 mL min-1. Elution fractions were collected every 0.5 mL and analysed for Cu+
and protein. For metal analysis of the elution fractions from the G75 column, an ICP-OE
(inductively coupled plasma optical emission) spectrometer (Varian Vista) was used, cal-
ibrated with ICP grade Cu standards (Fisher) diluted to appropriate concentrations. After
overnight incubation in 50% nitric acid (Primar Plus, Fisher) at 60 ◦C, elution buffer (as
baseline) and protein samples were diluted to appropriate concentrations in a final vol-
ume of 10 mL using HiPerSolv water (VWR) for a final concentration of 4% nitric acid.
Spectral line at 324.754 nm was used to determine Cu + concentrations. Data analysis
was performed using ICP Expert version 4.1. For protein analysis, HPLC-MS experiments
were performed using an UltiMate 3000 HPLC system (Dionex, Sunnvale, CA, USA), and a
Bruker micrOTOF-QIII electrospray ionisation (ESI) time-of-flight (TOF) mass spectrometer
(Bruker Daltonics, Coventry, UK), in positive ion mode. Protein samples were diluted 50-
fold into 2% acetonitrile and a 1 μL injection volume was applied to a ProSwift R© reversed
phase RP-1S column (4.6 × 50mm; Dionex) at 25◦C. Gradient elution was performed at a
flow rate of 200 μL/min using solvents A (0.1% formic acid) and B (acetonitrile, 0.1% formic
acid), with the following chromatographic method: isocratic wash (2% B, 0–1 min), linear
gradient from 2–100% B (1–3 min), followed by an isocratic wash (100% B, 3–7 min) and
column re-equilibration (2% B, 7–11 min). Mass spectra were recorded in the range 500 –
3400 m/z, using Bruker oTOF Control software with parameters as follows: dry gas flow 8
L/min, nebuliser gas pressure 1.8 Bar, dry gas 240◦C, capillary voltage 4500 V, offset 500
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V, collision RF 650 Vpp. The ESI-TOF was calibrated in the m/z range 300 – 2200 using
ESI-L Low Concentration Tuning Mix (Agilent Technologies, San Diego, CA). Processing
and analysis of MS experimental data was carried out using Compass DataAnalysis ver-
sion 4.1 (Bruker Daltonik, Bremen, Germany). The spectra were deconvoluted using the
ESI Compass version 1.3 Maximum Entropy deconvolution algorithm over a mass range
of 7000 – 20000 Da. Exact masses were determined from peak centroids.
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5.3 Results: ESI-MS of Cu(I) Binding To CopAab
It has been demonstrated previously that copper binding to CopAab is complex, with sev-
eral different Cu(I)-bound forms observed including a dimer. In order to assess the mixture
of species arising when CopAab binds copper, ESI-MS was carried out of CopAab at varied
stoichiometric ratios of Cu(I).
5.3.1 Cu(I) Binding To CopAab
The mass spectra prior to deconvolution of CopAab at 0.5, 1.0, 2.0 and 4.0 Cu / protein
are presented in Figure 5.3.1. The changes in intensity of the charge envelopes arise
due to progressive increase of dimerised CopAab peaks, which occurs as copper level is
increased.
The mass spectra revealed three charge state envelopes, one monomer (+8, +9) and
two dimer (+11 – +14; and +16 – +18). The dimer charge states comprise two separate
envelopes, suggesting the presence of two forms of the dimer species. The first charge en-
velope (11+, 12+, 13+, 14+) has fewer charges, suggesting a more compact dimer structure
while the second charge envelope with more charges (16+, 17+, 18+) likely corresponds
to a more open structure susceptible to greater protonation during ionisation. These two
species appear to coordinate the same total number of copper ions.
At 0.5 and 1.0 Cu / CopAab (Fig 5.3.1A and B, respectively), the monomer charge
envelope (8+, 9+) is predominant, with a small dimer envelope emerging. At 2.0 Cu /
CopAab (Fig 5.3.1C), an increased intensity of dimer peaks is observed with monomer
127
envelope (8+, 9+) still the most prominent. At 4.0 Cu / CopAab (Fig 5.3.1D), the dimer
peaks increase further in relative intensity, with both envelopes in approximately equal
proportion to each other.
Figure 5.3.1: Mass spectra for CopAab at varied Cu(I) levels. The mass spec-
tra prior to deconvolution of CopAab reconstituted with Cu(I) at: A) 0.5 Cu / protein,
B) 1 Cu / protein, C) 2 Cu / protein, D) 4 Cu / protein.
The mass spectra after deconvolution presented in Figure 5.3.2 focus on the monomer
and dimer regions. They confirm the trend observed across the mass spectra in Figure
5.3.1, monomer dominates at 0.5 and 1 Cu / CopAab, leading to a dimer/monomer mixture
at 2 and 4 Cu / CopAab. The only species observed in the spectra were different forms of
CopAab, and some sodium adducts.
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At 0.5 Cu / CopAab, the copper-bound species observed were CuCopAab and also
Cu2CopAab. Each domain (Aa and Ab) has a copper-binding motif and thus could co-
ordinate metal ions independently. With increasing copper level, the relative intensity of
Cu2CopAab increases to become the dominant copper-bound peak at 2 Cu / protein. At
4 Cu / protein, the mass spectra reveal that the dimeric form Cu6(CopAab)2 is the pre-
dominant copper-bound species, accompanied by a decrease in Cu2CopAab. At all levels
of copper, apo-CopAab, Cu4(CopAab)2, and Cu5(CopAab)2 are observed, albeit at low
intensity.
The exact masses and relative intensities of the species observed are presented in
Table 5.1. The observed masses in Table 5.1 are mostly within 1 Da of the predicted
mass. The observed masses of Cu6(CopAab)2 and Cu5(CopAab)2 are 2 – 4 Da higher
than predicted; the reason for this is unclear.
Table 5.1: Species observed via ESI-MS for CopAab at varied Cu(I) levels. Exact
masses and relative intensities of species observed in native mass spectra of CopAab
prepared at 0.5, 1.0, 2.0 and 4.0 Cu / protein. Exact masses not reported for low intensity
peaks below 3% relative intensity.
Species Pred (Da) 0.5 Cu / CopAab 1.0 Cu / CopAab 2.0 Cu / CopAab 4.0 Cu / CopAab
CopAab 15909.0 31% 15910.8 33% 15908.0 11% 15907.8 6% 15908.3
CuCopAab 15972.6 100% 15974.8 100% 15973.5 74% 15973.2 57% 15973.4
Cu2CopAab 16036.1 60% 16037.9 68% 16037.5 100% 16037.3 51% 16037.6
Cu3(CopAab)2 32008.7 <3% – <3% – <3% – 0% –
Cu4(CopAab)2 32072.2 <3% – <3% – 6% 32072.6 16% 32071.4
Cu5(CopAab)2 32135.8 <3% – 8% 32138.7 17% 32138.6 13% 32139.5
Cu6(CopAab)2 32199.3 0% – 10% 32201.3 33% 32201.4 100% 32202.3
In order to more clearly visualise changes occurring with copper level, Figure 5.3.3
presents the distribution of species at each copper loading as bar graphs, obtained by
averaging three independent measurements. Figure 5.3.2 presents a single data set and,
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Figure 5.3.2: Deconvoluted mass spectra for CopAab at varied Cu(I) levels.
The deconvoluted mass spectra of CopAab reconstituted with Cu(I) at: A) 0.5 Cu
/ protein, B) 1 Cu / protein, C) 2 Cu / protein, D) 4 Cu / protein.
thus, the relative intensities may not be identical to those in Table 5.1; this is represented
by a few large error bars in Figure 5.3.3.
As copper level increases from 0.5 – 4 Cu / CopAab, the bar graphs illustrate an
increase in intensity of CuCopAab and Cu2CopAab, followed by a decrease in intensity of
these species with increase of Cu6(CopAab)2 peak. The consistently low intensity of the
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other dimeric forms implies a cooperativity of Cu-binding to the dimeric form Cu6(CopAab)2,
which likely arises from the assembly of Cu2CopAab protomers.
The Cu3CopAab species is unexpected, as each domain possesses just a single
CXXC motif and intra-domain Cu(I) coordination is not possible due to the short linker length
between domains. This peak could represent a transient species arising from breakdown
of Cu6(CopAab)2, which would agree with its low relative intensity and (proportionately)
high error bar.
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Figure 5.3.3: Species distribution observed via ESI-MS of CopAab with in-
creasing levels of Cu(I). Species distribution in the deconvoluted mass spectra
of CopAab reconstituted with Cu(I) at: A) 0.5 Cu / protein, B) 1 Cu / protein, C) 2
Cu / protein, D) 4 Cu / protein.
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5.3.2 Cu(I) Binding To CopAab in the Presence of LMWT
To assess the effect of LMWT upon CopAab species distribution at elevated copper load-
ings, ESI-MS were recorded of CopAab (prepared at 4 Cu / protein) in the presence of
DTT and BSH at 1, 5, 10 and 25 per protein (for structural representations, see Section
4.2.3). Compared to the experiments in Chapter 4 for CopZ, the effect of LMWT was more
drastic at 5 / protein and, therefore, an additional experiment at a level of 1 thiol / protein
was carried out.
CopAab + DTT
The mass spectra, prior to deconvolution, are presented in Figure 5.3.4 of CopAab pre-
pared with 4 Cu / protein, in the presence of 1, 5, 10 and 25 DTT per protein. Two peak
envelopes are observed, monomer (+8, +9) and dimer (+12, +13). The dimer peak en-
velope is of low intensity, and represents the more compact of the two dimeric forms of
CopAab observed in Figure 5.3.1.
Compared to the thiol-free spectrum (Fig 5.3.1.D), there are fewer peaks, with only a
small amount of dimer envelope at 1 DTT / protein. The subsequent thiol loadings display a
fairly similar peak distribution, with a slight increase in proportion of the monomer peak with
increasing thiol. The presence of DTT caused neither the position nor number of peaks in
either peak envelope to shift, suggesting no major conformational changes in the protein
in the presence of thiol.
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Figure 5.3.4: Mass spectra for 4 Cu/CopAab at varied DTT levels. The mass
spectra prior to deconvolution of 4 Cu / CopAab in the presence of: A) 1 DTT /
protein, B) 5 DTT / protein, C) 10 DTT / protein, D) 25 DTT / protein.
.
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The deconvoluted mass spectra are presented in Figure 5.3.5 and stand in agree-
ment with the trend observed in the mass spectra above: at and above a thiol level of 5
/ protein, the spectra contain a similar peak distribution, with dimeric species abolished.
Unlike for CopZ in the presence of DTT (see Chapter 4), thiol adducts are observed for
CopAab. These adduct species feature one or two DTT molecules, which are likely to
serve as additional Cu(I) ligands given the higher than expected copper loadings (4, 5 and
6 per monomer). These species could somehow give rise to the peaks with unexpected
Cu/protein ratios, Cu3CopAab and Cu4CopAab.
Figure 5.3.5: Deconvoluted mass spectra for 4 Cu/CopAab at varied DTT
levels. Mass spectra of 4 Cu / CopAab in the presence of: A) 1 DTT / protein,
B) 5 DTT / protein, C) 10 DTT / protein, D) 25 DTT / protein. The regions of the
mass spectra, from left to right, are: CopAab monomer, DTT adducts of CopAab
monomer, and CopAab dimer.
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The observed masses and relative intensities of species in the mass spectra are
presented in Table 5.2. The masses are mostly within 1 Da of the predicted masses.
Cu2CopAab and Cu6(CopAab)2 are approximately 3 Da greater than their predicted masses;
the reason for this discrepancy is unclear.
Table 5.2: Species observed via ESI-MS for 4 Cu/CopAab at varied DTT levels. Exact
masses and relative intensities of species observed in native mass spectra of CopAab
prepared at 4.0 Cu / protein in the presence of DTT. Exact masses not reported for species
below 3% relative intensity.
Species Pred (Da) 1 DTT / CopAab 5 DTT / CopAab 10 DTT / CopAab 25 DTT / CopAab
CopAab 15909.0 9% 15909.0 0% – 4% 15908.2 <3% –
CuCopAab 15972.6 100% 15974.1 98% 15975.6 73% 15975.7 95% 15975.9
Cu2CopAab 16036.1 69% 16037.4 95% 16038.1 100% 16038.1 95% 16038.0
Cu3CopAab 16099.6 11% 16097.8 0% – 0% – 6% 16099.5
Cu4CopAab 16163.1 41% 16163.9 28% 16163.3 19% 16163.6 26% 16163.7
Cu4(CopAab:DTT) 16317.4 37% 16317.5 27% 16317.4 24% 16317.6 35% 16317.3
Cu5(CopAab:DTT) 16381.6 0% – 10% 16382.5 6% 16381.6 10% 16379.8
Cu6(CopAab:DTT) 16444.3 0% – 4% 16443.2 4% 16444.3 <3% –
Cu5(CopAab:DTT)2 16535.2 0% – 4% 16532.3 <3% – 6% 16534.3
Cu6(CopAab:DTT2 16598.8 9% 16597.3 13% 16597.3 7% 16599.4 9% 16595.8
Cu4(CopAab)2 32072.2 23% 32071.6 0% – 0% – 0% –
Cu5(CopAab)2 32135.8 12% 32135.8 0% – 0% – 0% –
Cu6(CopAab)2 32199.3 61% 32202.4 0% – 0% – 0% –
In order to more clearly visualise the species distribution, the relative intensities ob-
served the mass spectra are presented as bar graphs in Figure 5.3.6, taken as an average
of three independent measurements. The bar graphs clearly depict the dominance of the
monomeric forms CuCopAab and Cu2CopAab at and above a level of 5 DTT / protein. The
absence of of dimeric forms of CopAab suggests that DTT has competed for Cu(I).
The presence of DTT adduct species illustrates that DTT interacts with CopAab, with
the most intense adduct species (∼ 25%) Cu4(CopAab:DTT). This likely represents an
arrangement where DTT is acting as an additional ligand to Cu(I) at one of the CopAab
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domains, though it is unclear which domain (Aa or Ab). It also is not clear how many cop-
pers each domain has bound. Without the possibility for intra-protein domain interaction,
the domain not experiencing the influence of DTT likely only binds one Cu(I).
Figure 5.3.6: Species observed via ESI-MS for 4 Cu/CopAab at varied DTT
levels. Species distribution in deconvoluted mass spectra of 4 Cu / CopAab in
the presence of: A) 1 DTT / protein, B) 5 DTT / protein, C) 10 DTT / protein, D)
25 DTT / protein. Bar graphs generated from the average of three independent
measurements.
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CopAab + BSH
The mass spectra, prior to deconvolution, of CopAab prepared with 4 Cu / protein, in the
presence of 1, 5, 10 and 25 BSH per protein are presented in Figure 5.3.7.
Figure 5.3.7: Mass spectra for 4 Cu/CopAab at varied BSH levels. The mass
spectra prior to deconvolution of 4 Cu / CopAab in the presence of: A) 1 BSH
/ protein, B) 5 BSH / protein, C) 10 BSH / protein, D) 25 BSH / protein. Upon
increase in BSH level, the dimer envelopes are diminished, with the formation of
BSH adducts of copper-bound CopAab species, denoted by (◦).
As seen for CopZ in Chapter 4, BSH ionises readily leading to ion suppression in
the mass spectrum, affecting signal to noise ratio. For CopAab however, the peaks occur
higher on the m/z axis and do not overlap with BSH clusters even at the highest BSH level
tested. Three peak envelopes are observed, monomer (+8, +9) and two forms of dimer
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(+12 – +14; and +16 – +18). As the BSH level increased, the relative intensity of the dimer
peaks decreased; the response was quicker for the less compact, dimeric form (+12 – +14)
After deconvolution, the mass spectra presented in Figure 5.3.8 provide further in-
sight into the CopAab species present at increasing levels of BSH. Though the dimer
species dominate at 1 BSH / protein, their relative intensity declines leading to CuCopAab
as the dominant copper-bound species, and apo-CopAab the most intense peak at 25
BSH / protein. The presence of BSH has facilitated higher copper loadings by the dimeric
species, with the coordination of 7 and 8 Cu(I) ions. In addition, BSH adducts are observed:
Cu5(CopAab2:BSH) and Cu6(CopAab2:BSH).
Figure 5.3.8: Deconvoluted mass spectra for 4 Cu/CopAab at varied BSH
levels. The deconvoluted mass spectra of 4 Cu / CopAab in the presence of: A)
1 BSH / protein, B) 5 BSH / protein, C) 10 BSH / protein, D) 25 BSH / protein.
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The relative intensities and masses observed in the mass spectra are presented in
Table 5.3. As observed in the presence of DTT, the mass of CuCopAab is greater than
its predicted mass (here, ∼ 2 Da). The observed mass of Cu6(CopAab)2 is greater than
predicted (∼ 2 –3 Da) whereas the masses of Cu7(CopAab)2 and Cu8(CopAab)2 are lower
(∼ 2 –5 Da). In addition, a substantial mass difference is observed for the adduct species,
Cu6(CopAab2:BSH) (∼ 7 Da). The reason for these large mass discrepancies is not entirely
clear, but could arise due to the broadened peak shapes.
Table 5.3: Species observed via ESI-MS for 4 Cu/CopAab at varied BSH levels. Exact
masses and relative intensities of species observed in native mass spectra of CopAab
prepared at 4.0 Cu / protein in the presence of BSH.
Species Pred (Da) 1 BSH / CopAab 5 BSH / CopAab 10 BSH / CopAab 25 BSH / CopAab
CopAab 15909.0 <3% 15909.3 18% 15909.3 15% 15909.1 100% 15909.6
CuCopAab 15972.6 5% 15974.5 33% 15973.4 9% 15973.4 58% 15974.3
Cu2CopAab 16036.1 0% – <3% – 0% – 0% –
Cu3CopAab 16099.6 0% – 0% – 0% – 12% 16099.8
Cu4CopAab 16163.2 9% 16163.2 13% 16162.6 10% 16163.1 32% 16165.2
Cu4(CopAab)2 32072.2 0% – 0% – 0% – 21% 32073.8
Cu5(CopAab)2 32135.8 42% 32136.7 21% 32134.5 51% 32137.5 0% –
Cu6(CopAab)2 32199.3 69% 32203.2 69% 32202.5 72% 32200.6 36% 32201.5
Cu7(CopAab)2 32268.9 100% 32265.1 100% 32264.2 92% 32265.9 37% 32263.7
Cu8(CopAab)2 32332.4 85% 32326.3 69% 32325.3 76% 32329.4 0% –
Cu5(CopAab2:BSH) 32692.4 0% – 0% – 0% – 41% 32692.8
Cu6(CopAab2:BSH) 32756.0 36% 32745.3 68% 32745.7 79% 32745.3 23% 32753.0
The relative intensities of species in the mass spectra are presented as bar graphs in
Figure 5.3.9, by averaging the results from three independent measurements.
Though monomeric species increase in intensity across these spectra, the dimeric
peaks persist at all levels of BSH tested. The most intense dimeric form at lower BSH
levels is Cu7(CopAab)2, a species not observed with DTT or in the thiol-free spectrum. A
high proportion of Cu8(CopAab)2 is observed as well.
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With increasing BSH levels, CuCopAab becomes the dominant copper-bound species.
Instead of steadily increasing in intensity, a slight dip is observed at 10 BSH / protein for
CuCopAab; the reason for this is unclear. In addition, accumulation of Cu2CopAab is not
observed, suggesting one of the domains (CopAa or CopAb) does not bind Cu(I) in the
presence of BSH.
Figure 5.3.9: Species observed via ESI-MS for 4 Cu/CopAab at varied BSH
levels. Species distribution in the deconvoluted mass spectra of 4 Cu / CopAab
in the presence of: A) 1 BSH / protein, B) 5 BSH / protein, C) 10 BSH / protein,
D) 25 BSH / protein.
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5.4 Results: Cu(I) Binding To A Mixture Of CopAa And CopAb
Previous studies have demonstrated that CopAa exhibits instability in the presence of cop-
per; this effect was mitigated by the presence of CopAb, suggesting it has a stabilising
effect on the other domain [84]. To explore these observations, an experiment was carried
out to compare the copper-binding behaviour of a mixture of CopAa and CopAb with the
two domains in tandem CopAab. Copper was added to an equimolar mixture of CopAa
and CopAb (at 1, 2 or 4 per domain), the solution components resolved by size exclusion
chromatography (SEC), and the elution fractions analysed for metal (ICP-AES) and protein
(LCMS).
The resulting copper distribution between CopAa and CopAb at each copper level
is depicted in Figure 5.4.1. At 0.5 Cu / domain (Figure 5.4.1A), the gel filtration chro-
matogram (blue trace) reveals two overlapping peaks (12.8 mL and 13.8 mL). The LCMS
analysis illustrates that CopAa (green bars) elutes between 12 mL and 15 mL, with a slight
dip in relative intensity at 13.25 mL suggesting two different CopAa species are present.
CopAb (magenta bars) elutes between 12.5 mL and 15 mL.
The results suggest three species whose peaks overlap considerably: dimeric CopAa
(12.8 mL), and a mixture of monomeric CopAa and monomeric CopAb (13.8 mL). The metal
analysis illustrates that the samples containing copper were distributed fairly symmetrically
around 13.9 mL, suggesting that most of the copper is associated with the monomeric
protein species, though it is difficult to say with certainty whether CopAa or CopAb.
At 1.0 Cu / protein (Figure 5.4.1B), the SEC trace contains three overlapping peaks
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Figure 5.4.1: Cu(I) binding to the individual domains CopAa and CopAb In-
dividual domains CopAa and CopAb were prepared at A) 0.5 Cu / protein, B) 1 Cu
/ protein, C) 2 Cu / protein. Figures depict the overlaid gel filtration chromatogram
(blue trace), ICP-AE Cu+ analysis (red trace), bars represent the relative propor-
tion of individual domains present CopAa (green) and CopAb (magenta) in each
gel filtration fraction as determined by LC-MS analysis
(10.9 mL, 12.8 mL, 14.1 mL). LCMS illustrates CopAa eluting between 12 and 15 mL,
again with a dip in relative intensity (13.25 mL) suggesting two different CopAa species
overlapped, and CopAb eluting between 13 and 15 mL. The elution volumes coupled with
LCMS suggest that present are: dimeric CopAa (12.8 mL), a mix of monomeric CopAb
and CopAa species (14.1 mL). The metal analysis indicated that the majority of copper
is distributed around 13.9 mL, suggesting it is associated with the monomeric species,
though it is not possible to say whether CopAa or CopAb. Despite the presence of Cu(I)
and A280 nm at 10.9 mL, no protein was found via LCMS in the fractions at 10.9 mL; the
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reason for this discrepancy is unclear. However, it could suggest that higher order forms
are beginning to form / acquire copper at 1 Cu(I) per domain.
At 2.0 Cu / domain (Figure 5.4.1C) two overlapping peaks (10.9 and 13.1 mL) are
observed in the SEC trace. LCMS illustrates CopAa eluting mostly between 10 and 13
mL suggesting trimeric and/or tetrameric CopAa, low intensity peak between 13 and 14.5
mL a dimeric form of CopAa, and CopAb eluting between 12 and 14.5 mL, suggesting
dimeric and possibly monomeric CopAb. These results suggest the presence of tetramer
CopAa (10.9 mL), trimer CopAa or an equilibrium between tetramer and monomer (11.2
mL) and dimer CopAb (13.1 mL). Metal analysis indicated that copper levels are relatively
evenly distributed across all fractions and so associates with all protein species in this
sample. However, peak overlap and difference in absorbance response observed when
each protein binds copper [83] [82] makes it very difficult to say exactly which protein binds
what amount of copper in this sample.
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5.5 Discussion
Previous spectroscopic studies illustrated the complexity of the Cu(I)-binding behaviour of
CopAab, with Cu(I)-mediated dimerisation occurring above a level of 1 Cu / protein. How-
ever, these methods cannot be used to resolve mixed species in the case of, for example,
overlapping absorbance spectra or small mass differences. Here, ESI-MS was employed
to investigate the species which form at progressively increasing Cu(I) levels. The range of
copper-to-protein ratios, between 0.5 and 4.0 per protein, were chosen both to explore the
mixture of species at lower Cu(I) levels and examine the dimeric species present at higher
Cu(I) levels, as previously fluorescence quenching was observed beyond 2 per protein,
suggesting copper binding occurs beyond Cu4(CopAab)2 [163].
The charge state envelopes which appear in the mass spectra prior to deconvolution
illustrated the types of CopAab species present as Cu(I) levels are increased. Upon ad-
dition of Cu(I), the monomer envelope did not shift or take on additional charge states,
suggesting no major conformational changes between apo- and Cu-bound CopAab.
At 0.5 and 1 Cu / CopAab, the predominant copper-bound species is CuCopAab, along
with a sizable proportion of Cu2CopAab, with only a minor amount of dimer species present.
At 2.0 Cu / CopAab, the major copper-bound species is Cu2CopAab, with a substantial
proportion of CuCopAab present, along with copper-bound CopAab dimers, the most in-
tense of which coordinates six Cu(I) ions. At 4.0 Cu / CopAab, the predominant species is
Cu6(CopAab)2, with 20% relative intensity or less associated with the other copper-bound
dimer species, and a decreased relative intensity of copper-bound CopAab monomers.
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The two dimer envelopes suggest that two distinct dimeric CopAab species are present,
each coordinating six Cu(I) ions. An arrangement to fulfill this requirement would be two
monomers with one intra-domain interface coordinating four Cu(I) ions, and each of the re-
maining domains coordinating a single Cu(I) ion (Figure 5.5.1). A solvent-shielded tetranu-
clear cluster would agree with previously observed fluorescence quenching above 2 Cu /
CopAab [163]. Because the dimeric structure with the greater number of charges acquired
exactly double that of the CopAab monomer, this less compact version should have ap-
proximately the same surface area available as two CopAab monomers, which could be
achieved by an asymmetric arrangement where the single copper domains are not inter-
acting. The more compact dimer species with fewer charges could then be achieved if
two intra-domain interactions formed coordinating multiple ions, shielding a portion of the
dimer from protonation.
Figure 5.5.1: Possible structural representations of Cu6(CopAab)2. Struc-
tural arrangements Cu6(CopAab)2 where two CopAab monomers coordinate six
Cu(I) ions with A) the same surface area as two monomers, generating an ESI-
MS dimer envelope exactly double the number of charges B) less surface area
than two monomers, generating an ESI-MS dimer envelope with fewer charges .
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It was observed previously via NMR that the arrangement of the two domains is not
affected when Cu(I) is transferred to CopAab from CopZ, and that copper transfer occurs
simultaneously to Aa and Ab domain with no observable preference [80]. This behaviour
can be corroborated by examining the copper binding behaviour of the monomeric CopAab.
Upon addition of 1.0 and 0.5 Cu / CopAab, both one and two copper-bound monomers are
observed. Though it is not possible to say for certain which domains have bound Cu(I), if
binding of copper to a second site were to require saturation of the first copper-binding site,
Cu2CopAab would not be observed until above a level of 1 Cu / CopAab. Furthermore at
2.0 Cu / CopAab, Cu2CopAab is the major copper-bound species. The relative intensity
of Cu2CopAab was observed to be quite variable, except at 2 Cu / CopAab, as dimers are
beginning to form, where its relative intensity is 100% with small error bars. This perhaps
suggests this species is an intermediate in cooperative formation of higher order dimeric
CopAab species.
The lack of accumulation of dimer species coordinating fewer than six coppers sug-
gests cooperative formation of Cu6(CopAab)2 upon increasing of copper levels. Though it
cannot be ruled out that these species do not survive ionisation. For example, at higher
copper-loadings, a small amount of Cu3CopAab is observed. This species is not ex-
pected to form in solution and thus may be an artefact of breakdown of copper-bound
dimer species. However, interpreting the role of dimerisation should be carried out with
caution as, in vivo, these cytoplasmic MBDs are tethered to a membrane spanning AT-
Pase. Each MBD has been shown to play different roles in copper export, where one MBD
interacts with the A-domain to prevent phosphorylation in the absence of copper and is
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released upon copper binding when catalytic activity is utilised for copper export. Perform-
ing different physiological roles would be reason to expect each domain to exhibit different
copper-binding behaviour.
In order to compare the behaviour of tandem domains (CopAab) with individual do-
mains (CopAa and CopAb) for binding Cu(I), a mixture of the individual domains was
treated with 0.5, 1.0 or 2.0 Cu / domain. In order to determine the proportion of each
domain with Cu(I) bound, the mixtures were separated by gel filtration, and each fraction
subjected to ESI-MS and metal analysis. The solution structure of the individual domains
demonstrated that they have nearly identical folds and secondary structural elements when
in tandem or in isolation [164]. Though the fairly broad elution peaks from the gel filtration
chromatogram illustrate the trouble arising in a mixture of two proteins of comparable mass
(7692 and 8201 Da), both of which can form multimers even in the absence of copper, the
LCMS helped to resolve the species present in each elution fraction.
At 0.5 Cu / domain (1 Cu / protein), the protein was mostly monomeric CopAa and Co-
pAb and the copper was associated only with these fractions. This is supported by the ESI-
MS experiment (Figure 5.3.3B) where the major copper-bound species were monomeric
and very little dimer was present. Because tetrameric CopAa, previously observed in the
presence of Cu(I), was not observed, this may suggests it does not preferentially form in
the mixture of individual domains at low Cu(I) levels. It is not possible to tell from the SEC
experiment whether Cu(I) has a higher preference for CopAa or CopAb.
At 1.0 Cu / domain (2 Cu / protein), a similar trend is observed where a small amount
of dimeric CopAa was observed with the majority of protein monomeric. Most of the copper
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is associated with the monomer though a small amount of copper is associated with the
CopAa dimer. This does reflect the ESI-MS results at 2.0 Cu / CopAab, where the majority
of protein is monomeric with a small amount of dimeric copper-bound species present.
At 2.0 Cu / domain (4 Cu / protein), the domains were resolved as the majority of
CopAa formed a higher order species, and CopAb remained monomeric, or possibly a
monomer/dimer mixture. The copper appeared to be relatively evenly spread amongst the
protein containing fractions, suggesting the copper-bound species was a copper-bound
CopAa tetramer, and CuCopAb. The ESI-MS results at 4.0 Cu / CopAab suggest the major
copper-bound species to be Cu6(CopAab)2, which could arise from a tetra-copper cluster
at the interface of two domains, with each of the remaining domains coordinating a single
copper. Though it is difficult to compare directly the behaviour of the separated domains
with the two-domain construct, this arrangement would support the mixture of individual
domains forming a copper-bound dimer and monomer.
In order to examine the copper-binding behaviour of CopAab in the presence of LMWT,
ESI-MS was employed using samples of CopAab at 4 Cu(I) per protein, in the presence
of progressively increasing levels of DTT. Compared to the thiol-free spectrum, the mass
spectra (before and after deconvolution) illustrated changes in speciation. Upon the ad-
dition of 1 DTT per protein, a substantial reduction in intensity of the peaks in the dimer
envelopes is immediately seen, with entire removal of the dimer envelope at subsequent
DTT loadings. The monomer envelopes acquire additional low-intensity adduct peaks in
the presence of DTT.
Upon deconvolution, the peaks’ masses demonstrate DTT adducts and dimer break-
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down products. Seen at relative intensities of 40% and below are complexes formed be-
tween Cu-bound CopAab monomers and DTT. Due to the number of coppers bound (be-
tween 4 and 6), it can be inferred that DTT thiols serve as additional Cu(I) ligands in lieu of a
second CopAab. DTT was not observed to form adducts or complexes with CopZ species
(Chapter 4), though it is possible the increased proportion of CuCopZ with increasing DTT
points to it acting as an additional Cu(I) ligand. Here, however a substantial proportion of
complex with one and two DTT molecules were observed. The complexes with two DTT
molecules bind a higher number of coppers, 5 and 6, rather than 4 or 5 with one DTT
molecule. The presence of the species Cu4CopAab would not be expected and is quite
possiblly a breakdown artefact associated with the formation of Cu4CopAab:DTT species.
At each level of DTT / protein tested, the major copper-bound species remain CuCopAab
and Cu2CopAab, with somewhat proportionate relative intensities at each DTT loading.
This suggests the presence of DTT drives the most prevalent copper-bound species to be
monomeric with a fairly equal propensity for one or two copper-binding sites to be occupied,
and additional coppers coordinated with DTT thiols serving as additional ligands.
When samples of CopAab at 4 Cu(I) per protein were in the presence of low lev-
els of BSH, the mass spectra prior to deconvolution revealed a mixture of monomer and
dimer species. Upon increasing the BSH level, both dimer envelopes decreased pro-
gressively, but the less compact structure consistently had a greater peak intensity than
that of the more compact structure. This implies the presence of BSH affected these two
dimer species differently, and may point to an increased stability of the less compact struc-
ture in the presence of BSH. Decreasing relative intensity of the dimer envelope led to
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the monomer CopAab becoming the predominant species, a change which was also ob-
served in the deconvoluted mass spectra. Unlike spectra recorded in the presence of
DTT, no Cu2CopAab was observed, making CuCopAab the major copper-bound species
at higher copper loadings. Similarly to spectra recorded in the presence of DTT, small
amounts of Cu4CopAab were observed, which may be an artefact from the breakdown of
dimeric BSH adduct species. In the presence of BSH the CopAab dimer accommodated
additional Cu(I), with the dimer containing between 5 to 7 Cu(I) ions bound, rather than be-
tween 4 to 6 Cu(I) in the absence of BSH. However, no bacillithiolated CopAab monomer
was observed, and potentially the only BSH-coordinated CopAab species observed was
Cu5(CopAab)2:BSH (substantial mass difference for Cu6(CopAab)2:BSH makes this as-
signment tentative). This may suggest that, unlike that observed for cytoplasmic chaper-
one CopZ, bacillithiolation and LMWT Cu(I) coordination do not play a physiological role in
the behaviour of CopA MBDs.
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Chapter 6
Studies Of Cu(I) Transfer From CopZ To CopAab
6.1 Introduction
In order to prevent potential deleterious effects associated with Cu(I) ions, mechanisms of
copper management have arisen which chelate and move copper ions safely between traf-
ficking proteins. The Cu(I) P1B-ATPases contain multiple N-terminal cytosolic metal-binding
domains (MBDs), 1 – 2 in bacterial proteins and up to six in human ATP7A/B [47]. The func-
tion of these domains in copper transfer is not entirely clear, as they have been demon-
strated to play roles both in copper transfer and regulation of transport activity [161] [166].
In the crystal structure of Legionella pneumophila CopA, a copper chaperone “docking
station” was described [46], where copper could be transferred directly to the entrance of
the transmembrane channel without involvement of the MBDs, in support of their function
as a copper sensor regulator. In yeast, it has been demonstrated that, in the absence of
copper, the MBDs of Ccc2 play a regulatory role by serving to inhibit the ATPase catalytic
cycle. However, chaperone Atx1 was unable to transfer copper to a Ccc2 variant lacking
its MBDs, supporting their necessity in copper transfer [159]. Similar results were found
for Thermotoga maritima CopA, which was unable to undergo catalytic activation when the
MBDs were deleted [167].
Atx1-like metallochaperones exhibit extremely high affinities for Cu(I) (KD ∼ 1017M
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[168] [144] [169]) in order to adeptly acquire cytoplasmic copper. The multiple types of co-
ordination exhibited by the solvent-exposed cysteine-rich copper binding sites in these pro-
teins may be related to the copper transfer mechanism to their partner ATPase MBDs. For
monomeric human Atox1, two interconverting Cu(I) coordination geometries were found
[170] a more solvent-shielded digonal arrangement, and a solvent-exposed trigonal ar-
rangement. Two orientations of Cu(I)-binding cysteines also were observed in yeast Atx1
in its apo- and copper-bound states [41]. Tricoordination of Cu(I) has been observed pre-
viously for yeast [34] and B. subtilis [40], which may have emerged as an efficient way to
“grab” Cu(I) at an outward orientation to then promote its transfer to target proteins [170].
As the target copper-acquiring sites are typically less solvent-exposed, copper transfer is
facilitated by complementary electrostatic interactions between the proteins [171].
Because Cu(I) does not exist freely in the cytoplasm [34], the mechanism of copper
transfer does not comprise release of Cu(I) by chaperones, followed by chelation by re-
ceptor proteins and/or enzymes. Rather, it has been demonstrated in vitro that copper
transfer entails formation of a Cu-mediated heterocomplex to facilitate delivery of copper
from the chaperone to the ATPase MBDs, and then breakdown of the complex into protein
products [67] [57] [172]. Copper transfer within the complex is thought to involve rapid inter-
conversion of two different three-coordinate, copper-sulfur intermediates [34] [173] [174].
Flexibility in linkers near the copper binding sites has been demonstrated to facilitate rapid
copper transfer [171].
Copper exchange between the heteroprotein complex is not dictated by any substan-
tial thermodynamic gradient for copper transfer [175] [168]. Previous in vitro work has
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illustrated that, upon copper transfer, copper ends up almost equivalently distributed be-
tween CopZ and CopAab though, in some cases, a slightly larger amount was transferred
from CopZ to CopAab [163] [176]. Copper transfer between CopZ and CopAab has been
characterised by luminescence experiments [163] but, as a luminescent signal only arises
when CopAab reaches a level greater than 1 Cu / protein, this method could not be used
for lower copper loadings. Data characterising the thermodynamics of copper transfer be-
tween His6CopZ and CopAab was obtained at low copper loadings, where one protein was
copper-free and the other was prepared at 0.5 Cu / protein. Here, a Ni2+ IMAC affinity col-
umn was used to bind His6CopZ and CopAab (apo- or 0.5 Cu / protein depending upon
the His6CopZ sample) was applied to the column; after separate elution of each protein,
copper content was measured by ICP-AES. Regardless of whether CopZ or CopAab was
loaded with 0.5 Cu / protein, it was found that copper was equally distributed between the
two, suggesting a similar initial affinty for Cu(I) [177].
Because there is little thermodynamic drive for copper transfer, and transfer is re-
versible, more insight into the kinetic and structural aspects of copper transfer will be in-
strumental in defining the copper transfer mechanism between CopZ and CopAab, and
more generally for establishing the principles of transfer for chaperone target protein inter-
actions.
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6.2 Materials And Methods
6.2.1 Preparation of Apo- and Cu-loaded CopZ and CopAab Samples
CopZ and CopAab were prepared as described in Sections 4.2 and 5.2, respectively. Mass
spectrometry samples were prepared by first adding 15 mM DTT (Formedium) and remov-
ing reductant by passage down a G25 Sephadex column (PD10, GE Healthcare) in an
anaerobic glovebox (Faircrest Engineering, O2 concentration < 2 ppm) using 20 mM am-
monium acetate, pH 7.4 (Sigma) as the elution buffer. Protein concentrations were calcu-
lated using an extinction coefficient, ε276 nm, of 1450 M-1 cm-1 for CopZ [89] and 5800 M-1
cm-1 for CopAab [147]. UV-visible absorbance spectra were recorded on a Jasco V-550
spectrophotometer. To prepare Cu(I)-bound protein samples, a deoxygenated solution of
Cu(I)Cl prepared in 100 mM HCl and 1 M NaCl was added to anaerobic, reduced protein
using a microsyringe (Hamilton) in an anaerobic glovebox. Unbound Cu(I) was removed by
passage of the sample down a G25 Sephadex column (PD10, GE Healthcare) equilibrated
with working buffer. For solution-phase experiments, buffer was 100 mM MOPS, 100 mM
NaCl, pH 7.5. For ESI-MS experiments, buffer was 20 mM ammonium acetate, pH 7.4
and the protein sample was diluted with 20 mM ammonium acetate to a working sample
concentration of 15 μM.
6.2.2 Dialysis Assay Of CopZ Cu(I) off-rate
Cu-loaded and apo-proteins were prepared in an anaerobic glovebox as described previ-
ously (see Chapter 2) to generate 0.5 Cu/CopZ and apo-His6CopZ each in 100 mM MOPS,
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100 mM NaCl, pH 7.5, at a final concentration of 60 μM. Then 5 mL of each sample was
placed into separate dialysis cassettes submerged in same buffer. In order to maximise
diffusion within the beaker, gentle stirring was applied. UV-vis spectra were acquired at
several time points over the course of 48 hours. At this point, 2.5 mL of each protein
sample was mixed together and (after one hour incubation) applied to a 5 mL Ni2+ IMAC
column equilibrated with 100 mM MOPS, 100 mM NaCl, 20 mM imidazole, pH 7.5. The
column was washed with 3 × 5 mL fractions of binding buffer to elute CopZ and then 3
× 5 mL of elution buffer (binding buffer + 500 mM imidazole) to elute His6CopZ. Protein-
containing fractions (identified by SDS-PAGE) were pooled and buffer exchanged using
a 3 kDa MWCO spin concentrator (Sartorius), generating 2 × 5 mL samples in <1 mM
imidazole, 100 mM MOPS, 100 mM NaCl, pH 7.5, each 30 μM in protein.
6.2.3 Rapid Reaction Kinetics Of Cu(I) Transfer Between CopZ And CopAab
CopZ, His6CopZ and CopAab were prepared as described in Section 2.2. Copper transfer
experiments were carried out in 100 mM MOPS, 100 mM NaCl, pH 7.5. Prior to the addition
of Cu(I), in an anaerobic glovebox (Faircrest Engineering, O2 concentration < 2 ppm),
protein samples were treated with 15 mM DTT and excess reductant was removed via buffer
exchange using a G25 Sephadex column (PD10, GE Healthcare). Additions of Cu(I) were
made anaerobically using a solution of Cu(I)Cl in 1 M NaCl and 100 mM HCl. Reaction
kinetics were monitored at 25 ◦C using an Applied Photophysics Bio-Sequential DX.17MV
stopped-flow instrument. For each experiment, 2000 data points were collected over 0.5
seconds on a logarithmic time base, and three shots were averaged for each experiment.
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Copper transfer reactions were monitored in both directions (apo-His6CopZ + Cu(CopAab)
or Cu(His6CopZ)2 + apo-CopAab) with varied concentration of one protein (20, 40, or 60
μM) mixed with its partner protein at a fixed concentration (40 μM). Copper transfer was
monitored by detecting the change in Δε at 265 nm in units of M-1 cm-1; Absorbance kinetic
data were fitted using Origin software (OriginLab).
6.2.4 Native Electrospray Ionisation Mass Spectrometry of CopAab and CopZ
Mixtures
Mass spectra were acquired using a Bruker micrOTOF-QIII electrospray ionisation (ESI)
time-of-flight (TOF) mass spectrometer (Bruker Daltonics, Coventry, UK), in positive ion
mode. The ESI-TOF was calibrated in the m/z range 300 – 2200 using ESI-L Low Con-
centration Tuning Mix (Agilent Technologies, San Diego, CA). Native protein samples were
introduced to the ESI source via a syringe pump (Cole-Parmer) at 5 μL/min, and data ac-
quired for 2 min, with ions scanned between 500 – 3000 m/z. MS acquisition was controlled
using Bruker oTOF Control software, with parameters as follows: dry gas flow 5 L/min, neb-
uliser gas pressure 0.8 Bar, dry gas 180 ◦C, capillary voltage 4500 V, offset 500 V, isCID
energy 0 eV, quadrupole RF set at 2000 Vpp (25%) and 3200 Vpp (75%). Processing and
analysis of MS experimental data was carried out using Compass DataAnalysis version 4.1
(Bruker Daltonik, Bremen, Germany). The spectra were deconvoluted using the ESI Com-
pass version 1.3 Maximum Entropy deconvolution algorithm over a mass range of 7200 –
35000 Da. Overlapping peak envelopes were deconvoluted manually. Exact masses were
determined from peak centroids.
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6.3 Results: Kinetics of Copper Transfer Between CopZ and
CopAab
6.3.1 Kinetic Drive For Cu(I) Transfer Inhibited Without Protein Interaction
CopZ binds Cu(I) very tightly, as denoted by a high affinity constant, characteristic of a high
on-rate constant and/or a low off-rate constant. Monitoring the off-rate separately requires
an experimental design which allows dissociation of Cu(I) from CopZ to be measured in
competition with the reassociation reaction. To achieve this, CopZ, prepared at 0.5 Cu /
protein, and apo-His6CopZ were placed into separate dialysis cassettes both submerged
in buffer. This separation of the proteins allowed copper transfer to be monitored through
absorbance changes occurring in either sample, contingent upon copper being released
by CopZ into bulk solution first, and subsequently bound by His6CopZ. A trial run of this
experiment indicated that scattering due to protein precipitation began to occur on the third
day (data not shown) and therefore absorbance spectra were recorded at several time
points over 2760 minutes, or 46 hours. The overlaid spectra recorded for each protein are
presented in Figure 6.3.1, and the values of absorbance intensity at 265 nm are plotted
against time in Figure 6.3.2.
Monitoring the holo-CopZ sample revealed that during the first six hours, the four spec-
tra acquired overlaid exactly and the A265nm changed by -0.003, within the sensitivity limits
of the instrument. After 30.5 hours, the A265nm decreased by a further 0.028 AU, with slight
changes in spectral shape. After 46 hours, the A265nm of the holo sample had decreased
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Figure 6.3.1: Off-rate of Cu(I) from CopZ monitored by UV-visible ab-
sorbance. Overlaid UV-visible absorbance spectra acquired of of 0.5 Cu / CopZ
and apo-His6CopZ over 46 hours. The similarity of spectra throughout the exper-
iment illustrates that when the proteins are separated in dialysis cassettes and,
therefore cannot interact, little if any copper transfer is observed.
by a total of -0.056, a loss of 16% of the signal intensity at 265 nm from the first spectrum
recorded. The apo-His6CopZ sample experienced very slight fluctuations in A265nm during
the first 6 hours of the experiment, when the absorbance intensity at 265 nm varied within
4% of its intial intensity. These small changes were not accompanied by a decrease in
absorbance of the holo-CopZ sample. After 30.5 hours, the spectra showed slight shape
changes but the A265nm fluctuated by no more than 0.007 AU, 9% of the initial signal inten-
sity.
Though these changes could have indicated transfer of a small amount of copper, at
the end of the experiment, the samples were analysed for metal content via ICP-AES. The
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Figure 6.3.2: Off-rate (upper limit) of Cu(I) from CopZ. Change in absorbance
intensity at 265 nm plotted as a function of time of: A) 0.5 Cu / CopZ and B) apo-
His6CopZ. When the proteins were separated in dialysis cassettes, little to no
copper transfer was observed. The A265 nm of 0.5 Cu / CopZ was fitted to a single
exponential consistent with a first order dissociation process. This establishes an
estimated upper limit of off-rate of Cu(I) from CopZ.
results revealed that the CopZ contained Cu(I), whereas no copper was found associated
with the His6CopZ sample, nor the buffer in the beaker. Thus absorbance changes are
most likely not due to copper transfer and, are probably attributable to instrumental drift
and/or loss of protein signal. If it were assumed that absorbance changes were due to
holo-CopZ copper transfer, the data could represent the initial part of an exponential decay
due to Cu(I) transfer (Figure 6.3.2). This allows the estimation of an upper limit of the
off-rate to be established, ∼ 6 × 10 -5 s-1.
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6.3.2 Kinetics Of Cu(I) Transfer Between CopZ And CopAab Detected By
Stopped Flow Absorbance
The binding of Cu(I) to both CopZ and CopAab gives rise to high-energy absorbance bands,
assigned to cysteine-to-copper ligand to metal charge transfer transitions (LMCT) [150].
Figure 6.3.3 displays overlaid plots of the change in absorbance intensity during Cu(I)
titration for each protein, as characterised by extinction coefficients at 265 nm. Compared
to CopZ, the response of CopAab is shallower between 0 and 0.75 Cu(I) per protein, which
enabled monitoring the direction of Cu(I) transfer between CopZ and CopAab at low Cu(I)
levels.
Stopped flow absorbance was used to monitor absorbance changes at 265 nm which
occurred upon mixing 0.5 Cu / CopZ with apo-CopAab and the reverse reaction, apo-CopZ
mixed with 0.5 Cu / CopAab, see Figure 6.3.4. Due to the relative absorbance intensities
of CopZ and CopAab in the range of copper loading below 0.5 Cu / protein, it is expected
that copper transfer should be indicated clearly by the direction of change in ΔA265 ab-
sorbance. Copper transfer to CopZ from CopAab resulted in an increased absorbance of
approximately 0.007 AU (Figure 6.3.4A). Based upon the relative absorbance responses
of CopZ and CopAab, this increase in absorbance represents copper transfer from CopAab
to CopZ. Conversely, the reverse reaction (0.5 Cu / CopZ and apo-CopAab, Figure 6.3.4B)
results in a decrease in absorbance of approximately 0.005 AU, indicating that copper is
being transferred from CopZ to CopAab.
Approximately equal magnitudes of ΔA265 were in agreement with reversible copper
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Figure 6.3.3: Divergent A265nm responses during copper titration of CopAab
and CopZ. Plot of absorbance intensity at 265 nm against Cu / protein ratio during
titration of CopZ (40 μM) and CopAab (40 μM) with Cu(I). Overlaid plots depict the
distinct absorbance intensities the proteins ellicit at each Cu(I) loading. These
plots enable the prediction of the direction of absorbance change when apo- and
Cu-loaded samples are mixed together.
transfer previously demonstrated, which also resulted in equal distribution between the
two proteins [163]. In addition, this reaction, in both directions, is completed very quickly,
within 0.02 seconds. The data were fitted with a single exponential function, and the rate
constants determined; for copper transfer from CopAab to CopZ, k = 208 ± 2.6 s-1, from
CopZ to CopAab, k = 300 ± 3.8 s-1.
Identical experiments were carried out using His6CopZ to investigate whether the di-
rection and rate of copper transfer is affected by the addition of the His tag, see Figure
6.3.5. Mixing of 0.5 Cu / CopAab with apo-His6CopZ resulted in an absorbance increase
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Figure 6.3.4: Kinetics of Cu(I) transfer between CopZ and CopAab. After
rapid mixing at 25 ◦C of CopZ and apo-CopAab, the change in absorbance in-
tensity at 265 nm was recorded and plotted against time. The samples mixed
together contained: A) apo-CopZ (40 μM) and 0.5 Cu / CopAab (40 μM), and B)
0.5 Cu / CopZ (40 μM) and apo-CopAab (40 μM). The data were fit to a single
exponential function from which the rate constant was derived, and is labelled on
each plot.
of approximately 0.007 AU, in agreement with copper transfer from CopAab to His6CopZ.
Mixing of 0.5 Cu / His6CopZ with apo-CopAab resulted in a decrease in absorbance of ap-
proximately 0.007 AU consistent with copper transfer in the opposite direction, from CopZ
to CopAab. The magnitude of these changes is small, but a single exponential function
fitted the data well and, again, the reactions were complete within 0.02 sec. The rate con-
stant for copper transfer from CopAab to His6CopZ was 258 ± 2.6 s-1; from His6CopZ to
CopAab was 247 ± 2.2 s-1.
The results indicate copper transfer between CopZ and CopAab at this copper load-
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Figure 6.3.5: Kinetics of Cu(I) transfer between His6CopZ and CopAab. After
rapid mixing at 25 ◦C of His6CopZ and apo-CopAab, the change in absorbance
intensity at 265 nm was recorded and plotted against time. The samples mixed
together contained: A) apo-His6CopZ (40 μM) and 0.5 Cu / CopAab (40 μM), and
B) 0.5 Cu / His6CopZ (40 μM) and apo-CopAab (40 μM). The data were fitted to
a single exponential function from which the rate constant was derived, and is
labelled on each plot.
ing is reversible and extremely rapid. Though the transfer from CopAab to CopZ (Figure
6.3.4B) was slightly faster, nevertheless these results are in good agreement and it was
decided to use the His6CopZ to probe further the kinetics of copper transfer between these
two proteins.
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Kinetics of Cu(I) transfer at varied protein concentration
It is generally accepted that copper transfer between CopZ and CopAab proceeds by way
of two steps: formation of a heteroprotein complex, followed by dissociation of the complex
[178]. Were complex formation the rate-limiting step, it would be expected that the rate
constant could be varied by changing the concentration of one of the reactants. Therefore,
the dependence of the rate constant upon protein concentration was tested by carrying out
the same reactions, at 25 ◦C, and varying either the concentration of His6CopZ or CopAab
(20, 40 or 60 μM) while holding the concentration of its partner protein constant (40 μM).
For the reaction 0.5 Cu / His6CopZ + apo-CopAab, Figure 6.3.6 presents the resultant
plots when the protein concentrations were varied. Here, each of the curves depicts a de-
crease in absorbance at each concentration of His6CopZ, as expected for copper transfer
from His6CopZ to CopAab.
A single exponential decay function was used to fit the data, resulting in the following
constants for each concentration of CopZ: 280± 5.1 s-1 for 20 μM His6CopZ, 263± 2.2 s-1
for 60 μM His6CopZ. When the concentration of CopAab was varied, again, the resulting
rate constants: 278 ± 3.5 s-1 for 20 μM CopAab, and 270 ± 2.8 s-1 for 60 μM CopAab.
These values compare reasonably well with the rate constant (247 ± 2.2 s-1) calculated for
both His6CopZ and CopAab at 40 μM (see Fig 6.3.5).
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Figure 6.3.6: Kinetics of Cu(I) transfer of 0.5 Cu / His6CopZ at varied con-
centrations mixed with apo-CopAab, 25 ◦C. Change in absorbance intensity
at 265 nm plotted against time after rapid mixing of apo-CopAab at 40 μM mixed
with: A) 60 μM 0.5 Cu / His6CopZ B) 40 μM 0.5 Cu / His6CopZ C) 20 μM 0.5 Cu
/ His6CopZ. The data were fit to single exponential function from which the rate
constant was derived, and is labelled on each plot. These plots illustrate that the
rate constant is not dependent upon concentration of His6CopZ.
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Results from the reverse reaction, apo-His6CopZ + 0.5 Cu / CopAab, at 25 ◦C are
presented in Figure 6.3.7, where protein concentrations were varied as above. Each of the
curves depicts a increase in absorbance, in accordance with copper transfer from CopAab
to CopZ.
A single exponential decay function was fitted to each of the traces, giving rate con-
stants for each concentration of CopZ: 243 ± 3.6 s-1 for 20 μM His6CopZ, and 249 ± 3.5
s-1 for 60 μM His6CopZ. The following rate constants were found when concentration of
CopAab was varied: 231 ± 3.6 s-1 for 20 μM CopAab, and 321 ± 3.5 s-1 for 60 μM Co-
pAab. These values compare reasonably well to that obtained when both proteins at 40
μM CopAab, 258 ± 2.6 s-1 (see Fig 6.3.5).
The plots of copper transfer between CopAab and His6CopZ when one is loaded with
0.5 Cu(I) / protein illustrate that copper transfer in both directions is a rapid reaction com-
plete within 20 milliseconds. In addition, the agreement between rate constants obtained
in both directions of copper transfer indicates the same rate-limiting step occurs in both
reactions. The fact that the rate does not change with protein concentration suggests it is
a true first-order process.
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Figure 6.3.7: Kinetics of Cu(I) transfer of 0.5 Cu / His6CopZ mixed with apo-
CopAab at varied concentrations, 25 ◦C. Change in absorbance intensity at
265 nm plotted against time after rapid mixing of 0.5 Cu / His6CopZ at 40 μM
mixed with: A) 60 μM apo-CopAab B) 40 μM apo-CopAab C) 20 μM apo-CopAab.
The data were fit to single exponential function from which the rate constant was
derived, and is labelled on each plot. These plots illustrate that the rate constant
is not dependent upon concentration of apo-CopAab.
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Kinetics of Cu(I) transfer at varied temperature
At 25 ◦C, similar ΔA values were obtained for forward/reverse directions for reactions car-
ried out at complementary protein concentrations, suggesting that copper transfer is re-
versible. However, the change in absorbance did not represent the expected transfer of
half the copper; given the rapidity of this reaction, that suggested that some transfer oc-
curred within the dead time of the instrument. Therefore the reaction was carried out at
lower temperature, with the aim of slowing the reaction in order to determine the extent of
copper transfer.
For the reaction 0.5 Cu / His6CopZ + apo- CopAab (Figure 6.3.8), the concentration
of 0.5 Cu / His6CopZ and apo-CopAab was varied for this reaction, at 15 ◦C. Each of the
curves depicts an decrease in absorbance in each experiment, as expected for copper
transfer from CopZ to His6CopZ. A single exponential decay function was fitted to each
of the traces, resulting in similar rate constants for each concentration, as labelled in the
figure.
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Figure 6.3.8: Kinetics of Cu(I) transfer of apo-His6CopZ at varied concen-
trations mixed with 0.5 Cu / CopAab, 15 ◦C. Change in absorbance intensity at
265 nm plotted against time after rapid mixing of 0.5 Cu / CopAab at 40 μM mixed
with: A) 60 μM apo-His6CopZ B) 40 μM apo-His6CopZ C) 20 μM apo-His6CopZ.
The data were fit to single exponential function from which the rate constant was
derived, and is labelled on each plot. These plots illustrate that the rate constant
is not dependent upon concentration of His6CopZ.
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Again, for the same reaction 0.5 Cu / His6CopZ + apo- CopAab, the concentrations
of 0.5 Cu / His6CopZ and apo-CopAab were varied for this reaction, at 10 ◦C. Each of the
curves depicted in (Figure 6.3.9) displays a decrease in absorbance in each experiment, as
expected for copper transfer from CopZ to His6CopZ. A single exponential decay function
was fitted to each of the traces, resulting in rate constants as labelled in the figure.
Here, again, the calculated rate constants appeared to be independent of starting
concentration of either reactant, suggesting that the formation of the heteroprotein complex
is not the rate-limiting step. This would suggest that some element of copper transfer
within the complex, or dissociation of the complex into constitutent proteins, is the rate-
limiting step. Across these experiments, the rate decreases with decreasing temperature
(as expected), enabling a greater extent of copper transfer to be visualised. However,
the extent of copper transfer still does not seem to be represented by the ΔA265nm values
shown.
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Figure 6.3.9: Kinetics of Cu(I) transfer of apo-His6CopZ at varied concen-
trations mixed with 0.5 Cu / CopAab, 10 ◦C. Change in absorbance intensity at
265 nm plotted against time after rapid mixing of apo-His6CopZ at 40 μM mixed
with: A) 60 μM 0.5 Cu / CopAab B) 40 μM 0.5 Cu / CopAab C) 20 μM 0.5 Cu
/ CopAab. The data were fit to single exponential function from which the rate
constant was derived, and is labelled on each plot. These plots illustrate that the
rate constant is not dependent upon concentration of His6CopZ.
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6.4 Results: Copper Transfer Between CopZ and CopAab via
ESI-MS
6.4.1 Mixture Of Species Detected In Mass-To-Charge Spectrum
The native ESI mass spectra prior to deconvolution are presented in Figure 6.4.1 of sam-
ples containing: CopZ prepared at 0.5 Cu / protein and then mixed with apo-CopAab;
apo-CopZ mixed with CopAab prepared at 0.5 Cu / protein. The mass spectrum prior to
deconvolution of the sample containing 0.5 Cu / CopZ and apo-CopAab is shown in its
entirety in Figure 6.4.1A with an expanded view of the low-intensity, lower charge state
peaks. These spectra illustrate multiple peak envelopes which arise from the mixture of
species in solution: CopZ, CopAab and a complex formed between CopZ and CopAab.
The CopZ envelope comprises monomer with 3+, 4+, 5+ and 6+ charges, with a small
amount of dimer peak with 7+ charges (peak m/z 2097.0) and a small amount of CopZ
trimer peak with 10+ charges (m/z 2201.9). The CopAab envelope predominantly consists
of monomer peaks with 8+ and 9+ charges, and a low-intensity monomer peak with 7+
charges. Also present is an additional set of peaks corresponding to a complex formed by
CopZ and CopAab with 9+, 10+ and 11+ charges.
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Figure 6.4.1: Mass spectra for mixtures of CopZ and CopAab. Mass spec-
tra prior to deconvolution of samples containing: A) 0.5Cu / CopZ + apo-CopAab
B) expanded view of 0.5 Cu/CopZ + apo-CopAab C) apo-CopZ + 0.5Cu/CopAab
D) expanded view of apo-CopZ + 0.5 Cu/CopAab. Each protein envelope is la-
belled with the corresponding charge state of each peak, as follows: Aab, CopAab
monomer; Aab2, CopAab dimer; Z, CopZ monomer; Z2, CopZ dimer; Z3, CopZ
trimer; Z:Aab, CopZ-CopAab complex. The spectra illustrate the mixture of peak
envelopes arising in samples containing mixtures of the two proteins.
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The mass spectrum prior to deconvolution of the other sample, which contained a
mixture of apo-CopZ with CopAab prepared at 0.5 Cu / protein (Figure 6.4.1B) depict
a similar distribution of individual species: mostly CopZ monomer (4+, 5+, 6+) and Co-
pAab monomer (8+, 9+), with low-intensity peaks representing CopZ dimer (7+) and trimer
(10+), and CopAab dimer (12+, 13+). Also observed, as above, are peaks due to the CopZ-
CopAab complex (9+, 10+, 11+). The location and distribution of charge states agrees with
that observed in native ESI-MS experiements carried out with the individual proteins (see
Chapter 4 and 5), suggesting here that the proteins are folded in solution, with no major
conformational changes when they exist in a mixture, apart from formation of a heteropro-
tein complex between them.
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6.4.2 Copper-Bound CopZ:CopAab Complex Observed
The monomer and dimer species observed via ESI-MS in samples containing mixtures
of CopZ and CopAab are presented in Figure 6.4.2. As seen above, the spectra after
deconvolution reveal a mixture of CopAab and CopZ species. Despite the low intensity of
some species, the peaks were resolved from the baseline with minimal applied smoothing,
with sodium adduct formation observed.
Comparing the spectra from each sample reveals that, regardless of which protein
is copper-loaded prior to mixing, a similar species distribution results and the predomi-
nant copper-bound peak is CuCopAab. Also present is a significant proportion of apo-
CopAab, with the most intense species being apo-CopZ. Additional copper-bound peaks,
both monomer and dimer, are observed at low intensity: CuCopZ, Cu(CopAab)2, and
Cu2(CopAab)2.
The relative intensities and exact masses of these species are presented in Table 6.1.
The exact masses observed are mostly within 1 Da of the predicted mass. One exception
is Cu2(CopZ)2; the reason for the observed mass difference of ∼ 5 Da is likely due to its
low intensity.
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Figure 6.4.2: Deconvoluted mass spectra for mixtures of CopZ and CopAab.
The mass spectra prior to deconvolution containing: A) 0.5 Cu / CopZ + apo-
CopAab, and B) apo-CopZ + 0.5 Cu / CopAab. The species distribution result-
ing from copper transfer in either direction is similar, resulting in the predomi-
nant copper-bound species, CuCopAab. Additional low-intensity copper-bound
species, including CuCopZ, are observed.
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Table 6.1: Species observed via ESI-MS of mixtures of CopZ and CopAab. Relative
intensities and observed masses of species appearing in native ESI-MS spectra where
CopZ and CopAab were mixed, one apo- and one at 0.5 Cu / protein.
Species Pred (Da) 0.5 Cu/CopZ + apo-CopAab apo-CopZ + 0.5 Cu/CopAab
CopZ 7336.1 100% 7336.2 100% 7336.0
CuCopZ 7400.5 5% 7400.2 5% 7400.5
(CopZ)2 14673.2 11% 14672.6 7% 14671.7
Cu(CopZ)2 14723 0% – 0% –
Cu2(CopZ)2 14799.3 2% 14794.0 0% –
CopAab 15909.0 43% 15909.2 0% –
CuCopAab 15972.6 44% 15973.5 0% –
CopZ3 22008.3 5% 22009.6 0% –
CopZ:CopAab 23245.1 4% 23244.8 4% 23245.5
Cu(CopZ:CopAab) 23309.9 3% 23309.7 6% 23311.6
Cu2(CopZ:CopAab) 23374.2 7% 23374.0 10% 23374.5
Figure 6.4.3 illustrates the region in each spectrum where a copper-bound complex
between CopZ and CopAab was observed. These peaks are of low intensity, but this is
reasonable as their formation is expected to be transient and relies on encounters between
individual proteins. A small amount of copper-free complex may have arisen from disulfide-
bonded proteins, and two copper-bound complex species are observed: Cu(CopZ:CopAab)
and Cu2CopZCopAab. It is unclear which domain(s) of CopAab (a or b) participate in coor-
dination of copper, and it is possible that the Cu(CopZ:CopAab) species is disulfide bonded.
However, the Cu2(CopZ:CopAab) species suggests copper transfer between CopZ and
one domain from CopAab.
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Figure 6.4.3: Deconvoluted mass spectra for mixtures of CopZ and CopAab,
complex formation. The mass spectra depicting the CopZ:CopAab complex
formed in samples containing: A) 0.5 Cu / CopZ + apo-CopAab, and B) apo-CopZ
+ 0.5 Cu / CopAab.
In order to compare the species distribution in these mixtures of CopZ and CopAab, the
relative intensities of species present in these samples are plotted as bar graphs in Figure
6.4.4. Most of the peaks observed are at similar relative intensity in each sample. Re-
gardless of which protein is copper-loaded prior to mixing, the predominant copper-bound
species is CuCopAab, and its relative intensity is similar in both spectra. The intensities of
the CopZ:CopAab complex species are fairly similar in each sample, with a slightly higher
amount in the sample prepared by mixing apo-CopZ with 0.5 Cu / CopAab. The dominance
of apo-CopZ may mask the extent of copper transfer by suppressing other peaks; mass
spectra of CopZ (see Chapter 4) also revealed persistently high relative intensity of apo-
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Figure 6.4.4: Species distribution observed via ESI-MS of mixtures of CopZ
and CopAab. Bar graphs illustrating the relative intensity of each species present
in the deconvoluted mass spectra of samples as labelled.
CopZ. In addition, for the mass spectra at 0.5 Cu / protein of CopZ (Figure 4.2.3A) and Co-
pAab (Figure 5.3.2A), the relative intensity of the apo-protein peak was diminished. Here, it
is possible that the relative proportions of apo-CopZ/CuCopZ and apo-CopAab/CuCopAab
provide some indication of copper loading.
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6.5 Discussion
Despite the extremely high affinity for Cu(I) displayed by CopZ and CopAab, copper trans-
fer between the proteins is very rapid [163], with a transfer mechanism likely involving
a protein-protein interaction. Heteroprotein complex formation for cognate Atx1-like/MBD
pairs including CopZ and CopAab has been observed previously, leading to roughly equal
distribution of copper between the proteins [163] [66] [67]. Though the weak thermody-
namic drive for copper transfer implies copper exchange is under kinetic control [66], rate
measurements have not been reported.
In order to gain further understanding of Cu(I) transfer between CopZ and CopA, it
was desirable to measure the off-rate of Cu(I) from CopZ, in the absence of any influence
of protein-protein interactions. The formation constant which defines the first Cu(I)-bound
species, Cu(CopZ)2, was established previously (β2 = ∼ 10 22 M -2) and illustrates the
extremely high affinity of CopZ for Cu(I). However, at a ratio of 0.5 Cu / CopZ, a small
amount of CopZ monomer remains, suggesting that the affinity constant associated with
binding of the second CopZ is not particularly high, K2 ∼ 105 M-1 [89]. Therefore, the tight
binding is dominated by the stability constant K associated with binding of the first Cu(I) to
form CuCopZ.
Cu(I) + CopZ
K1
−−−−−−→ CuCopZ (6.1)
CopZ + CuCopZ
K2
−−−−−−→ CuCopZ2 (6.2)
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The affinity constant represents the association and dissocation reactions between Cu(I)
and CopZ as a ratio of the on-rate constant kon and the off-rate constant koff.
Cu(I) + CopZ
koff


kon
CuCopZ
Therefore the rate of change of concentration of the product, CuCopZ, can be expressed
as a combination of the association and dissociation terms:
d[CuCopZ]
dt
= [Cu][CopZ]kon − [CuCopZ]koff (6.3)
At equilibrium, the forward and reverse binding transitions would be balanced, therefore
these terms would be equal.
[Cu][CopZ]kon = [CuCopZ]koff (6.4)
This expression can be rearranged to express the dissociation constant as a ratio of off-rate
to on-rate constants, where koff has units of s -1, and kon has units M -1 s -1:
KD =
koff
kon
=
[Cu][CopZ]
[CuCopZ]
(6.5)
The maximum value of the on-rate constant is limited to that for a diffusion-controlled re-
action, kon ∼ 108 M-1 s-1, suggesting the upper limit for the off-rate constant is very low
(predicted to be 10-9 s-1). In order to measure the off-rate of Cu from CuCopZ “directly”,
reassociation was limited by placing the 0.5 Cu / CopZ sample into a dialysis cassette in a
beaker of buffer. As a receptor to monitor Cu(I) release, a second dialysis cassette was im-
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mersed containing apo-His6CopZ, which has been demonstrated to have identical copper-
binding behaviour as the non-tagged protein [179]. This experimental setup dictated that
copper transfer would first take place via dissociation of Cu from CopZ in solution, rather
than being facilitated by interaction between the two proteins.
Because of the extremely high affinity of copper chaperones for Cu(I) and the need to
protect the cytoplasmic environment from the deleterious effects of copper, it was expected
that very little, if any, copper would be released from CopZ over a measureable period.
Though the absorbance of Cu-bound CopZ did decrease slightly between 24 and 48 hours,
this was not accompanied by an appreciable increase in absorbance of apo-His6CopZ.
The beaker buffer was not found to contain any Cu(I), in agreement with previous studies
demonstrating that cytoplasmic Cu(I) content is virtually zero [180].
Therefore, it is likely that the majority of the absorbance change is not attributable to
loss of Cu(I) from CopZ but, rather, experimental constraints associated with measuring
small amounts of slow transfer of copper, such as slight instrument drift or a small amount
of protein loss due to adsorption to the dialysis membrane. The insignificant detection of
copper transfer over the course of two days is supportive of the prediction that the off-rate
constant in Equation 6.4 would have very small magnitude.
Although stability of CopZ was not sufficient to definitively determine the off-rate con-
stant, the data acquired do have utility in establishing its upper limit. This was achieved
by fitting a single exponential function to the data giving a rate constant of ∼ 10-5 s-1.
This would make the relationship between variables in Eqn 6.5 reasonable based upon the
limitations of this experiment, i.e., a difference of several orders of magnitude between koff
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and KD and an assumption of a diffusion-limited reaction ( ∼10-9 s-1). Regardless it can be
concluded that, if the mechanism for copper transfer relied upon dissociation of Cu(I) from
the Cu(CopZ)2 or CuCopZ complex, the rate would be exceptionally slow.
This kinetic limitation is overcome by Atx1-like chaperones’ interaction with their cog-
nate ATPase MBDs, in which a complex that facilitates Cu(I) transfer is formed at least
transiently. Such a complex has been observed for yeast Atx1 and Ccc2 [67], and B. sub-
tilis CopZ and CopAab [163], and human Atox1 and ATP7A/B [49]. Although Cu(I) transfer
occurs readily, the rate at which it occurs has not been determined for any chaperone
transfer pair.
In order to characterise the kinetics of copper transfer between CopZ and CopAab at
low copper loadings, a method was employed using stopped flow rapid mixing monitored
by UV-visible absorbance, where the proteins’ differing response in A265nm upon binding
of Cu(I) was exploited to monitor the direction and rate of copper transfer. Based upon
the relative absorbance changes for the individual proteins, the direction of copper transfer
was as expected: transfer from CopAab to CopZ resulted in an increase in signal, with a
decrease in signal observed for the reverse transfer from CopZ to CopAab.
Stopped-flow experiments carried out with His6CopZ here exhibited the same be-
haviour as the non-tagged construct, in agreement with previous data establishing its Cu(I)-
binding behaviour [177]. Repeating the experiments with His6CopZ and CopAab generated
comparable plots, whose exponential fits revealed rate constants of k = 258 ± 2.6 s-1 and
247 ± 2.2 s-1, in agreement with data obtained for non-tagged CopZ.
The observed changes in absorbance permitted the direct monitoring of copper trans-
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fer between the species, Cu(CopZ)2 and CopAab, and in the reverse direction between
CuCopAab and CopZ. At 25 ◦C, the magnitude of absorbance intensity changes were ap-
proximately the same in both directions, ∼0.007 AU, suggesting that the same amount
of copper was transferred in both reactions. These observations are in agreement with
a previous experiments which found copper to be equally distributed between the pro-
teins following equilibration and separation [177] and a shallow thermodynamic gradient
for transfer at higher copper loadings [163]. Here, the transfer reaction was found to be
rapid, being complete well within 20 milliseconds.
A single exponential function fitted the data well, with apparent first-order rate con-
stants of 200 – 300 s-1 in both directions, suggesting the rate-limiting step in both direc-
tions is the same. Previous luminescence data at higher copper loadings suggested the
rate constants differ for the “forward” and “reverse” direction of copper transfer, but this
could be due to conformational changes required for CopAab which is a dimer at higher
levels of copper [163]. Though CopZ is a dimer at this copper loading, the high affinity
is dominated by K1 as described above. Therefore, here the copper transfer measured is
likely to be carried out within a CopZ:CopAab complex.
In order to determine whether the copper transfer reaction rate was dominated by
formation or dissociation of the complex species, the concentration dependence of the
reaction was explored. After varying the concentrations of both reactants, there appeared
to be no effect upon the kobs, suggesting that the rate-limiting step is not complex formation.
These data concur with kinetics of copper transfer between CopZ and chelator BCS [84]
where the rate constant in both directions of copper transfer was found to be the same,
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suggesting that the same step was rate-limiting in both reaction directions.
Not only do the stopped flow data indicate that the rate of copper transfer is the same in
both directions, they illustrate that copper transfer from CopZ to CopAab by way of complex
formation proceeds at a ∼107-fold increase in Cu(I) off-rate than in the absence of protein
interaction.
To examine the species present at equilibrium upon transfer of copper between CopZ
and CopAab, native ESI-MS was carried out using: apo-CopZ + 0.5 Cu/CopAab, and 0.5
Cu/CopZ + apo-CopAab. The charge state distribution observed in these mass spectra
were in agreement to the individual proteins’ mass spectra (see Chapter 4 and 5), sug-
gesting the monomers remain folded without major structural changes when in a mixture.
The resulting spectra from both directions of copper transfer contained a similar mixture of
copper-bound and copper-free species. The major species observed was apo-CopZ, and
the most intense copper-bound species is CuCopAab. Additional low-intensity peaks were
observed, including a complex between CopZ and CopAab.
The dominance of CuCopAab in the ESI-MS spectra suggests that all copper is trans-
ferred to CopAab, but comparing these results to the individual mass spectra, the extent
of copper transfer is unclear. Though the low peak intensity makes it difficult to interpret
this spectrum with certainty, there are some indications that copper has been transferred
between the proteins. At 0.5 Cu / protein, the most intense species observed were CuCo-
pAab (Figure 5.3.2A) and CuCopZ (Figure 4.2.2A), and this would imply these species
form first at low copper loadings (even below 0.5 Cu / protein). Thus, a high proportion
of apo-CopZ and apo-CopAab would be expected. However, no appreciable amount of
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Cu2CopAab was observed, which was observed in the individual spectrum of CopAab pre-
pared at 0.5 Cu / protein. Here, had all the copper been transferred to CopAab, its loading
would be 0.5 Cu / protein and Cu2CopAab species would be expected. This suggests that
transfer of some, but not all copper has taken place.
Again, a sizeable proportion of apo-CopAab and apo-CopZ was expected, as the over-
all copper loading is 0.25 / protein. However, the apo-CopZ peak was always very intense
even in the presence of copper (see Chapter 4). Here, in the mixed samples, a noticeable
difference between the two spectra are the relative intensities of CopAab and CuCopAab
peaks. ESI-MS of CopAab at 0.5 Cu / CopAab (Figure 5.3.2A) revealed the apo-CopAab
peak to be of much lower intensity than CuCopAab. Here, that is not the case, perhaps
suggesting not all copper is bound by CopAab.
An important observation in the ESI-MS experiment is a hetero-complex observed
in both spectra, where CopZ:CopAab coordinates 1 or 2 copper ions. It is possible the
complex species CuCopZCopAab represents exchange between CuCopZ and one of the
CopAab domains (a or b). The species Cu2CopZCopAab could depict the same exchange
process with the other domain (a or b) in possession of copper. The expected products are
observed, CuCopAab ( ∼45%) and CuCopZ ( ∼5%). The different relative intensities of
these products could arise from dissimilar ionisation intensities, or from continual exchange
to form CuCopAab which results in decreased proportion of CuCopZ. The presence of a
complex species implies that that copper transfer indeed has taken place and is continually
being exchanged in this equilibrium mixture.
The data presented in this chapter support a copper transfer mechanism that involves
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rapid copper transfer between CopZ and CopAab, by way of a heteroprotein complex.
Further work is needed to establish ESI-MS data which reveal the species present during
copper transfer between these two proteins.
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Chapter 7
Studies Of Cu(I) Binding To Copper Chaperones From Streptomyces lividans
and Saccharomyces cerevisiae
7.1 Introduction
Metallochaperones are highly conserved throughout biology, transporting and effectively
distributing potentially dangerous copper ions throughout the cell. The exact mechanisms
of copper movement throughout the cell are not fully defined, but their action is known to
rely on binding Cu(I) with high affinity/specificity, such that essentially none exists in free
form in the cytoplasm.
The Atx1-like copper chaperones are ∼ 75 residue proteins, with a conserved βαββαβ
fold, exhibiting high affinity for Cu(I) (Kd ∼ 1018 M-1). Saccharomyces cerevisiae Atx1 is the
eponymous member of the Atx1-like copper chaperones demonstrated to transfer Cu(I) to
the N-terminal domains of its cognate transport protein, Ccc2, in a direct and reversible
manner [66] [34], similar to B. subtilis CopZ. Streptomyces lividans is a soil dwelling-
bacterium which requires copper ions for development [72]. The S. lividans copper eﬄux
system is upregulated through Cu(I) binding of copper sensitive operon repressor (CsoR).
Under the transcriptional control of CsoR are CopZ-3079 and CopZ-1317, two Atx1-like
proteins [73].
Like B. subtilis CopZ, these three copper chaperones have been characterised by
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solution-phase biophysical studies, and demonstrated to form both a monomer and dimer
in vitro with evidence of an effect of LMWT upon association state. In addition, examining
their behaviour enables comparisons to be made across multiple kingdoms of biology and
explore the effect of particular conserved residues. Comparing the amino acid sequences
of some Atx1-like proteins (Figure 7.1.1) illustrates their conserved residues.
Figure 7.1.1: Aligned primary sequences of Atx1-like copper chaperones.
The primary sequences of CopZ from S. lividans, S. cerevisiae and B. subtilis
are aligned with residues highlighted: those conserved among all four (black);
conserved among prokaryotic (gray); X3 and loop 5 residues (light gray)
CopZ-1317 and CopZ-3079 were demonstrated via BCS competition to exhibit high
affinity for Cu(I), with KD(Cu(I)) of: 2.1 × 10-17 M for CopZ-1317, and 3.7 × 10-18 M for
CopZ-3079 [74]. Transcription levels suggested that CopZ-3079 contributes far more to
Cu(I) resistance, as during copper stress, CopZ-1317 is less than 2% of transcription. In
titration experiments with a solution of BCA, this chelator was unable to remove any Cu(I)
from either CopZ-1317 or CopZ-3079 beyond a level of 1 Cu / protein. However, this may
indicate an overall copper / protein ratio within a mixture. Spectroscopic studies demon-
strated these proteins can form higher order assemblies at elevated copper levels, and size
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exclusion chromatography confirmed their inability to form in the presence of LMWT.
Residues other than cysteine in the conserved MX1CX2X3C motif typically do not par-
ticipate in metal binding (Figure 7.1.2). The X1 site usually contains a His, Thr, Asp or Ser;
X2 and X3 are frequently small and hydrophobic, or polar uncharged residues, such as Ala,
Gly, Ser [181]. However, many prokaryotic variants have a histidine at X3 for example in
B. subtilis CopZ whose crystal structure of Cu4(CopZ)2 revealed that this histidine serves
as an additional Cu(I) ligand in the dimerised form of the protein [81]. This may indicate a
greater propensity for prokaryotic Atx1-like chaperones, or at least those featuring histidine
at X3, to form dimers.
Another conserved residue thought to be functionally important is on loop 5 follow-
ing the last conserved glycine, typically a lysine in eukaryotes and a tyrosine in prokary-
otes. The cyanobacterial Atx1 contains a histidine, which acts as a Cu(I) ligand that is
released upon complex formation with a partner protein [182]. In other organisms, though
this residue does lie in proximity to the Cu(I) binding site, it does not serve as a Cu(I)
ligand [171]. The prokaryotic Tyr has been shown to form a hydrophobic patch through
its interaction with the conserved methionine, which may facilitate protein-protein recog-
nition with CopA [81]. In eukaryotes the positive charge of the lysine is thought to sta-
bilise the Cu(I) oxidation state through charge balance, and inhibit the need for dimerisa-
tion [183] [184] .
In addition, this residue may influence the solvent accessibility of the bound Cu(I)
ion, making it more buried in eukaryotic proteins than in their prokaryotic counterparts;
perhaps this limits the likelihood of dimerisation. For example, in S. cerevisiae Atx1, Lys65
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affects solvent accessibility of the Cu(I) [41] with the mechanism for Cu transfer involving
changes of the relative positioning of Lys65 and the Ccc2 MBD [185]. In human Atox1, the
positioning of Lys60 creates two alternating configurations of the coordination site, where
the copper is either more solvent-exposed or -buried. This arrangement is not present in
bacterial and yeast Atx1 proteins, and is proposed to have evolved to effectively capture
and then safely cradle Cu(I) ions [170]. Though this conserved Lys may confer a protective
effect in eukaryotes precluded in the prokaryotic versions by protein dimerisation, both
prokaryotic and eukaryotic proteins have been demonstrated to form higher order copper-
bound assemblies in vitro. Examples include human Hah1 [57] [186], yeast Atx1 [187], E.
hirae CopZ [188], Synechocysis PCC6803 Atx1 [139].
Figure 7.1.2: Cu(I)-binding site of B. subtilis CopZ. Ribbon structure of B.
subtilis CopZ with a single Cu(I) bound, along with an expanded view of the Cu(I)-
binding site. Residues from the conserved MX1CX2X3C motif are labelled: Met;
copper-coordinating Cys; residue in the X3 position (here, His15) and the con-
served loop 5 residue (here, Tyr65). Figure adapted from NMR solution structure
(PDB: 1K0V) [40].
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The physiological relevance of these higher order assemblies is debatable, due to
the influence of cytoplasmic low molecular weight thiols (LMWT), which exhibit moderately
high Cu(I) affinities [138] and can serve as exogenous Cu(I) ligands [40] [186]. It is unclear
whether the presence of a low molecular weight thiol species in vitro promotes or inhibits
dimerisation, even in the presence of copper. Human Atox1 has been reported to bind Cu(I)
as a monomer in a 1:1 ratio when prepared at 1 Cu / protein in the presence of DTT [189],
but also has been observed to dimerise when prepared in the absence of LMWT [57] and
again in the absence of LMWT though in the presence of tris(2-carboxyethyl)phosphine
(TCEP) [186].
Monomeric yeast CuAtx1 was reported in the solution structure in the absence of
LMWT [41] and also in the presence of LMWT, even when loaded with excess Cu(I) [66].
However, more recently the presence of LMWT was reported to induce dimerisation of
Atx1 [187] when in the presence of glutathione (GSH), Cu2Atx12GSH2 formed, which was
not observed in the absence of GSH [190]. In addition, a trimeric Cu(I)-bound form of Atx1
has also been reported in the presence of endogenous thiol ligands, in a crystal structure
solved after treatment with copper chelator tetrathiomolybdate (TM) (MoS4-) [191], though
this trimeric form may only occur in the case of molybdenum toxicity.
The effect that varied Cu(I) and LMWT levels have upon the mixture of copper-bound
species formed by copper chaperones is complex. Perhaps the prokaryotic histidine at X3
favours dimerisation, but this effect may be inhibited by LMWT due to Cu(I) competition
effects. In the absence of this histidine, the eukaryotic variants may not undergo dimerisa-
tion in the same way, also influenced by the conserved lysine residue at the copper-binding
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site. Thus it would be expected that dimerisation might occur for the eukaryotic proteins at
higher copper / protein levels. Observation of Cu2Atx12GSH2 combined with high intracel-
lular GSH concentrations implies this, too, is a physiologically relevant copper-bound form
of Atx1, with the LMWT serving as an additional Cu(I) ligand in the dimeric forms. Defining
the physiologically relevant copper-bound forms of these proteins requires consideration of
their copper-binding behaviour in the presence and absence of LMWT. To this end, ESI-MS
was carried out to examine the copper-bound species present at varied copper levels with
and without DTT of S. cerevisiae Atx1 and S. lividans CopZ-1317 and CopZ-3079.
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7.2 Materials And Methods
7.2.1 Preparation Of CopZ-3079, CopZ-1317 And Atx1 For ESI-MS
Samples of S. lividans CopZ-1317 and CopZ-3079 were kindly provided by Dr Jonathan
Worrall and S. cerevisiae Atx1 by Professor Christopher Dennison, which had been puri-
fied as described previously [74] [139]. Mass spectrometry samples were prepared with
reagents prepared in deoxygenated LC-MS grade water (HiPerSolv, VWR) in an anaerobic
glovebox (Faircrest Engineering, O2 concentration <2 ppm). Protein disulfide bonds were
reduced with 15 mM DTT (Formedium) and the protein was exchanged into 20 mM am-
monium acetate, pH 7.4 (Sigma) using a G25 Sephadex column (PD10, GE Healthcare).
Protein concentrations were determined by recording UV-visible absorbance spectra on a
Jasco V-550 spectrophotometer and using extinction coefficients, ε276 nm, of 2980 M-1 cm-1
(CopZ-1317), 1490 M-1 cm-1 (CopZ-3079), and 4470 M-1 cm-1 (Atx1) [74]. Protein samples
were diluted with 20 mM ammonium acetate to a working sample concentration of 5 – 10
μM. To prepare Cu(I)-bound protein samples, a deoxygenated solution of Cu(I)Cl prepared
in 100 mM HCl,1 M NaCl was added using a microsyringe (Hamilton) to anaerobic, reduced
protein exchanged into 250 mM HEPES, pH 7.5. Unbound Cu(I) was removed by passage
of the sample down a G25 Sephadex column (PD10, GE Healthcare) equilibrated with
20 mM ammonium acetate, pH 7.4. For DTT experiments, anaerobically prepared DTT
(Formedium) (for structural representation, see Section 4.2.3) was added to aliquots of
protein containing 2 molar equivalents of Cu(I), to yield thiol/protein ratios described for
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each protein.
7.2.2 Electrospray Ionisation Mass Spectrometry
Mass spectra were acquired using a Bruker micrOTOF-QIII electrospray ionisation (ESI)
time-of-flight (TOF) mass spectrometer (Bruker Daltonics, Coventry, UK), in positive ion
mode. The ESI-TOF was calibrated in the m/z range 300 – 2200 using ESI-L Low Con-
centration Tuning Mix (Agilent Technologies, San Diego, CA). Native protein samples were
introduced to the ESI source via a syringe pump (Cole-Parmer) at 3 μL/min, and data ac-
quired for 2 min, with ion scans between 50 – 3400 m/z. MS acquisition was controlled
using Bruker oTOF Control software, with parameters as follows: dry gas flow 5 L/min,
nebuliser gas pressure 0.8 Bar, dry gas 180 ◦C, capillary voltage 4500 V, offset 500 V,
quadrupole RF energy 1000 Vpp and 2575 Vpp (50:50), and transfer time 136 μs and 146
μs (50:50). The spectra were deconvoluted using the ESI Compass version 1.3 Maximum
Entropy deconvolution algorithm version 4.1 (Bruker Daltonik, Bremen, Germany) over a
mass range of 7000 – 30,000 Da. Overlapping peak envelopes were deconvoluted man-
ually. Exact masses were determined from peak centroids, with minimal (no more than
3-point Gaussian) smoothing applied.
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7.3 Results: Cu(I) Binding Of Copper Chaperones From Strep-
tomyces lividans
7.3.1 ESI-MS Of Cu(I) Binding To CopZ-3079
In order to investigate its copper-binding behaviour, mass spectra were recorded of CopZ-
3079 prepared at 0, 1 and 2 Cu / protein (Figure 7.3.1). The mass spectrum of apo-CopZ-
3079 (Figure 7.3.1A) contained three peaks comprising the monomer envelope with 4+,
5+ and 6+ charges; the peak with 6+ charges was most intense. At a copper level of 1
/ protein, the monomer peak envelope was present, along with a dimer peak envelope
with the predominant peak possessing 9+ charges, and some overlap between monomer
and dimer envelope at 4+/8+ and 5+/10+. When the copper level was increased to 2 Cu /
protein, the dimer peak containing 9+ charges became the most intense, with a decrease
in the monomer peaks’ intensities. The charge state distribution is very similar to that
observed for B. subtilis CopZ in its apo- and Cu-bound forms. In addition, the charge state
envelope does not shift upon Cu-binding, suggesting CopZ-3079 is folded before and after
copper binding occurs.
The deconvoluted mass spectra (Figure 7.3.2) illustrate the species present at each
copper loading, while their exact neutral masses and relative intensities are presented in
Table 7.1. The mass spectrum of CopZ-3079 prepared at 0 Cu / protein contains apo-CopZ-
3079 as its predominant peak. A low intensity CuCopZ-3079 peak has been assigned ( ∼
13%) but this is not very pronounced above the noise and could overlap with a trisodiated
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Figure 7.3.1: Mass spectra for CopZ-3079 at varied Cu(I) loadings. The mass
spectra prior to deconvolution of CopZ-3079 prepared at a level of: A) 0.0 Cu /
protein, B) 1 Cu / protein, C) 2 Cu / protein.
adduct of apo-CopZ-3079.
In the presence of copper, at a level of 1 Cu / protein, the most intense copper-bound
species are CuCopZ-3079 and Cu4(CopZ-3079)2, both near 100% relative intensity. The
next most intense copper-bound peak is Cu5CopZ-30792 at 34 % relative intensity. The
peaks for other dimeric forms, as well as apo-CopZ-3079 and Cu2Atx1 have diminished to
20% relative intensity.
When the copper level is raised to 2 Cu / protein, the most intense species is the
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dimeric copper-bound Cu6CopZ-30792. Also present are monomeric CuCopZ-3079 and
Cu2CopZ-3079, along with a diverse mixture of dimeric species. Among these copper-
bound dimeric peaks, Cu2(CopZ-3079)2 and Cu5CopZ-30792 are of elevated intensity
compared to the others, which could indicate that these species are intermediates favoured
during the formation of Cu6CopZ-30792.
Figure 7.3.2: Deconvoluted mass spectra for CopZ-3079 at varied Cu(I) load-
ings. Deconvoluted mass spectra of CopZ-3079 prepared at a level of: A) 0.0 Cu
/ protein, B) 1 Cu / protein, C) 2 Cu / protein. Diamond symbols represent Na+
adducts.
The observed masses are mostly within 1 Da of their predicted mass, with some slight
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Table 7.1: Species observed via ESI-MS of CopZ-3079 at varied Cu(I) loadings. Rela-
tive intensities and masses observed when CopZ-3079 prepared at 0, 1, and 2 Cu / protein.
Species Pred (Da) 0 Cu / CopZ 1.0 Cu / CopZ 2.0 Cu / CopZ
CopZ 8199.9 100% 8198.9 20% 8197.8 0% –
CuCopZ 8262.4 13% 8261.6 93% 8261.6 26% 8259.2
Cu2CopZ 8324.9 0% – 28% 8320.1 40% 8322.9
(CopZ)2 16399.9 7% 16396.6 26% 16394.6 0% –
Cu(CopZ)2 16462.4 0% – 23% 16458.3 9% 16456.2
Cu2(CopZ)2 16524.9 0% – 22% 16521.5 34% 16518.6
Cu3(CopZ)2 16587.4 0% – 18% 16585.5 11% 16583.5
Cu4(CopZ)2 16649.9 0% – 96% 16648.8 24% 16649.4
Cu5(CopZ)2 16712.4 0% – 34% 16709.8 45% 16710.9
Cu6(CopZ)2 16774.9 0% – 0% – 96% 16772.5
discrepancies. At 2 Cu / CopZ-3079, the masses of CuCopZ-3079 is 3.2 Da less than
predicted. The mass of Cu2CopZ-3079 is 2 – 4.8 Da less than predicted. The mass of
CopZ-30792 is 3.3 – 5.3 Da less than expected which most likely reflects the loss of hydro-
gens during disulfide formation, but is still slightly less than expected. Cu(CopZ-3079)2 is
3.9 – 6.2 Da less than expected, perhaps reflecting overlap with a trisodiated adduct, and
its ability to form one intramolecular disulfide while binding Cu(I) with another two cysteines.
The observed masses of the other dimeric forms are also 1.1 – 6.0 Da less than predicted
for reasons which are not clear. The size of the mass difference generally decreases with
increasing peak intensity, suggesting perhaps lower intensity peaks are less accurate due
to poorer peak shape/adduct overlap.
The bar graphs in Figure 7.3.3 illustrate that, as the Cu(I) level is increased, the pro-
portion of dimerised Cu(I)-bound CopZ-3079 increases. Two major species form at 1 Cu /
CopZ-3079: CuCopZ-3079 and Cu4(CopZ-3079)2; the low intensity of other dimer peaks
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Figure 7.3.3: Species observed via ESI-MS of CopZ-3079 at varied Cu(I) load-
ings. Species present in deconvoluted mass spectra of CopZ-3079 prepared at
a level of: A) 0 Cu / protein, B) 1 Cu / protein, C) 2 Cu / protein.
suggests cooperative formation of the tetra-copper species. At 2 Cu / CopZ-3079, the rel-
ative intensities of CuCopZ-3079 and Cu4(CopZ-3079)2 decrease, favouring formation of
Cu6(CopZ-3079)2. This implies an additional cooperative mechanism involved in formation
of a hexanuclear CopZ-3079 dimer species.
In order to compare the above data to solution-phase experiments, Figure 7.3.4 presents
unpublished data, acquired previously [192], size exclusion chromatography (SEC) of CopZ-
3079 at multiple copper loadings, and a plot representing change in absorbance occurring
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Figure 7.3.4: Size exclusion chromatography at multiple Cu(I) levels and UV-
vis Cu(I) titration for CopZ-3079. Unpublished data, acquired previously [192]
of: A) Size exclusion of CopZ-3079 prepared at molar equivalents of Cu(I) as
labelled B) Cu(I) binding by CopZ-3079 monitored using UV-visible absorbance
changes at 20 ◦C, pH 7.5. The absorbance changes observed for CopZ-3079
at 240 nm and 300 nm plotted as a function of Cu(I)/CopZ-3079 (CopZ-3079, 45
μM). Samples of CopZ-3079 were prepared in 10 mM MOPS pH 7.5, 150 mM NaCl
under anaerobic conditions, adding 0.5, 1.0, 1.5 or 2 molar equivalents of Cu(I) to
reduced CopZ-3079. Apo-CopZ-3079 concentrations were determined at 280 nm
using extinction coefficients based upon ProtParam ExPASy and concentrations
calculated using the Beer Lambert law. Size exclusion elution profiles created by
monitoring the absorbance at 280 nm on a 10/300 GL G-75 Superdex column
(GE-Healthcare) equilibrated in sample buffer. Absorbance measurements were
carried out on a a Varian Cary 50 UV-visible spectrophotometer set at 20 ◦C.
at selected wavelengths as Cu(I) was titrated into a solution of CopZ-3079. Fig 7.3.4A
displays the SEC chromatograms at 280 nm of CopZ-3079 at increasing ratios of Cu / pro-
tein, where it can be seen that CopZ-3079 forms higher order complexes when the Cu(I)
level is increased. The apo-protein elutes entirely as monomer (∼ 12.5 mL), at 0.5 molar
equivalent a small amount of dimer is present (∼ 11.5 mL), and above 0.5 molar equivalent
dimer is the majority species. At 1 Cu / protein, a small amount of monomeric protein is
present (∼ 12.5 mL), with the most intense peak (∼ 10.9 mL) according to the calibration
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curve corresponding to a molecular weight of ∼ 20 kDa. At 1.5 and 2 Cu / protein, the
monomeric peak is missing with only dimeric species present (∼ 10.9 mL). This species
distribution is similar to that observed in the mass spectra above.
The titration of Cu(I) into CopZ-3079 monitored by absorbance (Figure 7.3.4B) shows
changes in A240nm and A300nm with increasing Cu(I) level, which are in agreement with the
gel filtration data. At 1 Cu / CopZ-3079 distinct breakpoints are seen at both wavelengths,
and beyond this point the absorbance continually increases until a level of 2 Cu / protein
is reached. These trends are consistent with the ESI-MS data above, where a decrease
in monomer peak intensity was observed beyond 1 Cu / protein, favouring formation of
dimeric Cu6CopZ-30792.
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7.3.2 ESI-MS of Cu(I) Binding To CopZ-3079 In The Presence Of DTT
In order to examine the effect of LMWT upon Cu(I) binding by CopZ-3079, mass spectra
were recorded of 2 Cu / CopZ-3079 in the presence of 5, 10 and 40 DTT / protein. The mass
spectra prior to deconvolution are presented in Figure 7.3.5, revealing a fairly similar peak
distribution at all levels of DTT. Compared to the spectrum in the absence of DTT (Fig 7.3.1),
the monomer and dimer peak envelopes have not shifted, suggesting that CopZ-3079 does
not undergo major conformational changes in the presence of DTT and no DTT adduct
envelopes are observed. The dimer envelope intensity has greatly diminished, though
there is a low-intensity dimer peak with 9+ charges. The monomer peaks are most intense
with 5+ and 6+ charges being predominant, and a low intensity peak with 4+ charges.
Figure 7.3.5: Mass spectra for 2 Cu / CopZ-3079 at varied DTT levels. The
mass spectra prior to deconvolution of CopZ-3079 prepared at 2 Cu / protein in
the presence of: A) 5 DTT / protein, B) 10 DTT / protein, C) 40 DTT / protein.
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The deconvoluted mass spectra in Figure 7.3.6 illustrate the mixture of species present,
and their observed masses and intensities are presented in Table 7.2, and the relative in-
tensities of species present in the deconvoluted mass spectra are presented as bar graphs
in Figure 7.3.7. The spectra illustrate that a substantial proportion of the protein appears
as sodiated adducts. However, because these peaks occur in roughly equal proportion to
the protein species themselves, the relative intensities have been assigned based upon
the protein peaks alone. The species distribution is fairly similar at all levels of DTT, with
the dimer species being suppressed in favour of formation of Cu2CopZ-3079 at first (5 and
10 DTT / protein) and then the formation of CuCopZ-3079 (40 DTT / protein). Low-intensity
dimer peaks remain with a small amount of Cu2(CopZ-3079)2.
The observed masses, on average, are slightly less than the predicted masses. For
CopZ-3079 and Cu(CopZ-3079)2 this could be explained by intramolecular disulfide for-
mation. However, for the other copper-bound species the reason for these mass shifts is
not entirely clear.
Table 7.2: Species observed via ESI-MS of 2 Cu / CopZ-3079 at varied DTT levels.
Observed masses and relative intensities for CopZ-3079 prepared at 2 Cu / protein in the
presence of 5, 10 and 40 DTT / protein.
Species Pred (Da) 5 DTT / CopZ 10 DTT / CopZ 40 DTT / CopZ
CopZ 8199.9 2% 8198.6 8% 8198.6 14% 8199.0
CuCopZ 8262.4 44% 8261.3 67% 8261.5 100% 8261.6
Cu2CopZ 8324.9 100% 8323.6 100% 8323.1 76% 8323.9
Cu(CopZ)2 16462.4 0% – 5% 16459.6 4% 16459.4
Cu2(CopZ)2 16524.9 11% 16518.9 18% 16519.8 14% 16521.4
Cu3(CopZ)2 16587.4 7% 16582.6 8% 16583.0 6% 16586.9
Cu4(CopZ)2 16649.9 8% 16651.6 0% – 4% 16649.2
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Figure 7.3.6: Deconvoluted mass spectra for 2 Cu / CopZ-3079 at varied DTT
levels. Deconvoluted mass spectra of CopZ-3079 prepared at 2 Cu / protein in
the presence of: A) 5 DTT / protein, B) 10 DTT / protein, C) 40 DTT / protein. Na+
adducts indicated by ♦ symbols.
Bar graphs in Figure 7.3.6 illustrate the species distribution at each DTT loading. In
the absence of DTT, the most intense species present was Cu6CopZ-30792, but in the
presence of DTT, this and other dimer species are not present. With increasing DTT level,
the dimer species distribution shows slight tendency toward formation of Cu2(CopZ-3079)2,
but overall the dimer species have been abolished. At 5 and 10 DTT / protein, the dominant
species is Cu2CopZ-3079 with a progressive increase in intensity of CuCopZ-3079 until it
becomes the most intense peak at 40 DTT / protein.
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Figure 7.3.7: Species observed via ESI-MS of 2 Cu / CopZ-3079 at varied
DTT levels. Species present in deconvoluted mass spectra of 2 Cu / CopZ-3079
prepared at a level of: A) 5 DTT / protein, B) 10 DTT / protein, C) 40 DTT / protein.
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7.3.3 ESI-MS Of Cu(I) Binding To CopZ-1317
In order to investigate the Cu(I)-binding behaviour of CopZ-1317, mass spectra were recorded
of CopZ-1317 in the presence of 0, 1 and 2 Cu / protein (Figure 7.3.8). In the absence of
copper, the monomer peak envelope was predominant with 5+ and 6+ charges, with low
intensity dimer peaks present possessing 8+ and 9+ charges. In the presence of copper,
the position of these charge state envelopes did not shift suggesting no major conforma-
tional changes in the presence of copper. The intensities of the dimer peaks increased,
and a trimeric peak envelope emerged with 11+, 12+ and 13+ charges. This suggests a
diverse mixture of CopZ-1317 metalloforms.
Figure 7.3.8: Mass spectra for CopZ-1317 at varied Cu(I) levels. The mass
spectra prior to deconvolution of CopZ-1317 prepared at a level of: A) 0.0 Cu /
protein, B) 1 Cu / protein, C) 2 Cu / protein.
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The deconvoluted mass spectra (Fig 7.3.9) illustrate the CopZ-1317 species which
form in the presence of increasing Cu(I) levels. In the absence of copper, the major species
is apo-CopZ-1317. However, the presence of a significant CuCopZ-1317 peak suggests
that the sample contained some copper despite being prepared without copper added.
At 1 Cu / protein, the most intense species is disulfide-bonded CopZ-13172; the copper-
bound species present are CuCopZ-1317, Cu(CopZ-1317)2 and Cu2(CopZ-1317)2. These
are the major copper-bound species at 2 Cu / protein as well, though their intensities shift
to favour Cu2(CopZ-1317)2, with the intensity of the CopZ-13172 peak having decreased
substantially.
Figure 7.3.9: Deconvoluted mass spectra for CopZ-1317 at varied Cu(I) lev-
els. Deconvoluted mass spectra of CopZ-1317 prepared at a level of: A) 0.0 Cu /
protein, B) 1 Cu / protein, C) 2 Cu / protein. Na+ adducts indicated by ♦ symbols.
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Most of the monomer peaks have an exact mass within a 1 – 2 Da of their predicted
mass. For the dimeric species, the agreement is variable between predicted and observed
exact mass, see Table 7.3. The reduced mass of CopZ-13172 could be explained by
disulfide bond formation. The dimeric species with 3, 4, 5 and 6 coppers bound are mostly
within 2 – 3 Da of their predicted mass. The species Cu(CopZ-1317)2 and Cu2(CopZ-
1317)2 are ∼ 6 Da less than their predicted mass, despite being of high relative intensity.
Typically the mass becomes closer to the expected mass with increasing peak intensity but,
here, that is not the case. The intensity of trimeric species is roughly within 2 Da except
for Cu8CopZ-13173.
Table 7.3: Species observed via ESI-MS for CopZ-1317 at varied Cu(I) levels. Ob-
served masses and relative intensities when CopZ-1317 prepared at: 0, 1 and 2 Cu /
protein.
Species Pred (Da) 0 Cu / CopZ 1.0 Cu / CopZ 2.0 Cu / CopZ
CopZ 8063.8 100% 8061.7 46% 8061.5 5% 8061.8
CuCopZ 8126.3 59% 8125.6 34% 8124.7 29% 8124.4
Cu2CopZ 8188.8 0% – 6% 8185.8 4% 8188.2
CopZ2 16127.7 22% 16123.6 100% 16123.0 21% 16121.9
Cu(CopZ)2 16190.2 0% – 73% 16184.4 53% 16184.5
Cu2(CopZ)2 16252.7 0% – 53% 16245.6 100% 16246.0
Cu3(CopZ)2 16315.2 0% – 20% 16313.9 0% –
Cu4(CopZ)2 16377.7 0% – 24% 16376.7 13% 16375.5
Cu5(CopZ)2 16440.2 0% – 15% 16440.1 26% 16437.4
Cu6(CopZ)2 16502.7 0% – 10% 16502.1 24% 16500.0
Cu5(CopZ)3 24504.0 0% – 24% 24502.6 8% 24502.2
Cu6(CopZ)3 24566.5 0% – 35% 24565.1 18% 24565.0
Cu7(CopZ)3 24629.0 0% – 0% – 27% 24626.8
Cu8(CopZ)3 24691.5 0% – 0% – 27% 24686.7
The bar graphs in Figure 7.3.10 illustrate the distribution of CopZ-1317 species with
increasing Cu(I) levels. At 1 Cu / protein, a diverse mixture of species is observed with
the major species being disulfide bonded CopZ-13172. This would not likely form under
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the reducing conditions of the cell and most likely indicates some sort of oxidative driving
force in the sample. The next most intense species is Cu(CopZ-1317)2 with a substan-
tial intensity of CuCopZ-1317 and Cu2(CopZ-1317)2 as well. Also observed are trimeric
species with 5 and 6 coppers bound. When the copper level is increased to 2 Cu / pro-
tein, the major species shifts to Cu2(CopZ-1317)2, with approximiately equal proportions of
CuCopZ-1317 and Cu(CopZ-1317)2. The relative intensity of other dimeric copper-bound
species has not increased. The relative intensity of the trimeric copper-bound species also
has not increased but has shifted to form higher copper loaded trimeric species.
Figure 7.3.10: Species observed via ESI-MS of CopZ-1317 at varied Cu(I)
loadings. Species present in deconvoluted mass spectra of CopZ-1317 prepared
at a level of: A) 0.0 Cu / protein, B) 1 Cu / protein, C) 2 Cu / protein.
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Figure 7.3.11: Size exclusion chromatography at multiple Cu(I) levels and
UV-vis Cu(I) titration for CopZ-1317. Previous data, acquired previously [192],
of: A) Size exclusion of CopZ-1317 prepared at molar equivalents of Cu(I) as
labelled B) Cu(I) binding by CopZ-1317 monitored using UV-visible absorbance
changes at 20 ◦C, pH 7.5. The absorbance changes observed for CopZ-1317
at 240 nm and 335 nm plotted as a function of Cu(I)/CopZ-1317 (CopZ-1317, 39
μM). Samples of CopZ-1317 were prepared in 10 mM MOPS pH 7.5, 150 mM NaCl
under anaerobic conditions, adding 0.5, 1.0, 1.5 or 2 molar equivalents of Cu(I) to
reduced CopZ-1317. Apo-CopZ-1317 concentrations were determined at 280 nm
using extinction coefficients based upon ProtParam ExPASy and concentrations
calculated using the Beer Lambert law. Size exclusion elution profiles created by
monitoring the absorbance at 280 nm on a 10/300 GL G-75 Superdex column
(GE-Healthcare) equilibrated in sample buffer. Absorbance measurements were
carried out on a a Varian Cary 50 UV-visible spectrophotometer set at 20 ◦C.
In order to compare the above data to solution-phase experiments, Figure 7.3.11
presents unpublished data, acquired previously [192]: size exclusion chromatography of
CopZ-1317 at multiple copper loadings, and UV-vis absorbance data obtained when Cu(I)
was titrated into a solution of CopZ-1317.
The size exclusion chromatography elution profiles of CopZ-1317 at increasing ratios
of Cu / protein illustrate that this protein forms higher order complexes in the presence
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of increased Cu(I) level. According to the column calibration, the apo protein is entirely
monomer. CopZ-1317 remains predominantly monomeric at 1 molar equivalent of Cu(I)
with a peak at ∼ 12.3 mL elution volume. At 2 molar equivalents of Cu(I) CopZ-1317 exists
primarily as a higher order assembly at an elution volume of ∼ 9.4 mL corresponding to a
molecular weight of ∼ 43 kDa. This suggests that CopZ-1317 is some form of higher-order
assembly (trimer or tetramer) upon addition of 2 molar equivalents of Cu(I), however the
higher order peak centred on ∼ 9.4 mL has a shoulder, perhaps illustrating a mixture of
higher-order species.
The titration of Cu(I) into CopZ-1317 monitored by absorbance (Figure 7.3.11B) shows
changes in A240nm and A335nm with increasing Cu(I) level. The absorbance changes are
complex and it is difficult to make predictions of the species distribution. The progressively
increased absorbance suggests continuing binding of Cu(I) by CopZ-1317. There is a
slight breakpoint at 1 Cu / protein which could support the speciation change observed in
the mass spectra between 1 and 2 Cu / protein where the dimeric copper-bound forms of
CopZ-1317 become predominant.
213
7.3.4 ESI-MS Of Cu(I) Binding To CopZ-1317 In The Presence Of DTT
In order to examine the effects of LMWT on Cu(I) binding, mass spectra were recorded
for CopZ-1317 prepared with 2 molar equivalents copper, plus 1, 5 and 20 DTT / protein
(Figure 7.3.12). At 1 DTT / protein, the relative intensities of the monomer and dimer
peak envelope are similar to those observed in the absence of thiol. When the DTT level
is increased to 5 / protein, a decrease in intensity of dimer peaks (8+ and 9+ charges)
is accompanied by an increase in relative intensity of the monomer peaks (5+ and 6+
charges). There is a further decrease in the dimer peaks’ relative intensity at 20 DTT
/ protein. Also present are adduct peaks at +405 Da (monomer) and +812 Da (dimer),
suggesting each monomer has acquired an adduct species of ∼ 405 – 406 Da. With
increasing DTT levels, the relative intensity of these adduct peaks progressively decreases.
Figure 7.3.12: Mass spectra for 2 Cu/CopZ-1317 at varied DTT levels. The
mass spectra prior to deconvolution of CopZ-1317 prepared at 2 Cu / protein in
the presence of: A) 1 DTT / protein, B) 5 DTT / protein, C) 20 DTT / protein.
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The deconvoluted mass spectra (Figure 7.3.13) illustrate changes in CopZ-1317 species
distribution with increasing levels of DTT. The relative intensities of species present in the
deconvoluted mass spectra of CopZ-1317 in the presence of DTT are presented as bar
graphs in Figure 7.3.14, with the exact masses and relative intensities presented in Table
7.4.
Figure 7.3.13: Deconvoluted mass spectra for 2 Cu/CopZ-1317 at varied DTT
levels. Deconvoluted mass spectra of CopZ-1317 prepared at 2 Cu / protein in the
presence of: A) 1 DTT / protein, B) 5 DTT / protein, C) 20 DTT / protein. Diamond
symbols represent Na+ adducts.
At 1 DTT / protein, the species distribution is similar to that recorded in the absence
of thiol at 2 molar equivalents of copper (Fig 7.3.9). The distinct differences are that the
low-intensity copper-bound dimeric and trimeric species are not observed, and the relative
intensity of CuCopZ-1317 has decreased. However, similarly, the predominant copper-
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bound species is Cu2(CopZ-1317)2, the intensity of Cu(CopZ-1317)2 peak is sizable, and
low intensity peaks of apo-CopZ-1317 and disulfide bonded (CopZ-1317)2 can be seen.
Figure 7.3.14: Species observed for 2 Cu/CopZ-1317 at varied DTT levels.
Species present in deconvoluted mass spectra of 2 Cu / CopZ-1317 prepared at
a level of: A) 1 DTT / protein, B) 5 DTT / protein, C) 20 DTT / protein.
When the DTT level is increased to 5 / protein, the intensity of the monomeric peaks
increases, though a substantial proportion of copper-bound dimeric species is present. The
major copper-bound species is CuCopZ-1317, with a large proportion of Cu(CopZ-1317)2
and Cu2(CopZ-1317)2 are present.
At 20 DTT / protein, the dimer peaks are almost eliminated entirely, with copper-
bound monomer species prevailing. The intensity of dimeric species Cu(CopZ-1317)2 and
Cu2(CopZ-1317)2 has diminished. The predominant peak is CuCopZ-1317, and the pro-
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Table 7.4: Species observed for 2 Cu/CopZ-1317 at varied DTT levels. Observed
masses and relative intensities for CopZ-1317 prepared at 2 Cu(I) / protein in the presence
of 1, 5 and 20 DTT / protein.
Species Pred (Da) 1 DTT / CopZ 5 DTT / CopZ 20 DTT / CopZ
CopZ 8063.8 3% 8061.3 47% 8062.6 78% 8063.2
CuCopZ 8126.3 9% 8124.7 100% 8124.7 100% 8125.2
Cu2CopZ 8188.8 0% – 32% 8188.0 26% 8188.5
CopZ2 16127.7 12% 16122.7 14% 16123.8 8% 16123.8
Cu(CopZ)2 16190.2 48% 16185.0 43% 16185.3 17% 16185.6
Cu2(CopZ)2 16252.7 100% 16246.6 77% 16247.0 24% 16247.6
portion of apo-CopZ-1317 increased.
The exact masses observed for the monomeric species are within ∼ 2 Da of the ex-
pected mass. The dimeric species are lower than that expected, by ∼ 4 – 5 Da. Though
intra- and intermolecular disulfide bonds are possible for apo-CopZ-1317 and (CopZ-1317)2,
respectively, the reason for the other mass differences is not clear.
Increasing the proportion of DTT seems to favour formation of CuCopZ-1317 as the
major copper-bound species, and results in a large apo-CopZ-1317 peak. This species
distribution does not account for the initial copper level of the sample, and suggests that
DTT competes against the protein for copper, but does not ionise, leaving the highest-
affinity species to form, CuCopZ-1317.
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7.4 Results: Cu(I) Binding To Atx1 From Saccharomyces cere-
visiae
7.4.1 ESI-MS Of Cu(I) Binding To Atx1
In order to investigate the copper-binding behaviour of Atx1, mass spectra were recorded
for Atx1 prepared with Cu(I) at 0, 0.5, 1.0, 1.5 and 2.0 Cu / protein. The mass spectra
prior to deconvolution (Figure 7.4.1) illustrate a series of overlapping peak envelopes cor-
responding to monomer, dimer and trimer species. In the absence of copper, the monomer
peaks (4+, 5+, 6+) are predominant. Upon addition of 0.5 Cu / protein, additional peak en-
velopes emerge corresponding to dimer (7+, 8+, 9+) and trimer (10+, 11+, 12+, 13+). The
subsequent copper loadings contain a similar distribution of species, indicating a mixture
of monomeric, dimeric and trimeric Atx1 is present. The positions of these peak envelopes
are in accord with that observed for the prokaryotic copper chaperones. The location of
these envelopes do not shift upon addition of copper suggesting no major conformational
changes upon binding of copper. As the copper level is increased, the monomer peak
envelope decreases in intensity with a concomitant increase in the intensity of the dimeric
peaks, while the intensity of the trimeric peaks remains consistently low.
The deconvoluted mass spectra of Atx1 in the presence of copper (Figure 7.4.2) reveal
the mixture of species present. The intensities and exact neutral masses observed are
reported in Table 7.5, and the peak intensities are presented as a bar graph in Figure
7.4.3.
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Figure 7.4.1: Mass spectra for Atx1 at varied Cu(I) levels. Species present in
the mass spectra prior to deconvolution of Atx1 prepared at a level of: A) 0 Cu(I)
/ protein, B) 0.5 Cu / protein, C) 1.0 Cu / protein, D) 1.5 Cu / protein, E) 2.0 Cu /
protein.
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In the absence of copper, the Atx1 mass spectrum contains mostly apo-Atx1 whose
mass (8089.4 Da) reflects the loss of the N-terminal methionine, a typical eukaryotic post-
translational modification. Also observed are low-intensity peaks for disulfide bonded species:
(Atx1)2 and (Atx1)3. Also present is a low-intensity peak ( ∼ 19%) in agreement with the
predicted mass of CuAtx1, suggesting that, despite that no copper was added, a small
amount of copper is present in the sample.
Table 7.5: Species observed via ESI-MS for Atx1 at varied Cu(I) levels. Observed
masses and relative intensities for Atx1 prepared at 0, 0.5, 1, 1.5 and 2 Cu / protein.
Species Pred (Da) 0 Cu / Atx1 0.5 Cu / Atx1 1.0 Cu / Atx1 1.5 Cu / Atx1 2.0 Cu / Atx1
Atx1 8089.4 100% 8088.5 100% 8087.5 100% 8088.4 100% 8088.4 85% 8088.3
CuAtx1 8151.9 19% 8151.8 53% 8151.2 66% 8151.2 75% 8151.2 69% 8150.6
Cu2Atx1 8214.4 0% - 13% 8214.0 13% 8210.3 20% 8211.6 15% 8210.6
(Atx1)2 16178.8 23% 16176.4 15% 16174.5 16% 16174.5 35% 16174.9 57% 16174.9
Cu(Atx1)2 16241.3 10% 16240.1 9% 16238.6 9% 16238.6 7% 16239.6 7% 16238.6
Cu2(Atx1)2 16303.8 6% 16303.7 23% 16302.6 28% 16302.6 23% 16303.9 19% 16303.4
Cu3(Atx1)2 16366.3 0% - 16% 16365.4 18% 16365.7 30% 16366.1 23% 16366.3
Cu4(Atx1)2 16428.8 0% - 14% 16428.2 41% 16428.8 93% 16428.8 100% 16428.8
(Atx1)3 24268.1 13% 24267.3 5% 24261.9 5% 24259.1 13% 24264.2 12% 24262.3
Cu3(Atx1)3 24455.6 0% - 17% 24454.0 19% 24456.8 24% 24455.2 14% 24455.6
Cu4(Atx1)3 24518.1 0% - 12% 24516.2 19% 24519.3 36% 24518.9 32% 24518.8
Cu5(Atx1)3 24580.6 0% - 0% - 6% 24579.6 30% 24580.4 34% 24581.1
Cu3(Atx1)4 32545 0% - 7% 32544.8 7% 32545.1 6% 32544.8 7% 32544.8
Cu4(Atx1)4 32607.5 0% - 14% 32604.8 16% 32609.1 22% 32609.4 14% 32609.4
Cu5(Atx1)4 32670 0% - 0% - 8% 32673.2 11% 32673.2 10% 32673.2
Cu4(Atx1)5 40696.9 0% - 4% 40698.7 4% 40701.8 7% 40702.4 7% 40702.1
Cu5(Atx1)5 40759.4 0% - 6% 40756.5 7% 40766.4 8% 40766.4 6% 40766.4
With the addition of 0.5 Cu / protein, a mixture of monomeric, dimeric and trimeric
species is observed, with the major copper-bound species being CuAtx1 and the most in-
tense peak overall is apo-Atx1. The proportion of disulfide-bonded (Atx1)2 and (Atx1)3 has
decreased slightly. In addition to CuAtx1 ( ∼ 53% relative intensity), a second monomeric
copper-bound species, Cu2Atx1 is present. A variety of dimeric/trimeric copper-bound
species are observed, all below 25% relative intensity, the most intense of which is Cu2Atx12.
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Figure 7.4.2: Deconvoluted mass spectra for Atx1 at varied Cu(I) levels. De-
convoluted mass spectra of Atx1 prepared at a level of: A) 0 Cu(I) / protein, B)
0.5 Cu / protein, C) 1.0 Cu / protein, D) 1.5 Cu / protein, E) 2.0 Cu / protein.
At 1.0 Cu / protein, the species distribution is similar to that at 0.5 Cu / Atx1. The
predominant species is apo-Atx1, and the most prominent copper-bound peak is CuAtx1,
though its relative intensity has now increased to ∼ 66%. Again, a diverse mixture of
dimeric and trimeric copper-bound peaks is observed, mostly below 25% relative intensity.
One distinct change at this copper loading, is the increase in intensity of Cu4Atx12 to 41%
relative intensity.
At 1.5 Cu / protein, the predominant species is still marginally apo-Atx1, with the inten-
221
Figure 7.4.3: Species observed via ESI-MS for Atx1 at varied Cu(I) levels.
Species present in deconvoluted mass spectra of Atx1 prepared at a level of: A)
0 Cu(I) / protein, B) 0.5 Cu / protein, C) 1.0 Cu / protein, D) 1.5 Cu / protein, E)
2.0 Cu / protein.
sity of the Cu4Atx12 peak having increased to 93% relative intensity. The intensities of the
other dimeric forms have stayed relatively similar to that observed at 1.0 Cu / protein, as
does the monomeric Cu2Atx1. The intensities of the peaks for disulfide-bonded Atx12 and
Atx13 have increased slightly. The relative intensities of the trimeric copper-bound peaks
have increased, with the most intense species being Cu4Atx13.
At 2.0 Cu / protein, the most intense species becomes Cu4Atx12, with still a large
proportion of apo-Atx1. The intensities of the peaks for disulfide-bonded Atx12 and Atx13
have increased further from that observed at 1.5 Cu / protein. The intensities of monomeric
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CuAtx1 and Cu2Atx1, and also the 1-, 2-, and 3-copper dimeric forms have stayed relatively
similar to that observed at 1.5 Cu / protein. The peak intensities of the copper-bound
trimeric peaks stays fairly similar to that observed at 1.5 Cu / protein, except for a slight
decrease in the Cu3Atx13 species.
The exact masses observed for Atx1 species are mostly within ∼ 1 – 2 Da of their
predicted mass. The decreased mass observed for apo-Atx1, Atx12, and Atx13 are likely
due to intra- and intermolecular disulfide bond formation. The decreased mass observed
for the Cu2Atx1 peak could be attributed to its low intensity, in which case overlap with a
trisodiated adduct of CuAtx1 influences the peak position. A similar influence could occur
for the trimeric Atx1 peaks. For example, Cu4Atx13 occurs at a lower mass than expected
when at 12% relative intensity (0.5 Cu/protein), but in subsequent spectra, when the peak
relative intensity is higher, the observed mass is close to the predicted mass.
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7.4.2 ESI-MS Of Cu(I) Binding To Atx1 In The Presence Of DTT
In order to observe the species present when copper-loaded Atx1 is mixed with progres-
sively increasing levels of thiol, mass spectra were recorded for 2 Cu / Atx1 at 5, 10 and 20
DTT / protein and are presented in Figure 7.4.4. The mass spectrum prior to deconvolu-
tion in the absence of thiol revealed a mixture of monomer, dimer and trimer peaks with the
dimer envelope being predominant. In the presence of DTT, the same species can be seen
as the peak envelopes are not shifted appreciably: monomer (4+, 5+ 6+), dimer (7+, 8+,
9+) and trimer (10+, 11+, 12+, 13+) observed. However, the intensities of the dimer and
trimer envelopes are diminished significantly reflecting loss of intensity of these species.
Figure 7.4.4: Mass spectra for Atx1 prepared at 2 Cu(I) / protein with varied
DTT levels. Mass spectra prior to deconvolution of Atx1 prepared at 2 Cu(I) /
protein in the presence of: A) 5 DTT / protein, B) 10 DTT / protein, C) 20 DTT /
protein
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Deconvolution of these mass spectra (Figure 7.4.5) reveals the species present, the
exact neutral masses and relative intensities are presented in Table 7.6. The relative in-
tensities are presented as bar graphs in Figure 7.4.6.
The species distribution at each level of DTT is fairly similar, with the most intense
species being apo-Atx1, the most intense copper-bound species is CuAtx1, with a sizeable
proportion of Cu2Atx1. Though, in the absence of thiol, the proportion of disulfide-bonded
Atx12 was high, very little is observed in the presence of DTT, presumably due to the
presence of this reducing agent in the sample.
Figure 7.4.5: Deconvoluted mass spectra for Atx1 prepared at 2 Cu(I) / pro-
tein with varied DTT levels. Deconvoluted mass spectra of Atx1 prepared at 2
Cu(I) / protein in the presence of: A) 5 DTT / protein, B) 10 DTT / protein, C) 20
DTT / protein
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Table 7.6: Species observed via ESI-MS for Atx1 at varied DTT levels. Observed
masses and relative intensities for Atx1 prepared at 2 Cu / protein in the presence of: 5,
10 and 20 DTT / protein.
Species Pred (Da) 5 DTT / Atx1 10 DTT / Atx1 20 DTT / Atx1
Atx1 8089.4 100% 8089.1 100% 8089.1 100% 8089.0
CuAtx1 8151.9 52% 8151.7 52% 8151.6 67% 8151.5
Cu2Atx1 8214.4 29% 8215.3 40% 8215.2 45% 8215.8
Cu3Atx1 8276.9 16% 8277.0 24% 8277.0 26% 8277.9
(Atx1)2 16178.8 34% 16177.7 35% 16175.5 34% 16179.6
Cu(Atx1)2 16241.3 0% – 0% – 0% –
Cu2(Atx1)2 16303.8 52% 16304.4 58% 16304.2 54% 16303.8
Cu3(Atx1)2 16366.3 37% 16366.5 44% 16366.7 28% 16366.3
Cu4(Atx1)2 16428.8 35% 16428.5 49% 16428.3 42% 16429.0
(Atx1)3 24268.1 0% – 0% – 0% –
Cu3(Atx1)3 24455.6 47% 24455.8 52% 24456.3 50% 24456.4
Cu4(Atx1)3 24518.1 42% 24519.2 47% 24518.6 47% 24519.7
Cu5(Atx1)3 24580.6 0% – 0% – 0% –
In contrast to the spectrum in the absence of DTT, here in the presence of DTT, the
intensity of the dimeric copper-bound species are diminished to 25% relative intensity and
below. This could be explained by DTT binding Cu(I) and reducing the likelihood of dimeric
species formation. However, in the presence of DTT the intensity of Cu2Atx1 has also
increased and the species Cu3Atx1 appears around 20% relative intensity at all levels of
DTT. Both of these species, which possess unexpected copper:protein ratios, could arise as
breakdown products of dimeric species which do not readily survive the ionisation process.
The observed masses of all Atx1 species are very close to their predicted masses,
mostly within ∼ 1 – 2 Da. The mass of apo-Atx1 is nearly exact in all cases, perhaps
reflecting the effect of DTT preventing an intramolecular disulfide bond formation. Again,
the decreased mass observed for disulfide bonded Atx12 species (present at much lower
levels than in the presence of DTT) is expected due to loss of cysteine hydrogens. The
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masses of copper-bound monomeric, dimeric and trimeric species are all very close to that
expected mass. The only differences greater than 1 Da are at 20 DTT / protein, where
Cu2Atx1 and Cu43 are ∼ 1.4 Da and 1.8 Da greater than expected. Both peaks are of
moderate intensity and the reason for this mass difference is not clear.
Figure 7.4.6: Species observed via ESI-MS for 2 Cu / Atx1 at varied DTT
levels. Species distribution observed in deconvoluted mass spectra of Atx1
prepared at 2 Cu(I) / protein in the presence of: A) 5 DTT / protein, B) 10 DTT /
protein, C) 20 DTT / protein
The mass of Cu2Atx1 is as expected at first (0.5 Cu / CopZ), but subsequently is ∼ 4
Da lower (at 1.0, 1.5, 2.0 Cu / CopZ), a mass change suggesting these peaks could shift
slightly due to overlap with a tri-sodiated adduct peak of CuAtx1. Though the dimeric Atx1
species with 2, 3 and 4 coppers bound are all within 2 Da of their predicted mass, the mass
of CuAtx12 is lower than expected, perhaps reflecting the potential for a single disulfide to
be formed while one copper is coordinated by the other cysteine pair.
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7.5 Discussion
Atx1-like copper chaperones function in such a way that cellular copper is entirely se-
questered, with none ”free” in the cytoplasm. Defining the physiologically relevant copper-
bound forms of these proteins is essential to understanding the mechanisms of cellular
copper management. Though higher order copper-bound assemblies have been reported
for several members of the Atx1-like chaperone family, their physiological relevance is un-
clear, particularly due to the potential influence of cytoplasmic LMWT. ESI-MS experiments
using prokaryotic CopZ-1317 and CopZ-3079 from S. lividans, and eukaryotic Atx1 from S.
cerevisiae have demonstrated that these proteins form a variety of copper-bound species,
both in the presence and absence of LMWT.
ESI-MS of S. cerevisiae Atx1
The mass spectra of S. cerevisiae Atx1 contained monomeric apo-protein as the major
species in the absence of copper, though showed evidence of a low level of Cu(I) present as
a low-intensity CuAtx1 peak was observed. Low intensity Atx12 and Atx13 peaks suggest
disulfide bonded protein arising from a small amount of oxygen in the sample, or driven
by the ESI process itself [101]. The observed masses of the Atx1 species present are in
close proximity to their predicted masses, mostly within ∼ 1 – 2 Da, including the most
intense copper-bound species CuAtx1 and Cu4Atx12. Deviations could be accounted for by
loss of hydrogen in disulfide bond formation (Atx12 or Atx13) or low-intensity peaks shifting
slightly due to overlap with other adduct peaks (Cu2Atx1). Upon addition of Cu(I), the
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monomeric peak envelope did not shift appreciably suggesting no major structural changes
upon copper binding, which was also observed in the solution structure [41].
The major species formed in the presence of copper were CuAtx1 (0.5 and 1 Cu /
protein) and Cu4Atx12 (1.5 and 2.0 Cu / protein). The Atx1 NMR solution structure [41]
was solved using a sample prepared at 0.9 Cu(I) / Atx1 in the absence of LMWT, where the
only species observed was CuAtx1. Though the mass spectrum at a similar stoichiometric
ratio of 1 Cu / protein displayed the same major peak (66 % relative intensity), a mixture
of additional dimeric and trimeric species also are present (e.g., Cu4Atx12, 41% relative
intensity). Though the reason these higher order assemblies were not observed via NMR
is not entirely clear, protein dimerisation can lead to loss of signals (as observed previously
for B. subtilis [80]), meaning that this portion of the sample may have been not visible by
NMR.
At higher copper levels, except for a slight bump in intensity of the Cu2Atx12 peak,
no significant accumulation of any copper-bound dimeric or trimeric Atx1 species was ob-
served, suggesting cooperativity in formation of Cu4Atx12. It is noted that Atx12 accu-
mulates with increasing copper, perhaps as a results of the cooperative formation of the
tetranuclear species from two Cu2Atx12 yielding apo-Atx1.
The effect of LMWT upon the Atx1 species distribution was illustrated by the mass
spectra of 2.0 Cu / Atx1 prepared at 5, 10 and 25 DTT / protein. Here, Cu4Atx12 is no
longer the most intense peak but, rather, the monomeric species apo-Atx1 and CuAtx1.
The presence of DTT appeared to reduce disulfide bonds, with reduced intensity observed
for Atx12and Atx13 peaks. In addition, here the observed apo-Atx1 mass was closer to the
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predicted mass (within 0.4 Da), suggesting decreased capacity for it to form an intramolec-
ular disulfide in the presence of DTT.
Some of the observed changes in the presence of DTT arise due to its ability to com-
pete for Cu(I), such as the reduced intensity of dimeric Atx1 species. In addition, the dom-
inance of the apo-Atx1 peak could reflect loss of copper to DTT. Previously, it has been
demonstrated that Atx1 prepared with 2.5 molar equivalents of copper, in the presence of
20 DTT / protein, generated a CuAtx1 species, but with the sample containing a final Cu /
protein ratio of 0.75 [34]. Though it is difficult to infer species distribution from the total Cu
/ protein ratio, this result could arise from competition for Cu(I) by DTT. Here, the ESI-MS
data did not show CuAtx1 as the stable copper-bound species, displaying dimeric species
at all levels of copper and thiol tested. However, the dominance of monomer species Cu-
Atx1 was observed at lower copper loadings (0.5 and 1.0 Cu / protein) in the absence of
thiol, and at higher copper loadings (2.0 Cu / protein) in the presence of thiol. The per-
sistent drive toward formation of this species suggests it is stable and perhaps dominant
under a variety of solution-phase conditions.
More recently, it was reported that the presence of LMWT induces Atx1 dimerisa-
tion, as Cu2Atx12GSH2 was formed in vitro in the presence of GSH [187]. However, here,
dimeric species were not dominant at any DTT level and time constraints did not allow test-
ing in the presence of GSH. Instead, the mass spectra of 2 Cu / Atx1 contained a diverse
mixture of monomeric Atx1 species at all thiol levels tested, with dimeric and trimeric peaks
of consistently low-intensity.
Though trimeric species were observed at all copper and thiol levels tested, their rela-
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tive intensities peaked upon formation of Cu4Atx13, and were consistently low. It is unclear
what role they play in the copper binding mechanism of Atx1, but could suggest that trimeric
forms are an intermediate, perhaps in cooperative formation of Cu4Atx12 in the absence
of thiol ligands. Previously, an Atx1 trimer has been observed in a crystal structure after
treatment with tetrathiomolybdate (TM), MoS4-, where each Atx1 in the cluster retains the
canonical βαββαβ fold [191]. This illustrates the possibility for a stable trimeric Atx1 species
to form in the presence of endogenous thiol ligands.
The proposed Cu(I)-binding arrangement of Cu2Atx12GSH2 was one copper coor-
dinated only by cysteine, and the other more exposed with GSH as exogenous ligands,
perhaps mimicking or facilitating the process of copper transfer [190]. It is possible that
DTT would not be able to induce formation of a similar dimeric species, perhaps due to its
differing properties to GSH (such as charge). If Cu2Atx12DTT2 were present in solution,
the thiol competition could result in removal of a DTT-Cu(I) species prior to or during ioni-
sation. Alternately, the thiol affinity could be too low for this thiol adduct species to survive
ionisation. In either case, possible products could be CuAtx12 or Cu2Atx12. These species
were not observed here, but also were not present in the absence of LMWT suggesting
they may not be amenable to ionisation. In that case, the formation of DTT adducts may ul-
timately result in the observation of apo-Atx1 and CuAtx1, which here are the most intense
species observed in the spectra at all levels of DTT.
ESI-MS of S. lividans CopZ-1317 and CopZ-3079
The mass spectra of apo-CopZ-1317 led to a typical peak distribution for a metallochaper-
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one of this size, with no peak shifts upon binding of Cu(I). Addition of 1 Cu(I) /CopZ-1317
led to a mixture of copper-bound forms, predominantly CuCopZ-1317, CuCopZ-13172,
and Cu2CopZ-13172. The prominent peak corresponding to disulfide-bonded CopZ2 likely
arose due to the introduction of oxygen or was facilitated by the oxidising ESI process itself,
as this species would be unexpected.
Upon increase of Cu(I) level from 1 to 2 molar equivalents, the dominant species
shifted from CuCopZ-13172 to Cu2CopZ-13172, in agreement with the absorbance changes
above 1 Cu / protein at 335 nm, indicative of formation of a multinuclear Cu(I) interaction.
The SEC chromatogram (Figure 7.3.11) suggested that at 1 Cu / CopZ-1317, there was
more monomeric than dimeric protein present, though this would be the case, too, in the
mass spectra if the disulfide bonded Atx12 existed as monomeric apo-protein. The changes
observed in the SEC chromatogram between a level of 1 and 2 Cu / CopZ-1317 are also
consistent with the mass spectra, as the higher order assemblies become dominant as the
Cu level is increased above 1 / protein. However, unlike in the SEC where this higher or-
der CopZ-1317 species appeared to be tetrameric, no such peak envelope was observed
in the mass spectrum of CopZ-1317 prior to deconvolution. Some trimeric CopZ-1317
was observed as a component of a diverse mixture of various higher order assemblies.
Cu2CopZ-13172 could simply arise from being amenable to ionisation, as a breakdown
product of Cu4CopZ-13174.
At the lowest level of DTT tested, the low-intensity dimeric and trimeric peaks are abol-
ished, suggesting these species do not bind Cu(I) with very high affinity. In addition, the
monomeric forms are not present, supporting the idea that the most stable species at 2 Cu /
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protein in the absence of LMWT is Cu2CopZ-13172, or the presence of thiols somehow sta-
bilises this species. In the presence of 10 – 20-fold excess of DTT, the SEC data revealed
that higher order CopZ-1317 assemblies were unable to form with elution peaks being en-
tirely monomeric at all levels of copper loading tested. The ESI-MS corroborates these
results, where with increasing DTT levels up to 20-fold excess, the dimeric CuCopZ-13172
and Cu2CopZ-13172 were suppressed with increase in monomeric forms CuCopZ-1317
and apo-CopZ-1317.
CopZ-3079 is the principal copper chaperone in S. lividans as it is present at higher
cellular concentration, and with a slightly higher affinity for Cu(I), than CopZ-1317. The
ESI-MS data suggested that in the absence of thiol the copper-bound species observed
are CuCopZ-3079 and Cu4CopZ-30792 (at 1 Cu/CopZ-3079), leading to the formation of
Cu6CopZ-30792 (at 2 Cu/CopZ-3079). At 1 Cu / CopZ-3079, the mass spectra displayed a
diverse mixture of copper-bound forms with CopZ-3079 and Cu4CopZ-30792 predominant
and of equal intensity. The species distribution observed in the mass spectra of CopZ at 1
Cu / protein fits with the absorbance titration data, suggesting that the monomer CuCopZ-
3079 forms up until 0.5 Cu / protein, with subsequent copper additions leading to formation
of Cu4CopZ-30792. Though ESI-MS data was not acquired at 0.5 Cu / CopZ-3079, this
pattern was observed for the ESI-MS data for B. subtilis CopZ (Section 4.3.2). This is
in reasonable agreement with the SEC chromatogram at 1 Cu / protein, although SEC
suggests that more dimer than monomer was present. This slight discrepancy could easily
be explained by slightly different ionisation efficiencies of the monomeric and dimeric forms,
or variations in absorbance changes due to multinuclear centres, compared with that for
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the monomeric CuCopZ-3079 species.
At 2 Cu / protein the mass spectrum of CopZ-3079 revealed a diverse mixture which
is almost entirely dimeric with Cu6CopZ-30792 clearly predominant. This is in agreement
with the SEC chromatogram revealing entirely dimeric species at 2 molar equivalents of
copper. The mass spectral and SEC data can be juxtaposed with the absorbance titration
data, where beyond 1 Cu / protein the shallower absorbance changes could arise from loss
of monomer as Cu6CopZ-30792 becomes the predominant species.
The presence of DTT led to near entire removal of dimerised species in the mass spec-
trum, though with increasing DTT level from 10 to 20-fold excess the major copper-bound
species becomes CuCopZ-3079. At approximately the same DTT level, SEC confirmed
that no higher order assemblies were formed, suggesting that Cu2CopZ-3079 is not rep-
resentative of some breakdown product as no dimers should exist in solution. This would
suggest that DTT is somehow acting as a ligand to support CopZ-3079 to coordinate an ad-
ditional copper ion, but does not survive ionisation to be observed as a DTT adduct species.
This conclusion was also made in the mass spectra of B. subtilis CopZ containing DTT.
The ability of DTT to inhibit dimerisation may be due in part to its ability to compete for
Cu(I). The affinity of DTT is lower (Kd ∼ 10-15 M) than that of CopZ-1317 (Kd ∼ 10-17 M),
CopZ-3079 (Kd ∼ 10-18 M) [74], and Atx1 (Kd ∼ 10-18 M) [138], but at increasing levels of
DTT, it would become more competitive, leading to the formation of the monomeric copper-
bound forms. These were observed for each protein.
In addition, the relative affinities of the individual proteins fell in line with the extent to
which DTT abolished the dimeric assemblies. For CopZ-1317, with the lowest affinity for
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Cu(I), 20-fold excess of DTT was sufficient to remove the dimeric species entirely. However,
for Atx1, with a slightly higher affinity than CopZ-1317, a 20-fold excess of DTT did diminish
the dimeric species but they were not removed entirely. Perhaps, a greater proportion of
DTT would have accomplished this, such as observed for CopZ-3079 (with similar Cu(I)
affinity to Atx1), where at a 40-fold excess of DTT did, in fact, lead to a near entire removal
of dimeric species.
Figure 7.5.1: Chaperone complexes with a high proportion of copper Struc-
tural representations of higher-order copper chaperone complexes with copper-
to-protein ratios greater than 2:1. Here, the number of available Cys per copper
ion is less than one, suggesting that additional residues would be involved in Cu(I)
coordination.
The spectra presented here illustrate a diverse mixture of species as the copper / pro-
tein ratio in each sample is fluctuated. Higher-order copper chaperone complexes featuring
multicopper clusters typically involve no greater than a 2:1 ratio of copper to protein. This
is influenced by the number of available Cys ligands per protomer (here, two), and is true
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for the majority of species observed in the mixtures of copper chaperone species. At and
above this 2:1 copper-to-protein ratio, additional ligands may be involved, as observed for
B. subtilis Cu4CopZ2 (His15) [81] and the CuA site of Thermus thermophilus cytochrome
c oxidase [193], where the carbonyl oxygen of a nearby Gln served as a weak ligand to a
Cu2S2 cluster.
A few species with copper-to-protein ratios above 2:1 (Figure 7.5.1) were observed
in mass spectra presented here. As described in Section 3.2.1, the relative intensity scale
is based upon peaks normalised to the most intense species. This means that, as an
example, a moderate relative intensity (∼ 15 – 20%) could actually represent quite a low
proportion of the molecular population (∼ 2 – 4%). In addition, the ESI-MS data obtained
represent a snapshot of the equilibrium mixture of coordinate complexes under different
conditions. Here, nearly all the species at elevated copper-to-protein ratios were observed
below 30% relative intensity suggesting they are transient intermediates, and at low con-
centration in solution.
The exceptions were Cu5CopZ-30792 and Cu6CopZ-30792. CopZ-3079 does feature
some sequence differences to CopZ-1317, such as Lys just before the conserved MX-
CXXC motif which could charge balance the Cu(I) centre as for Atx1, or several Gln in
its sequence which have been observed elsewhere as weak copper ligands as described
above. However, without a solution or crystal structure, it is unclear which residues would
lie proximal to the copper-binding site.
Despite some divergent structural features between prokaryotic and eukaryotic copper
chaperones, all proteins formed higher association state assemblies at higher levels of
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copper. The conserved Lys65 in yeast Atx1 is located close to the metal ion, and is thought
to provide a balancing positive charge to stabilise the Cu(I) oxidation state that inhibits
the need for protein dimerisation. In addition, its MXCXXC motif lacks the histidine at
X3 found to coordinate Cu(I) in the dimeric copper-bound forms of CopZ [81], which may
limit the likelihood of dimerisation. Nonetheless, here, in the absence of LMWT, Atx1 was
able to dimerise and also formed trimeric species though this required a higher copper /
protein ratio than observed for other prokaryotic versions, as Atx1 dimeric species were not
dominant until above a level of 1 Cu / protein. Studies of CopZ where Tyr65 was mutated
to Lys did not prevent CopZ association into a trimer, but did require a higher copper level
as Y65K CopZ remained monomeric below 0.5 Cu / protein [179].
This may then be consistent with the idea that Lys65 inhibits multimer formation. It is
in agreement with the fact that here, the yeast Atx1 dimeric form dominated at a higher Cu
/ protein level than for the prokaryotic variants. Also, the lack of histidine may be overcome
by the abundance of LMWT in the cytosol and explain the enhancement of dimerisation
observed in the presence of GSH, which was able to serve as a Cu(I) ligand. The fact that
these species were not observed i.e., Cu2Atx12DTT2, could result from the low ionisation
efficiency of this DTT-bound complex resulting, rather, in loss of CuDTT and observation
of a mixture of Atx1 and CuAtx1 in the mass spectra.
In B. subtilis CopZ, Tyr65 may be involved in copper binding or affect the protein as-
sociation state as it forms a hydrophobic contact with Met11, (of the MXCXXC motif) and
this hydrophobic patch is thought to interact with CopA, facilitating protein-protein interac-
tion with CopA [171] [81]. CopZ-3079 contains a phenylalanine residue at this location.
237
Interestingly, this is typically the conserved residue at the complementary position within
ATPase MBDs [194]. CopZ-3079 formed dimeric species with 4 and 6 Cu(I), suggesting
that neither a Tyr nor a Lys are required for dimerisation. CopZ-1317 contains a conserved
Tyr71, and exhibits a slightly lower affinity for Cu(I), which was not affected by mutating this
Tyr71 to a Phe [74]. Here, CopZ-1317 protein dimerisation occurred at 1 Cu / protein and
trimeric forms were observed as well. All three of these prokaryotic versions of Atx1-like
proteins contain histidine at the X3 position; perhaps this residue facilitates dimerisation
at slightly lower copper / protein ratios compared to eukaryotic homologues. Of particular
note is that the two S. lividans CopZ proteins exhibit quite distinct Cu(I)-binding behaviour,
which may well be connected to different phsyiological roles.
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Chapter 8
Purification Of Integral Membrane Protein, CopA
8.1 Introduction
In Bacillus subtilis, copper is exported from the cell by way of the integral membrane AT-
Pase, CopA, which utilises energy harvested from ATP hydrolysis to drive copper translo-
cation (see Chapter 1). CopA in B. subtilis is an 803 amino acid protein, encoded by
the gene copA [78], whose major structural features are depicted in Figure 8.1.1. These
include cytoplasmic metal-binding domains (MBDs), eight transmembrane helices, an ac-
tuator domain (A-domain), and the ATP-binding region (P- and N-domains) [47]. Most, but
not all, P1B-type ATPases contain two additional TM helices at the N-terminal side of the
core domain, MA and MB [47].
P1B-type ATPases engage in catalytic phosphorylation coupled with active transport
of a Cu(I) ion across a transmembrane channel, which follows the major conformational
states of the Albers-Post catalytic cycle: E1 (ATP and metal-binding) and E2 (phosphory-
lation and metal release). In the E1 state, ATP binds the N-domain while metal binds the
cytoplasmic TM transport site (TMBS). In the E2 state, the metal is translocated across the
membrane and, as metal is released, aspartic acid of a conserved DKTGT sequence in
CopA is phosphorylated. One ATP is coupled with transport of up to two Cu+ ions [195]
and the rate-limiting step appears to be metal release, with slower rates observed for P1B-
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ATPases (<10 s-1) than for other ion subclasses P2- and P3-ATPases [167].
Figure 8.1.1: Structural representation of CopA. Conserved structural features
of CopA include: eight transmembrane helices (MA and MB at the N-terminus,
and M1-M6), an ATP-binding region comprising the nucleotide-binding (N) and
phosphorylation (P) domains, and the actuator domain (A). As a member of the
P1B-1 family of P-type ATPases, CopA contains a CPC transmembrane copper-
binding motif in M4. In addition, the conserved DKTGT domain found in M3 con-
tains the aspartate that is phosphorylated during the catalytic cycle. The soluble
MBDs, CopAa and CopAb, are located at the N-terminus.
The two soluble MBDs of CopA, CopAa and CopAb are located at the N-terminus
and contain conserved MXCXXC copper-binding motifs. Thus far, copper transfer from the
cytoplasmic metallochaperone CopZ to B. subtilis CopA has been characterised using a
truncated construct comprising these two MBDs, CopAab. In Thermotoga maritima, copper
transfer to the CopA MBDs was demonstrated to be required for enzyme function [167] but
it has not yet been demonstrated copper transfer out of the cell occurs by way of binding to
the MBDs. A regulatory role has been proposed [160] for MBDs in copper trafficking. For
example, in the human ATP7A, it has been demonstrated in vitro that the MBDs interact with
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the ATP-binding domain; this interaction is ablated upon Cu(I) binding by the MBDs [196].
Thus, understanding the physiological mechanisms of copper export in B. subtilis in-
volves the characterising the behaviour of the full-length integral membrane protein. To
this end, a plasmid construct has been generated to heterologously express the full-length
CopA (CopA-FL).
Purification of integral membrane proteins requires a specialised procedure whereby,
after overexpression, the membrane-bound protein is first isolated via differential centrifu-
gation and then the membrane-spanning regions are solubilised using buffer systems con-
taining detergent [197]. Detergents generally consist of a hydrophobic moiety (often an
alkane chain or aromatic hydrocarbon) with a polar or charged head group, and form mi-
celles around the hydrophobic regions, leaving the hydrophilic regions exposed to solu-
tion [198]. The minimal concentration for micelle formation (CMC) varies among deter-
gents. Generally speaking, the CMC is determined by the length of the alkyl chain, while
the head group affects the detergent’s interaction with the protein, i.e., the resulting stabil-
ity [199]. To guarantee complete micelle formation, solubilisation is usually carried out at
substantial concentrations above the CMC (established experimentally) and subsequent
experiments carried out at a decreased working concentration of detergent.
In addition to purification and solubilisation of CopA-FL, its capacity as an enzyme
must be established by a functional assay. As ATP is turned over by CopA, the resulting
inorganic phosphate (Pi) can be quantified through its reaction with acidified ammonium
molybdate, to form the phosphomolybdate anion, PMo12O403- [200]. The Mo(VI) is reduced
to generate an α-Keggin molydenum heteropoly complex, with a blue color that can be
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monitored spectroscopically at 710 nm to quantify Pi [201]. Carrying out this activity assay
tests the ability of CopA to turn over ATP and ensures the enzyme is active in its purified,
solubilised form.
The desired outcomes of this work were to: establish that the heterologous host is able
to overexpress CopA, effectively isolate membrane-bound CopA via cell lysis and centrifu-
gation, solubilise CopA from the membranes using a suitable type and concentration of
detergent, purify the solubilised CopA using Ni2+ IMAC, develop and carry out an assay to
establish the enzyme activity of CopA.
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8.2 Materials and Methods
8.2.1 Overexpression of His6CopA
The plasmid construct for expression of full-length CopA, pBSCOPA1, was prepared by
Genscript (Piscataway, NJ, USA), shown in Figure 8.2.1 where copA is encoded in the ex-
pression vector pET21a under control of the inducible T7 promotor, containing a C-terminal
hexa-histidine tag. For overexpression of CopA in E. coli BL21(DE3), 2.5 L (5× 500 mL) of
LB medium with 100 μg/mL ampicillin was inoculated with 5 × 5 mL of an overnight culture
containing pBSCOPA1, and incubated at 37 ◦C and 200 rev/min. When OD600 reached 0.4
– 0.6, IPTG (Formedium) was added to a final concentration of 0.5 mM and the cultures
were incubated at 37 ◦C and 200 rev/min for a further 4 hours. Cells were harvested by
centrifugation at 5,000 × g for 20 min at 4 ◦C and pellets frozen at -20 ◦C.
8.2.2 Solubilisation of CopA with Brij-35 and Triton X-100
For Brij-35 and Triton X-100 solubilisation trials, the pellets were resuspended in 40 mL
of resuspension buffer (here, 50 mM sodium phophate, 200 mM NaCl, 1 mM DTT, 10%
glycerol, pH 7.2). After adding DNAse I (Sigma) to a final concentration of 2 μg/mL, the
cells were lysed by 2 passes through a French pressure cell at 1000 psi, with breaks on
ice between cycles. The lysate was centrifuged at 20,000 × g for 30 min at 4 ◦C using a
Beckman Coulter Avanti J25 centrifuge (Beckman Coulter Inc., USA), and the supernatant
was centrifuged at 105,000 × g for 120 min at 4 ◦C using a Beckman Coulter Optima
LE-80K Ultracentrifuge and 70Ti Rotor (Beckman Coulter Inc., USA). Cell pellets were
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Figure 8.2.1: Sequence encoded by pBSCOPA1. The isotopically averaged
molecular mass and primary sequence of full-length CopA, as produced using
pBSCOPA1.
resolubilised for 60 min at 4 ◦C, in 4 × 25 mL solubilisation buffer, i.e., resuspension buffer
containing final concentrations (where % is w/v) of: Brij-35 at 1 mM (0.125%), Brij-35 at 10
mM (1.25%), Triton X-100 at 1 mM (0.06%), or Triton X-100 at 10 mM (0.6%). The samples
were centrifuged at 200,000 × g for 45 min at 4 ◦C. CopA solubilised in Brij-35 (both 1 and
10 mM, supernatant fraction) was applied to a 5 mL IMAC HiTrap FF Ni-NTA column (GE
Healthcare) equilibrated with 25 mL (5 × CV) of solubilisation buffer containing 50 mM
imidazole, and eluted with a 30 mL (6 × CV) imidazole gradient of 50 – 500 mM imidazole,
with CopA eluting at approximately 100 mM imidazole.
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8.2.3 Solubilisation of CopA with DDM
For the second purification trial, incorporating a high salt wash to remove nucleic acid,
and a more commonly used detergent, n-dodecyl-β-D-maltoside (DDM), cell pellets were
resuspended in 6 mL/g (here, ∼ 55 mL) of resuspension buffer (100 mM HEPES, 200
mM NaCl, 1 mM DTT, 10% glycerol, pH 7.2). After adding DNAse I (Sigma) to a final
concentration of 2 μg/mL, the cells were lysed by 2 passes through a French pressure cell
at 1000 psi, with breaks on ice between cycles. The lysate was centrifuged at 20,000 × g
for 20 min at 4 ◦C using a Beckman Avanti J25 centrifuge (Beckman Coulter Inc., USA),
and the supernatant was centrifuged at 105,000 × g for 120 min at 4 ◦C using Beckman
Coulter Optima Max Ultracentrifuge with MLS-50 rotor (Beckman Coulter Inc., USA). Pellets
were resuspended in 4 × 5 mL solubilisation buffer, i.e., resuspension buffer containing
15 mM DTT and final concentrations (where % is w/v) of DDM at: 0.3 mM (0.03%), 1.2
mM (0.08%), 2.5 mM (0.15%) and 5 mM (0.30%). These samples were incubated for 14
hours at 4 ◦C, and then centrifuged at 200,000 × g for 2 hours at 4 ◦C. After selecting
the most effectively solubilised CopA sample (5 mM DDM, based on SDS-PAGE analysis),
this sample was loaded onto a 5 mL IMAC HiTrap FF Ni-NTA column (GE Healthcare),
previously equilibrated with 25 mL (5 × CV) of binding buffer (100 mM HEPES, 200 mM
NaCl, 10% glycerol, 50 mM imidazole, 15 mM DTT, 5 mM DDM, pH 7.2). The column was
washed with 100 mL (20 × CV) of binding buffer containing 1 M NaCl to remove nucleic
acid, before eluting CopA with a 50 mL (10 × CV) gradient of 50 – 500 mM imidazole (in
binding buffer). Semi-pure CopA fractions were pooled and frozen at -20 ◦C.
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8.2.4 ATPase activity assay
All reagents were prepared in plastic. The stop solution was prepared on ice with stirring, by
adding 15 mL of 1 M HCl to 10.5 mL of 0.5 mM ascorbic acid, and incubating for 10 minutes,
then adding 1.5 mL 10% w/v (NH4)2MoO4 (from stock prepared in a volumetric flask), and
4.5 mL sodium dodecyl sulfate (SDS) (10% w/v), ensuring the solution appeared yellow and
not blue-green. The reducing solution is prepared by first dissolving 1.75 g bismuth citrate,
and then 1.75 g sodium citrate, in 1 M HCl to a final volume of 50 mL. For the standard
calibration curve, 500 μL samples of K2HPO4 (stock prepared in a volumetric flask) were
prepared at a final concentration of Pi between 0 and 200 μM, in 3 mL spectrophotometric
cells. For the protein samples, CopA was exchanged into assay buffer: 100 mM HEPES,
200 mM NaCl, 1 mM Brij-35, 10% glycerol, pH 7.2, using a G25 Sephadex column (PD-10,
GE Healthcare). Then 450 μL of CopA was mixed in a 3 mL spectrophotometric cell with
50 μL 1 mM Na2ATP (stock prepared in volumetric flask), and incubated for 15 minutes
before assay. The assay was carried out in duplicate by adding 1 mL of stop solution to
each spectrophotometric cell, followed by 10 minutes of incubation on ice. Then 1.5 mL
reducing solution is added followed by 10 minutes incubation at 37 ◦C. Absorbance was
then measured at 710 nm.
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8.3 Results
With the aim of characterising full-length CopA in vitro, a protocol was established to purify
solubilised, functionally active CopA. First, pBSCOPA1 encoding CopA with a C-terminal
hexa-histidine tag was overexpressed in E. coli BL21(DE3). The growth conditions de-
scribed in the methods section were used in this host for the production of other proteins
from the same expression vector (pET21a), and were first tested on a small (10 mL) scale
(data not shown), before carrying out a full 2.5 L overexpression.
After overexpression, the isolation of membrane-bound CopA from the E. coli cell
pellets using a French pressure cell and centrifugation are depicted in Figure 8.3.1, lanes 1
– 5. Here, SDS-PAGE analysis illustrates CopA (mol. wt. ∼ 87.1 kDa) under the molecular
weight marker at 100 kDa.
The lysate generated by the pressure cell (Figure 8.3.1, lane 1) was centrifuged at
20,000 × g with a high proportion of CopA then found in the pellet (lane 2) suggesting it
was contained in large insoluble sections of membrane or unbroken cells. Sonication was
also attempted as an alternate lysis method, but resulted in only small quantities of CopA
in the centrifugation supernatant (data not shown). The pressure cell supernatant (lane 3)
was then centrifuged at 105,000 × g in order to separate the membrane-bound CopA into
the pellet (lane 4). This step was moderately effective as half (or less) of CopA remained
in the supernatant (lane 5).
Solubilisation trials were carried out using three nonionic detergents typically used in
purification of integral membrane proteins; their structures are depicted in Figure 8.3.2,
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Figure 8.3.1: Isolation of CopA and solubilisation in Triton X-100. After over-
expression, CopA was isolated via centrifugation at 20,000 × g and then 105,000
× g. SDS-PAGE analysis reveals proteins present in: 1) Pre-induction culture,
2) Post-induction culture, 3) Cell lysate, 4) pellet after centrifugation at 20,000 ×
g, 5) supernatant after centrifugation at 20,000 × g, 6) pellet after centrifugation
at 105,000 × g, 7) supernatant after centrifugation at 105,000 × g. After isola-
tion, the semi-pure CopA (Lane 4) was solubilised in two different concentrations
of Triton X-100 (1 mM and 10 mM) and centrifuged at 200,000 × g, generating:
8) Soluble fraction at 1 mM (0.06%) Triton X-100, 9) Insoluble fraction at 1 mM
(0.06%) Triton X-100, 10) Soluble fraction at 10 mM (0.6%) Triton X-100, 11) In-
soluble fraction at 10 mM (0.6%) Triton X-100.
along with the reported CMC value for each detergent. Solubilisation of CopA was carried
out using a concentration 4- to 40-fold in excess of the CMC.
SDS-PAGE analysis of solubilisation of membrane-bound CopA using Triton X-100
and Brij-35 are depicted in Figure 8.3.1 and Figure 8.3.3, respectively. The semi-pure,
solubilised CopA samples were applied to a Ni2+ IMAC column. The samples solubilised
in Triton X-100 did not bind to the column (data not shown). At both concentrations of
Brij-35, CopA did bind the IMAC column, the column flow-through (lanes 3 and 8) did not
contain a large amount of CopA, and CopA eluted in 2 × 5 mL fractions (lanes 4, 5, 8,
and 9), at approximately 100 mM imidazole. Though SDS-PAGE indicated these fractions
were fairly pure, the absorbance spectrum revealed an Amax = 260 nm, suggesting nucleic
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Figure 8.3.2: Detergents tested for the solubilisation of CopA. DDM, Brij-35
and Triton X-100 are all nonionic detergents used in solubilisation trials of CopA.
The CMC for Triton X-100 is reported to be ∼ 0.220 mM (0.016% w/v). The CMC
for Brij-35 is reported to be ∼ 0.10 mM (0.012% w/v) [202]. The CMC for DDM
is reported to be ∼ 0.170 mM (0.009% w/v) [203].
acid contamination (Figure 8.3.4).
The ATPase assay was tested using fractions containing CopA solubilised in Brij-35,
but a large absorbance intensity at 710 nm arose, suggesting the presence of phosphate,
which likely was carried over from the phosphate buffer used in the purification of the pro-
tein (data not shown). Therefore the protein was buffer exchanged, and the enzyme activity
of CopA was assessed using the ATPase functional assay in a HEPES buffer system. The
results are presented in Figure 8.3.5, with the standard curve reporting on the presence of
inorganic phosphate. The samples containing combinations of buffer, water and ATP did
not exhibit absorbance at 710 nm, suggesting no phosphate was found in those materials.
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Figure 8.3.3: Purification of CopA in Brij-35. After CopA overexpression and
isolation, semi-pure CopA (Figure 8.3.1, Lane 4) was solubilised in Brij-35 and
applied to a Ni2+ IMAC column. Here, SDS-PAGE analysis depicts the results in
both concentrations of Brij-35 (1 mM and 10 mM). After solubilisation at 1 mM
Brij-35, 1) Soluble fraction, 2) Insoluble fraction, 3) IMAC flow-through, 4) IMAC
F2, 5) IMAC F3. A similar proportion of CopA was solubilised and recovered from
the Ni2+ IMAC column after solubilisation at 10 mM Brij-35: 6) Soluble fraction, 7)
Insoluble fraction, 8) IMAC flow-through, 9) IMAC F2, 10) IMAC F3.
The sample containing CopA and ATP exhibited an absorbance of 1.58 at 710 nm sug-
gesting the presence of 1.96 mmoles Pi. Though Pi could have arisen partially due to ATP
turnover, the level measured exceeds the molar quantity of ATP added to the sample (0.05
μmoles). This suggests additional phosphate was present in the sample, perhaps further
carryover from the phosphate buffer, thus the assay results cannot confirm ATPase activity
of the protein.
With the aim of improving the protocol, a second overexpression was carried out and
the purification modified in the following ways: use of HEPES buffer instead of phosphate,
use of n-dodecyl-β-D-maltoside (DDM) for solubilisation which was found to be common
in protocols for P-type ATPase purification [46], [204], [205], along with addition of a salt
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Figure 8.3.4: UV-visible absorbance of CopA in Brij-35. Absorbance spectrum
of elution fractions from Ni2+ IMAC column containing CopA. The Amax = 260 nm
suggests nucleic acid contamination in these fractions. The baseline anomaly
at approximately 325 nm likely arises due to the baseline and sample cells con-
taining different levels of oxidised DTT, which causes a yellow-brown colour and
absorbance at ∼ 325 nm.
wash during IMAC in order to remove nucleic acid.
The SDS-PAGE analysis of the second purification of CopA using DDM is depicted
in Figure 8.3.6. Centrifugation of the lysate at 20,000 × g generated a pellet (lane 2)
containing a high proportion of CopA, but a substantial amount of CopA was also found
in the supernatant fraction (lane 3). This suggests that approximately half the CopA re-
mained in unbroken cells or very large insoluble membrane sections. Centrifugation of the
supernatant at 105,000 × g resulted in half of the CopA being isolated in the pellet (lane
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Figure 8.3.5: ATPase activity assay of CopA. ATPase assay where inorganic
phosphate reacts with (NH4)2MoO4 and is quantified by monitoring absorbance
at 710 nm. Inset: standard curve samples. The standard curve (filled diamonds)
establishes the absorbance expected at increasing levels of phosphate. The sam-
ples containing Buffer + ATP (filled circle) or Buffer + water (hollow circle) or ATP
+ water (filled triangle) generated zero absorbance at 710 nm. The absorbance
observed for CopA + ATP (filled square) illustrates that ∼ 2 mmoles Pi is present.
However, rather than indicating ATPase activity it is likely that this is due to carry-
over from the purification protocol where a phosphate buffer was used.
4).
After solubilising the membranes in DDM for 14 hours (at 0.03%, 0.08%, 0.15% or
0.3%), the remaining insoluble material was removed via centrifugation (200,000 × g).
SDS-PAGE analysis illustrates that, with increasing DDM concentration, a progressively
increasing amount of CopA was recovered in the supernatant (Figure 8.3.6, lanes 6 – 9).
The semi-pure CopA solubilised at 5 mM (0.3%) DDM was applied to a Ni2+ IMAC column,
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and CopA was the primary species observed in the elution fractions (2 × 5 mL), but was
not the only species present. Thus, the purification protocol described above generated
only semi-pure CopA. To continue studies of CopA, the yield and purity resulting from this
protocol should be improved upon in future.
Figure 8.3.6: Purification of CopA in DDM. SDS-PAGE analysis of CopA lysis
and centrifugation, solubilisation in DDM, and Ni2+ IMAC: 1) Cell lysate, 2) Pellet
after centrifugation at 20,000 × g, 3) Supernatant after centrifugation at 20,000 ×
g, 4) Pellet after centrifugation at 95,000 × g, 5) Supernatant after centrifugation
at 95,000 × g, 6) Supernatant after solubilisation in 0.5 mM (0.03 %) DDM, 7)
Supernatant after solubilisation in 1.2 mM (0.08 %) DDM, 8) Supernatant after
solubilisation in 2.5 mM (0.15 %) DDM, 9) Supernatant after solubilisation in 5
mM (0.30 %) DDM, 10) IMAC flow through, 11) IMAC elution fraction.
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8.4 Discussion
The lysis and isolation portion of the protocol resulted in good recovery of membrane-bound
CopA, but this could perhaps be improved as the lysate pellet contained a large proportion
of CopA. The centrifugation speeds chosen here were consistent with those reported in
established protocols [46] [204], with low speed aimed at removal of debris/unbroken cells
in the pellet, and the high speed included to isolate the membrane fraction from soluble
unwanted proteins or unfolded CopA. Though reduction of the first centrifugation speed
[205] perhaps could result in improved recovery of the membrane fraction (and thus CopA),
this also may lead to contamination with unbroken cells/debris.
It is also possible that amending the lysis step could improve the yield of CopA. Other
established purification protocols including P-type ATPases [206] [207] utilise a pressure
cell for cell lysis. Accordingly, here, the pressure cell liberated a high proportion of the
membrane fraction compared to sonication. In both instances of using the pressure cell,
two passes at 1000 psi were used. Perhaps a greater number of passes or increased
pressure would improve the membrane fraction yield.
For intact protein analysis, it is generally better to use a mild detergent with low CMC,
preferably nonionic, and/or one with a larger headgroup or longer hydrocarbon chain [198].
With this in mind, three nonionic analytical grade detergents were selected. Triton X-100
is a mild, low CMC detergent used for solubilisation of membrane and ATP-binding pro-
teins [208]. Despite its success at solubilisation, CopA in Triton X-100 did not bind the
IMAC column. It would not have been an ideal choice due to its absorbance in the UV
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region which interferes during purifcation [197]. Brij-35 is a low CMC detergent similar in
structure to octaethylene glycol (OG; C12E8), a detergent used in solibilising membrane
proteins including a P1B-type ATPase [46]. While solubilisation was effective in Brij-35 with
recovery of nearly all CopA at both concentrations, its use is not as prevalent in purification
of ATPase proteins, and therefore for the second purification in non-phosphate buffer, a
third detergent, DDM, was tested.
After incubation of the ultracentrifugation pellet in DDM, the solubilisation seemed to
recover less CopA compared to Brij-35 and Triton X-100 at similar proportions (10 × CMC,
Brij-35; 5 × CMC, Triton X-100; 3 and 9 × CMC, DDM). Increased concentration to 17
× CMC improved recovery and for 33 × CMC (0.3%) approximately half the CopA was
solubilised; perhaps a further increase in DDM concentration would be worth exploring. It
has been demonstrated in certain cases, the detergent concentration during solubilisation
can be up to 100-fold excess DDM [209] and sometimes 200-fold in excess of the CMC [46].
It was expected that the interaction between the His-tag and the IMAC resin may be
obstructed due to the large micelles formed by DDM [210]. However, this was not the case
as the column-flow through contained little protein, with nearly all protein including CopA
found in the IMAC elution fractions. However, additional proteins solubilised by DDM also
were recovered via IMAC. This could suggest that additional, small proteins are incorpo-
rated into the micelle. Employing a step gradient could be effective in isolating CopA from
other proteins, but would be difficult as CopA elutes at a fairly low imidazole concentration
( ∼100 mM). Lowering the detergent concentration may lead to CopA binding the column
more tightly, and enable better separation from other protein species. Because IMAC is
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usually effective at isolating the target His-tagged protein, it is possible that some other
proteins are degradation products of CopA. Addition of a protease inhibitor could reduce
protein degradation, and the length of time spent on this purification procedure ( ∼ two
weeks) should naturally be reduced to ∼ 2 –3 days once an optimised protocol is estab-
lished.
The ATPase assay calibration curve suggests that this assay is an effective quantitative
measure of inorganic phosphate. Phosphate cross-contamination during CopA purification
was alleviated, but not eradicated, via preparation of assay solutions in plastic and sample
buffer exchange, which led to an accurate standard curve and control samples free of
Pi. The absorbance intensity of the sample containing CopA and ATP suggested that this
sample contained 1.96 mmoles Pi, far exceeding the quantity of ATP present in the sample
(0.05 μmoles). Because phosphate was not found in samples containing buffer, water or
ATP, this suggests that though buffer exchange did significantly lower the Pi concentration,
the protein sample may have contained residual phosphate carryover and additional buffer
exchange steps are likely required. Therefore, though this small-scale trial demonstrates
the workings of the assay, the results here cannot reliably validate the ATPase function of
the protein.
Clearly this work is unfinished and time constraints meant that it was not possible to
continue these investigations. However, they map out the successful over-expression and
purification of significant quantities of CopA (albeit in a semi-pure state) and, as such, lay
the ground work for future studies of the full length CopA protein.
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Chapter 9
General Discussion
Copper trafficking proteins have previously been characterised by spectroscopic and
biophysical methods, which revealed information about their copper-binding behaviour. To
further this, here, ESI-MS and kinetic studies were employed using Bacillus subtilis copper
chaperone (CopZ) and the soluble N-terminal domains (CopAab) of the integral membrane
export ATPase CopA. Cu(I)-binding behaviour in the presence and absence of low molecu-
lar weight thiols (LMWT) was explored, as was the Cu(I) binding behaviour of other copper
chaperones from Saccharomyces cerevisiae and Streptomyces lividans.
The binding of Cu(I) to CopZ is complex with dimerisation occurring in the presence
of copper. Here, native ESI-MS was employed to examine the species distribution of each
of these proteins with changing copper levels. Previous data supported a model where
CopZ dimerised upon binding Cu(I), forming Cu(CopZ)2 at 0.5 Cu / protein, with binding
of additional Cu(I) ions to form Cu4(CopZ)2 at 2 Cu / CopZ [89]. The ESI-MS data at 0.5
/ CopZ presented here revealed the major species to be monomeric CuCopZ with a large
amount of apo-CopZ present; given the previous solution studies, this is likely to arise as
a result of breakdown of Cu(CopZ)2. At 1 Cu / protein, the relative intensity of CuCopZ
decreased, with a diverse mixture of CopZ species present, both monomeric and dimeric;
the most intense copper-bound species being Cu4(CopZ)2. The tetranuclear species was
observed previously, as a crystal structure generated from a CopZ sample prepared at 1
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Cu / protein [81]; this suggests that Cu4(CopZ)2 is a thermodynamically stable form. The
continued dominance of Cu4(CopZ)2 in mass spectra at higher copper levels (1.5 and 2
/ protein) without accumulation of Cu2(CopZ)2 or Cu3(CopZ)2 is indicative of cooperative
formation of Cu4(CopZ)2 by CopZ as the Cu(I) level is increased.
The role low molecular weight thiols (LMWT) play in vivo is multifaceted and complex
as they participate in redox buffering, and form protective mixed disulfides with cellular
proteins under oxidative stress [154]. The high affinity of their thiol groups for soft metals
also potentially makes them influential in metal trafficking. Here, an interesting aspect was
the ability to use the physiologically relevant LMWT, bacillithiol (BSH) [211]. To assess
its capacity for Cu(I) binding, through competition with Cu(BCS)23-, the affinity of BSH for
Cu(I) was established to be β2(BSH) = 4.1 ± 1.5 × 1017 M-2 . A Cu(I) titration of CopZ in the
presence of 20-fold excess BSH was monitored by UV-visible spectroscopy and circular
dichroism, yielding similar results to previous data acquired using Cys and GSH [52]: little
effect upon Cu(I) binding up to 0.5 Cu / CopZ, beyond which a departure from thiol-free
behaviour was observed, including a reduction in number of binding phases.
ESI-MS revealed the effect of LMWT upon the species distribution observed in the
thiol-free spectrum of CopZ prepared at 1 Cu / protein. In the presence of all thiols tested
(BSH, GSH, DTT), a reduced intensity of higher order Cu(I)-bound forms was observed,
presumably due to competition of LMWT for Cu(I). The effect was seen immediately us-
ing DTT, as CuCopZ was the predominant species observed at low levels of DTT. With
increasing DTT, a decreasing proportion of apo-CopZ was observed, which could indicate
some stabilising effect of DTT upon CuCopZ. DTT has been demonstrated to serve as an
258
additional ligand for Cu(I) in CuCopZ in vitro [40], but no DTT adducts were observed here
by ESI-MS to directly confirm this.
GSH and BSH led to reduction in dimeric CopZ forms but unlike observed for DTT, the
effect was gradual as the ratio of thiol/protein was increased. In addition, glutathionylation
and bacillithiolation were observed, where thiol adducts are formed between LMWT and
protein; in vivo this process is a safeguard against irreversible overoxidation of sulfide. In
higher order CopZ complexes, the Cys thiols are involved in Cu(I) coordination; here it is
therefore likely that BSH and GSH are serving as additional Cu(I) ligands.
The process of dimerisation by prokaryotic copper chaperones is thought to be in-
fluenced by two residues (see Figure 7.1.2). One is the X3 residue in the conserved
MX1CX2X3C binding motif, where prokaryotes have a conserved histidine that can act as
an additional Cu(I) ligand in higher order complexes. Another residue is found at the end
of loop 5, typically a tyrosine in prokaryotes, which is thought to facilitate protein-protein in-
teraction and dimerisation through its proximity to the Cu(I)-binding site. Here, eukaryotes
typically possess a lysine, which is thought to preclude the need for dimerisation by reduc-
ing the bound copper’s solvent-accessibility, and stabilise the cysteine thiolate by way of
charge balancing the metal centre. To explore the potential effect of these residues upon
the copper-bound species distribution of prokaryotic and eukaryotic copper chaperones,
ESI-MS was carried out upon S. lividans CopZ-1317 and CopZ-3079, and S. cerevisiae
Atx1.
The S. lividans copper chaperones are predicted to play different roles in copper traf-
ficking and, consistent with this, ESI-MS revealed rather different distributions of copper-
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bound species. For CopZ-3079 prepared at 1 Cu / protein, a diverse mixture of species
was present with CuCopZ-3079 and Cu4CopZ-30792 dominant (in agreement with SEC
data [192] that showed a mixture of monomer/dimer). At 2 Cu / protein, monomeric species
were diminished with Cu6CopZ-30792 dominant (supported by absorbance titration which
revealed rising absorbance ≥ 1.5 Cu / protein, and SEC where dimeric species domi-
nated ≥ 1.5 Cu / protein). The species distribution observed implies cooperative formation
of Cu6CopZ-30792, with progressively elevated intensity of Cu2CopZ-3079 and Cu2CopZ-
30792 suggesting they exist as intermediates. It is unclear how a dimeric form coordinating
five or six Cu(I) ions would be arranged.
The ESI-MS data of CopZ-1317 was more complex. At 1 Cu / protein mass spectra il-
lustrated a diverse mixture of monomeric, dimeric and trimeric species. Assuming the dom-
inant peak CopZ-13172 represents disulfide bonded apo-protein, the species distribution
observed in ESI-MS could be supported by the SEC elution profile [192] that demonstrated
monomeric forms dominate in solution at 1 Cu / protein. At 2 Cu / protein, the predominant
species observed was Cu2CopZ-13172, with a diverse mixture of low-intensity species,
including trimeric forms which coordinated up to 8 Cu(I) ions. Previous data revealed mul-
tiphasic increases in absorbance intensity between 1 and 2 Cu / protein [192] (which could
support this diverse mixture of species) and elevated copper levels resulting in formation
of a higher order form at a stoichiometry of 1:1, proposed to be Cu4CopZ-13174 [74]. The
ESI-MS species distribution suggests that elevated copper levels leads to formation of
Cu2CopZ-13172 either instead of, or as a breakdown of Cu4CopZ-13174.
Due to higher transcription levels and five-fold higher affinity for Cu(I), CopZ-3079 is
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proposed to be more involved in buffering cellular Cu(I) than CopZ-1317 [74]. In line with
their proposed divergent cellular roles in copper trafficking, CopZ-3079 and CopZ-1317 dis-
played different copper-binding behaviour. Both possess the X3 histidine in their conserved
MX1CX2X3C copper-binding motifs, but at the end of loop 5 CopZ-1317 (like B. subtilis
CopZ), possesses a conserved tyrosine where CopZ-3079 has a phenylalanine, unusual
for a prokaryotic copper chaperone. Despite this, for both proteins, dimeric copper-bound
forms dominated at elevated copper levels: CopZ-3079 with a higher Cu(I) affinity formed
Cu6CopZ-30792; for CopZ-1317 with the lower Cu(I) affinity, Cu2CopZ-13172 dominated.
Thus the lack of conserved tyrosine at the end of loop 5 for CopZ-3079 did not inhibit
dimerisation; in fact, dimeric forms dominated at a lower copper/protein ratio for CopZ-
3079 in agreement with SEC data. Perhaps the X3 histidine is a key factor in stabilisation
of dimeric forms, which has been demonsrated in its ability to serve as an additional ligand
in the tetranuclear copper cluster observed for B. subtilis Cu4(CopZ)2 [81]. It cannot be
ruled out that the tyrosine somehow affects the stability of higher order forms as trimeric
forms here were only observed for CopZ-1317. Previously, a trimeric complex of B. sub-
tilis CopZ containing a trinuclear Cu(I) cluster was observed in a high-resolution crystal
structure [163], where Tyr65 played a central role in stabilising the structure.
ESI-MS of S. cerevisiae Atx1 in the presence of increasing Cu(I) revealed monomeric
CuAtx1 as the major species at low copper levels (0.5 and 1.0 Cu / protein) followed by
cooperative formation of Cu4Atx12 (1.5 and 2.0 Cu / protein). Atx1 lacks an X3 histidine
and at the end of loop 5 possesses a lysine. In agreement, the dominance of the dimeric
form Cu4Atx12 was observed at a higher Cu / protein ratio than for the prokaryotic coun-
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terparts. This idea can be supported by mutagenesis experiments involving Y65K CopZ
which demonstrated a higher Cu / protein ratio required for dimerisation [179].
Spectroscopic studies demonstrated S. lividans CopZ-1317 and CopZ-3079, at ele-
vated copper levels, can form higher order assemblies, which were demonstrated via SEC
not to form in the presence of LMWT. In the presence of low levels of LMWT, the spectrum
of 2 Cu / CopZ-1317 predominantly contained a mixture of Cu(CopZ)2 and Cu2(CopZ)2,
suggesting the dimeric and trimeric species with higher copper loadings observed in the
thiol-free spectrum were low-affinity complexes. With increasing LMWT, no higher order
complexes were observed suggesting DTT competes effectively for Cu(I) at higher load-
ings. Though the predominant peaks observed were a mixture of CopZ-1317 and CuCopZ-
1317, the dimeric Cu2(CopZ-1317)2 persisted (∼ 20% relative intensity) even at the highest
level of DTT tested. This is in contrast to the presence of LMWT in a spectrum of 2 Cu /
CopZ-3079, which resulted in immediate near complete removal of all dimerised species’
peaks. The predominant species observed were a mixture of CuCopZ and Cu2CopZ. No
apo-CopZ-3079 was observed, perhaps reflecting the higher Cu(I) affinity of this protein
compared to CopZ-1317. For both CopZ-3079 and CopZ-1317, in the presence of ele-
vated levels of LMWT, this unexpected stoichiometry Cu2CopZ were observed, which may
indicate a stabilising effect or that DTT can provide additional ligands to the Cu(I), but which
does not survive the ionisation process.
A similar species distribution was observed for Atx1 at all DTT levels tested though
this differed from the thiol-free spectrum of 2 Cu / Atx1. This suggests that the presence
of DTT redistributes Cu(I). Some of the species observed have unexpected stoichiometric
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ratios of Cu:protein, which could suggest that DTT serves as an additional Cu(I) ligand. In
addition, the high intensity of apo-Atx1 would be in agreement that DTT competes for cop-
per. Despite the fact that Cu2Atx12GSH2 was observed previously, the equivalent species
Cu2Atx12DTT2 was not observed. Although no DTT adducts were observed directly, per-
haps the stabilised intensity of Cu2Atx1 and Cu2Atx12 points to the presence of this species
in solution.
Prior to undertaking the ESI-MS based studies, substantial spectroscopic data sup-
ported a model where CopAab binds Cu(I) with high affinity as a monomer up to a ratio of
1 Cu / protein, beyond which a multinuclear, dimerised form of CopAab was observed [80].
Between 1 – 4 Cu / protein, the model proposes gradual formation of Cu8(CopAab)2 [147].
The ESI-MS data between 0 and 1 Cu / protein confirmed CopAab to be monomeric, as
either CuCopAab or Cu2CopAab. Between 1 – 2 Cu / protein, the ESI-MS data depart
from the previous model by showing that CopAab is primarily monomeric with the major
species Cu2CopAab. However, a Cu4(CopAab)2 species was detected. The Cu2CopAab
species does possess the same stoichiometric ratio as the sample (2:1) and is in agree-
ment with previous NMR data demonstrating that both the a and b domains bind Cu(I)
with equal preference [80]. However, CopAab was demonstrated to be dimeric at 2 Cu
/ protein by analytical ultracentrifugation and size exclusion chromatography. This could
indicate poor ionisation efficiency/gas-phase stability of Cu4(CopAab)2, which is supported
by low peak intensity of this species in the mass spectrum, and the lack of Cu2(CopAab)2 or
Cu3(CopAab)2 species. The previous model based upon fluorescence and circular dichro-
ism data illustrated that dimeric CopAab continually binds Cu(I) ions beyond a level of 2
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Cu / protein. Though it was not explicitly demonstrated, this model suggested that, ulti-
mately, Cu8(CopAab)2 was formed. ESI-MS confirmed the binding of Cu(I) ions by the
CopAab dimer beyond 2 / protein, but at 4 Cu / CopAab the observed major species was
Cu6(CopAab)2.
Two different dimeric species were indicated by separate ESI-MS peak envelopes,
each with equal copper-to-protein ratios; the lower charge state peaks likely resulted from
a more compact arrangement. This led to the proposal of a compact, symmetric form with
two trinuclear Cu(I) clusters, and also a less compact asymmetric form, where a domain
from each monomer jointly coordinates a tetranuclear Cu(I) cluster and the remaining two
domains each coordinate a single Cu(I) ion. Previous NMR data have shown that domain
a is less stable, and is subject to unfolding upon binding of copper [83] [212]. Thus, it is
also a possibility that the less compact structure could result from the symmetric dimer
undergoing partial unfolding.
Though CuCopAab and Cu2CopAab were both observed via ESI-MS, it was unclear
which domains participated in higher order copper-bound CopAab species, and whether
Cu(I) binding is equivalent to both domains of CopAab as copper levels are increased.
Intraprotein multinuclear cluster formation cannot occur due to the short length of the linker
tethering the domains of CopAab. Thus when a multinuclear cluster is formed, it can only
result from interaction of domains from two different proteins. Therefore though a CopAab
dimer does involve four domains, it is not possible for them to all act as ligands to the same
copper ion. This would imply that each domain functions independently within CopAab,
exhibiting its own copper-binding behaviour and, potentially, its own function in the copper
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trafficking pathway.
Previous spectroscopic studies have established the Cu(I) binding behaviour of the
individual domains, CopAa [83] and CopAb [82]. Each of the individual domains binds Cu(I)
with high affinity and forms multinuclear copper centers. Independently, CopAa exhibits
instability upon Cu(I) binding, particularly at high levels (> 1 Cu / protein), but this instability
is lessened within a mixture of CopAa and Ab, suggesting the two domains interact in
solution.
In order to assess whether a mixture of the individual domains (CopAa and CopAb)
behave differently when combined as separate domains in solution compared to the two
domain protein CopAab, Cu(I) was added (at 0.5, 1, or 2 per domain) to an equimolar Co-
pAa/CopAb mixture. The solution composition was resolved by SEC and fractions anal-
ysed for protein by ESI-MS, and metal by ICP-OES. The data at 0.5 and 1.0 Cu / domain
revealed mostly monomeric CopAa and CopAb (with copper associated) and, in agreement
with the ESI-MS data, revealed mostly monomeric CopAab. A small amount of homod-
imeric CopAa (with little copper associated) implied that initial dimeric species observed
at low Cu(I) loadings in ESI-MS of CopAab involve copper coordination by the CopAa do-
mains.
At 2 Cu / domain (4 Cu / protein), the ESI-MS data (Fig 5.3.3D) depicted a high pro-
portion of dimeric CopAab with a multinuclear copper cluster. The SEC data revealed that
copper was evenly distributed among the tetrameric CopAa and dimeric species (mostly
CopAb). Here, it is not entirely clear whether the dimeric species are homodimeric, whether
any of the tetrameric CopAa has exhibited loss of secondary structure, or whether a multi-
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nuclear cluster has formed. Further work establishing the speciation of individual domains
CopAa and CopAb would be useful to determine (qualitatively) the level of secondary struc-
ture preserved, and also what copper-bound forms of CopAa exist at high Cu(I) levels.
The effect of DTT upon copper binding of CopAab was assessed by ESI-MS. Because
we wanted to explore the species distribution at higher copper levels, which did not fully
support the binding model established using previous spectroscopic data, 4 Cu / CopAab
was chosen. Unlike in the mass spectra of CopZ, DTT adducts were observed for several
monomeric CopAab species. Higher levels of DTT (5, 10 and 25 molar equivalents) did
lead to loss of the dimer peak envelope. However, at the lowest level of DTT (1 molar
equivalent), dimeric species were still present. A slight increase in intensity of CopAab
species containing 4 Cu(I) may indicate a stabilising effect upon [Cu2CopAab]2, the species
which previously had been suggested to bind additional Cu(I) and lead to formation of other
higher order species [163]. This stabilising effect may be corroborated by the appearance
of DTT adducts on monomer CopAab containing 4 – 6 Cu ions, not observed in the absence
of thiol. One of these peaks persisted (∼ 25%, Cu4CopAab:DTT) even at the highest level
of DTT tested.
Compared to the thiol-free mass spectra, the physiologically relevant BSH appeared to
confer a stabilising effect on dimeric forms of CopAab, which appeared at much higher rel-
ative intensity than in the absence of thiol, and persisted to the highest thiol level tested. In
addition, CuCopAab was the only copper-bound monomeric form present; this could occur
as Cu2CopAab was present in thiol-free spectra as a breakdown product of [Cu2CopAab]2.
No bacillithiolation of monomeric CopAab was observed. The copper-binding capacity of
266
the dimer appeared to be higher in the presence of BSH, as Cu7(CopAab)2 and Cu8(CopAab)2
were observed. Concomitantly, the monomer peak intensity was much lower with Cu7(CopAab)2
being the major copper-bound species at the lower three BSH levels tested. This stabilising
effect is also suggested by the observation of BSH adducts on dimeric forms of CopAab
containing 5 and 6 Cu(I) ions. The more compact dimeric form of CopAab diminished more
readily in the presence of BSH, which could occur because BSH is able to penetrate the
less compact structure more easily to serve as a stabilising force.
Despite the extremely high affinity for Cu(I) displayed by CopZ and CopAab, copper
transfer between the proteins is rapid and reversible [163]; previously a weak thermody-
namic drive for exchange [66] has been reported for these types of proteins. Because
copper transfer is thought to occur within a protein:protein complex under kinetic control,
rate measurements were carried out of copper transfer between CopAab and CopZ.
To confirm that protein interaction is required for copper transfer, complex formation
was prevented by loading apo- and copper-bound CopZ into separate dialysis cassettes,
submerged in the same buffer. The intention was that monitoring absorbance would enable
direct measurement of the dissociation of Cu(I) from CopZ. No absorbance increases were
observed for apo-CopZ, and copper analysis revealed copper only to be associated with
holo-CopZ, not with the (original) apo-protein or in the buffer itself. The absorbance of the
copper-loaded CopZ sample did decrease slightly over the course of the experiment but
this probably, at least partially, indicates loss of protein on the dialysis membrane rather
than loss of copper. The results confirmed that the offrate of Cu(I) from CopZ is extremely
low; extrapolation of the data established an upper limit of 6 × 10-5 s-1. This is consistent
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with the proposal that copper transfer does not involve release of free Cu(I) and requires
protein-protein interaction.
The low dissociation rate of copper from CopZ is due to a large kinetic barrier which
is offset when protein complex formation is permitted. Copper transfer between CopZ and
CopAab, measured by stopped flow absorbance, revealed extremely rapid reactions, com-
plete within 0.02 s under the conditions tested, consistent with the prediction that protein-
protein interaction facilitates expedient copper transfer. The reversibility of copper transfer
was confirmed based upon ΔA265 with the sign of the change in accordance with the di-
rection of copper transfer.
Varying the concentration of both proteins revealed that, in both directions of copper
transfer, the calculated rate constant was approximately equal: 247 ± 2.2 s-1 from CopZ to
CopAab, and 258 ± 2.6 s-1 from CopAab to CopZ. The approximate equivalence of these
rate constants indicates the rate limiting step is the same in both directions. In addition,
varying the concentration of each reactant revealed the rate constant to be concentration-
independent, indicative of a true first-order process. This eliminates the possibility that it
could be complex formation, which would be a second order process. This is consistent
with predictions of it being rearrangement of a three-coordinate thiolate-Cu site (2 chaper-
one/1 MBD to 1 chaperone/2 MBD) or dissociation of the complex [34] [213].
This complex involves an interaction between CopZ and one of the domains of Co-
pAab. Both of these proteins reveal dimerised species via ESI-MS, thus in order to explore
the utility of ESI-MS for revealing complexes of CopZ/CopAab, mass spectra were acquired
of 0.5 Cu/CopZ + apo-CopAab, and also of apo-CopZ + 0.5 Cu/CopAab. The charge state
268
distribution of these spectra were comparable to each other, and similar also to the spectra
of the individual proteins at 0.5 Cu / protein, suggesting there are no major structural dif-
ferences occurring within the mixture. Because copper transfer has been demonstrated to
be rapid and reversible and, very little dimerised protein was observed in either individual
protein spectra at this copper level, it was expected that an equal mixture of CuCopAab
and CuCopZ would be observed. Though the most intense copper-bound species ob-
served was CuCopAab, this should be interpreted with caution as the relative intensities
of copper-bound peaks could be overshadowed by the high intensity of apo-CopZ. Slight
differences between the mixed and individual spectra may indicate that copper transfer has
taken place: the intensity of CuCopZ peak was lower than apo-CopZ (not the case in the
0.5 Cu/CopZ mass spectrum), and no Cu2CopAab was observed.
An important observation from this experiment was addditional peaks corresponding
to copper-bound CopZ:CopAab complex, which contained 1 or 2 copper ions bound; in
addition, apo-complex was observed. The low intensity of the complex peaks is plausible
as transfer would be dependent upon encounters between individual proteins. Regardless,
further work needs to be done to establish the mixture of species resulting from copper
transfer between these proteins.
Fully defining the mechanism of copper export from the cell will involve characterisation
of the function of the full-length, membrane-bound CopA, including the role of the MBDs.
To further this aim, here, purification of a CopA-FL using new construct pBSCOPA1 was
carried out and a purification was developed to generate partially pure, solubilised CopA.
Recovery of CopA could perhaps be improved by optimisation of the lysis step in order to
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break more cells. It was unclear whether contamination of CopA with other proteins arose
due to degradation of CopA, or additional proteins being incorporated into the micelles. In
future, completion of the protocol more quickly and addition of a protease inhibitor could
inhibit protein degradation. Also, it is possible that other proteins could be released from the
micelles by reducing the concentration of DDM during IMAC while the CopA was bound
to the column. Quantification of ATPase turnover relies on absorbance arising from the
presence of inorganic phosphate; the initial use of phosphate buffers resulted in carryover
which confounded the results. Nonetheless, a method was developed to carry out this
quantitative assay in future.
In order to continue the study of copper trafficking proteins, some subsequent work to
be carried out includes modelling the cooperativity of copper binding to CopZ in formation
of higher order complexes. Too few data points were recorded here to effectively complete
this analysis, but possibly could be achieved by gradually introducing copper into a CopZ
sample and monitoring real-time formation of Cu4(CopZ)2 via ESI-MS. This approach has
been carried out elsewhere via ESI-MS [214], and could be taken to further investigate the
copper-bound forms of CopZ (or other chaperones) at high metal-to-protein ratios and/or
and mixture of higher order forms. Refer to Appendix for plots illustrating a summary of
species distribution from each set of ESI-MS data; with additional data points these types
of plots could allow binding cooperativity to be modelled in future.
Additional future studies could be carried out to characterise complex formation during
copper transfer between CopZ and CopAab. This could be accomplished via ESI-MS for
samples of CopAab/CopZ mixtures, where one protein is copper-free, and and the other at
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varied Cu/protein ratios. To further explore the physiological relevance of the higher order
complexes, these experiments could be carried out in the absence and presence of BSH.
Another facet of copper transfer to examine would be conformational changes that
may take place in CopAab upon binding copper, and their effect upon the function and
ATPase activity of CopA. It has been proposed that CopAab may serve to sense copper,
or ”switch” on ATPase activity (see Chapter 6). This work could be carried out using the
full-length construct of catalytically active CopA.
Further goals could be to quantify the amount of copper transferred between the pro-
teins via ESI-MS and stopped-flow absorbance. To further define the role of each individual
domain CopAa and CopAb, ESI-MS could be used to investigate the copper-bound com-
plexes formed by the individual and mixed proteins.
271
Bibliography
[1] Hodgkinson, V.; Petris, M. J., “Copper Homeostasis at the Host-Pathogen Interface,”
Journal of Biological Chemistry, vol. 287, no. 17, pp. 13549–13555, 2012.
[2] Crichton, R. R.; Pierre, J. L., “Old Iron, Young Copper: from Mars to Venus,” Biomet-
als, vol. 14, no. 2, pp. 99–112, 2001.
[3] Cordano, A.; Baertl, J. M.; Graham, G. G., “Copper Deficiency in Infancy,” Pediatrics,
vol. 34, pp. 324–336, 1964.
[4] Waddell, J.; Elvehjem, C. A.; Steenbock, H.; Hart, E. B., “Nutritional Anemia on
Whole Milk Diets and its Correction with the Ash of Beef Liver,” Science, vol. 67,
no. 1727, pp. 139–140, 1928.
[5] Ridge, P. G.; Zhang, Y.; Gladyshev, V. N., “Comparative Genomic Analyses of Cop-
per Transporters and Cuproproteomes Reveal Evolutionary Dynamics of Copper Uti-
lization and its Link to Oxygen,” PLoS One, vol. 3, no. 1, p. e1378, 2008.
[6] Rubino, J. T.; Franz, K. J., “Coordination Chemistry of Copper Proteins: How Nature
Handles a Toxic Cargo for Essential Function,” Journal of Inorganic Biochemistry,
vol. 107, no. 1, pp. 129–143, 2012.
[7] Solioz, M.; Abicht, H. K.; Mermod, M. and Mancini, S., “Response of Gram-positive
Bacteria to Copper Stress,” Journal of Biological Inorganic Chemistry, vol. 15, no. 1,
pp. 3–14, 2010.
[8] Pushie, M. J.; Zhang, L.; Pickering, I. J.; George, G. N., “The Fictile Coordination
Chemistry of Cuprous-thiolate Sites in Copper Chaperones,” Biochimica et Biophys-
ica Acta, vol. 1817, no. 6, pp. 938–947, 2012.
[9] Hu, J.; Dong, L.; Outten, C. E., “The Redox Environment in the Mitochondrial Inter-
membrane Space is Maintained Separately from the Cytosol and Matrix,” Journal of
Biological Chemistry, vol. 283, no. 43, pp. 29126–29134, 2008.
[10] Silver, S.; Phung le, T., “A Bacterial View of the Periodic Table: Genes and Pro-
teins for Toxic Inorganic Ions,” Journal of Industrial Microbiology and Biotechnology,
vol. 32, no. 11-12, pp. 587–605, 2005.
[11] Macomber, L.; Imlay, J. A., “The Iron-Sulfur Clusters of Dehydratases are Primary
Intracellular Targets of Copper Toxicity,” Proceedings of the National Academy of
Science USA, vol. 106, no. 20, pp. 8344–8349, 2009.
[12] Bertini, I.; Cavallaro, G.; and McGreevy, K. S., “Cellular Copper Management - a
Draft User’s Guide,” Coordination Chemistry Reviews, vol. 254, no. 5, pp. 506–524,
2010.
[13] Festa, R. A.; Thiele, D. J., “Copper: an Essential Metal in Biology,” Current Biology,
vol. 21, no. 21, pp. R877–883, 2011.
[14] Robinson, N. J.; Winge, D. R., “Copper Metallochaperones,” Annual Review of Bio-
chemistry, vol. 79, pp. 537–562, 2010.
272
[15] Tapiero, H.; Townsend, D. M.; Tew, K. D., “Trace Elements in Human Physiology
and Pathology. Copper,” Biomedical Pharmacotherapy, vol. 57, no. 9, pp. 386–398,
2003.
[16] Peterson, R. L.; Galaleldeen, A.; Villarreal, J.; Taylor, A. B.; Cabelli, D. E.; Hart,
P. J.; Culotta, V. C., “The Phylogeny and Active Site Design of Eukaryotic Cu-only
Superoxide Dismutases,” Journal of Biological Chemistry, 2016.
[17] Gleason, J. E.; Galaleldeen, A.; Peterson, R. L.; Taylor, A. B.; Holloway, S. P.;
Waninger-Saroni, J.; Cormack, B. P.; Cabelli, D. E.; Hart, P. J.; Culotta, V. C., “Can-
dida albicans SOD5 Represents the Prototype of an Unprecedented Class of Cu-
only Superoxide Dismutases Required for Pathogen Defense,” Proceedings of the
National Academy of Science USA, vol. 111, no. 16, pp. 5866–5871, 2014.
[18] Culotta, V. C.; Klomp, L. W.; Strain, J.; Casareno, R. L.; Krems, B.; Gitlin, J. D.,
“The Copper Chaperone for Superoxide Dismutase,” Journal of Biological Chemistry,
vol. 272, no. 38, pp. 23469–23472, 1997.
[19] Wang, M.; Zhao, Q.; Liu, W., “The Versatile Low-molecular Weight Thiols: Beyond
Cell Protection,” Bioessays, vol. 37, no. 12, pp. 1262–1267, 2015.
[20] Priora, R.; Coppo, L.; Salzano, S.; Di Simplicio, P.; Ghezzi, P., “Measurement
of Mixed Disulfides Including Glutathionylated Proteins,” Methods in Enzymology,
vol. 473, pp. 149–159, 2010.
[21] Antelmann, H. and Helmann, J. D., “Thiol-based Redox Switches and Gene Regu-
lation,” Antioxidants and Redox Signalling, vol. 14, no. 6, pp. 1049–1063, 2011.
[22] Fang, Z. and Dos Santos, P. C., “Protective Role of Bacillithiol in Superoxide Stress
and Fe-S Metabolism in Bacillus Subtilis,” Microbiology Open, vol. 4, no. 4, pp. 616–
631, 2015.
[23] Ma, Z.; Chandrangsu, P.; Helmann, T. C.; Romsang, A.; Gaballa, A.; Helmann, J. D.,
“Bacillithiol is a Major Buffer of the Labile Zinc Pool in Bacillus Subtilis,” Molecular
and Microbiology, vol. 94, no. 4, pp. 756–770, 2014.
[24] Hatori, Y. and Lutsenko, S., “An Expanding Range of Functions for the Copper Chap-
erone/antioxidant Protein Atox1,” Antioxidants and Redox Signalling, vol. 19, no. 9,
pp. 945–957, 2013.
[25] Jozefczak, M.; Remans, T.; Vangronsveld, J.; Cuypers, A., “Glutathione is a Key
Player in Metal-induced Oxidative Stress Defenses,” International Journal of Molec-
ular Sciences, vol. 13, no. 3, pp. 3145–3175, 2012.
[26] Jothivasan, V. K.; Hamilton, C. J., “Mycothiol: Synthesis, Biosynthesis and Biolog-
ical Functions of the Major Low Molecular Weight Thiol in Actinomycetes,” Natural
Product Reports, vol. 25, no. 6, pp. 1091–1117, 2008.
[27] Newton, G. L.; Rawat, M.; La Clair, J. J.; Jothivasan, V. K.; Budiarto, T.; Hamilton,
C. J.; Claiborne, A.; Helmann, J. D.; Fahey, R. C., “Bacillithiol is an Antioxidant Thiol
Produced in Bacilli,” Nature Chemical Biology, vol. 5, no. 9, pp. 625–627, 2009.
[28] Banci, L.; Bertini, I.; Cantini, F.; Ciofi-Baffoni, S., “Cellular Copper Distribution:
a Mechanistic Systems Biology Approach,” Cellular and Molecular Life Sciences,
vol. 67, no. 15, pp. 2563–2589, 2010.
273
[29] Chillappagari, S.; Miethke, M.; Trip, H.; Kuipers, O. P.; Marahiel, M. A., “Copper Ac-
quisition is Mediated by YcnJ and Regulated by YcnK and CsoR in Bacillus Subtilis,”
Journal of Bacteriology, vol. 191, no. 7, pp. 2362–2370, 2009.
[30] Lewinson, O.; Lee, A. T.; Rees, D. C., “A P-type ATPase Importer That Discrimi-
nates Between Essential and Toxic Transition Metals,” Proceedings of the National
Academy of Sciences, vol. 106, no. 12, pp. 4677–4682, 2009.
[31] Banci, L.; Bertini, I.; McGreevy, K. S.; Rosato, A., “Molecular Recognition in Copper
Trafficking,” Natural Product Reports, vol. 27, no. 5, pp. 695–710, 2010.
[32] Balasubramanian, R.; Rosenzweig, A. C., “Copper Methanobactin: a Molecule
Whose Time Has Come,” Current Opinion in Chemical Biology, vol. 12, no. 2,
pp. 245–249, 2008.
[33] Boal, A. K.; Rosenzweig, A. C., “Structural Biology of Copper Trafficking,” Chemical
Reviews, vol. 109, no. 10, pp. 4760–4779, 2009.
[34] Pufahl, R. A.; Singer, C. P.; Peariso, K. L.; Lin, S. J.; Schmidt, P. J.; Fahrni, C. J.;
Culotta, V. C.; Penner-Hahn, J. E.; O’Halloran, T. V., “Metal Ion Chaperone Function
of the Soluble Cu(I) Receptor Atx1,” Science, vol. 278, no. 5339, pp. 853–856, 1997.
[35] Radford, D. S.; Kihlken, M. A.; Borrelly, G. P.; Harwood, C. R.; Le Brun, N. E.; Cavet,
J. S., “CopZ from Bacillus Subtilis Interacts in vivo with a Copper Exporting CPx-type
ATPase CopA,” FEMS Microbiology Letters, vol. 220, no. 1, pp. 105–112, 2003.
[36] Ohrvik, H.; Wittung-Stafshede, P., “Identification of New Potential Interaction Part-
ners for Human Cytoplasmic Copper Chaperone Atox1: Roles in Gene Regulation?,”
International Journal of Molecular Sciences, vol. 16, no. 8, pp. 16728–16739, 2015.
[37] Arnesano, F.; Banci, L.; Bertini, I.; Cantini, F.; Ciofi-Baffoni, S.; Huffman, D. L.;
O’Halloran, T. V., “Characterization of the Binding Interface Between the Copper
Chaperone Atx1 and the First Cytosolic Domain of Ccc2 ATPase,” Journal of Biolog-
ical Chemistry, vol. 276, no. 44, pp. 41365–41376, 2001.
[38] Banci, L.; Bertini, I.; Del Conte, R.; Mangani, S.; Meyer-Klaucke, W., “X-ray Ab-
sorption and NMR Spectroscopic Studies of CopZ, a Copper Chaperone in Bacillus
subtilis: the Coordination Properties of the Copper Ion,” Biochemistry, vol. 42, no. 8,
pp. 2467–2474, 2003.
[39] Pitts, A. L.; Hall, M. B., “Investigating the Electronic Structure of the Atox1 Copper(I)
Transfer Mechanism with Density Functional Theory,” Inorganic Chemistry, vol. 52,
no. 18, pp. 10387–10393, 2013.
[40] Banci, L.; Bertini, I.; Del Conte, R.; Markey, J.; Ruiz-Duenas, F. J., “Copper Traffick-
ing: the Solution Structure of Bacillus Subtilis CopZ,” Biochemistry, vol. 40, no. 51,
pp. 15660–15668, 2001.
[41] Arnesano, F.; Banci, L.; Bertini, I.; Huffman, D. L.; O’Halloran, T. V., “Solution Struc-
ture of the Cu(I) and apo Forms of the Yeast Metallochaperone, Atx1,” Biochemistry,
vol. 40, no. 6, pp. 1528–1539, 2001.
[42] Blindauer, C. A., “Bacterial Metallothioneins: Past, Present, and Questions for the
Future,” Journal of Biological Inorganic Chemistry, vol. 16, no. 7, pp. 1011–1024,
2011.
274
[43] Gold, B.; Deng, H.; Bryk, R.; Vargas, D.; Eliezer, D.; Roberts, J.; Jiang, X.; Nathan,
C., “Identification of a Copper-binding Metallothionein in Pathogenic Mycobacteria,”
Nature Chemical Biology, vol. 4, no. 10, pp. 609–616, 2008.
[44] Sutherland, D. E. K.; Stillman, M. J., “The ”Magic Numbers” of Metallothionein,” Met-
allomics, vol. 3, no. 5, pp. 444–463, 2011.
[45] Ruttkay-Nedecky, B.; Nejdl, L.; Gumulec, J.; Zitka, O.; Masarik, M.; Eckschlager, T.;
Stiborova, M.; Adam, V.; Kizek, R., “The Role of Metallothionein in Oxidative Stress,”
International Journal of Molecular Sciences, vol. 14, no. 3, pp. 6044–6066, 2013.
[46] Gourdon, P.; Liu, X. Y.; Skjorringe, T.; Morth, J. P.; Moller, L. B.; Pedersen, B. P.;
Nissen, P., “Crystal Structure of a Copper-Transporting PIB-Type ATPase,” Nature,
vol. 475, no. 7354, pp. 59–64, 2011.
[47] Rosenzweig, A. C.; Arguello, J. M., “Toward a Molecular Understanding of Metal
Transport by P(1B)-Type ATPases,” Current Topics in Membranes, vol. 69, pp. 113–
136, 2012.
[48] Gonzalez-Guerrero, M.; Arguello, J. M., “Mechanism of Cu+-Transporting ATPases:
Soluble Cu+ Chaperones Directly Transfer Cu+ to Transmembrane Transport Sites,”
Proceedings of the National Academy of Science USA, vol. 105, no. 16, pp. 5992–
5997, 2008.
[49] Walker, J. M.; Huster, D.; Ralle, M.; Morgan, C. T.; Blackburn, N. J.; Lutsenko, S.,
“The N-terminal Metal-binding Site 2 of the Wilson’s Disease Protein Plays a Key
Role in the Transfer of Copper from Atox1,” The Journal of Biological Chemistry,
vol. 279, no. 15, pp. 15376–15384, 2004.
[50] Achila D; Banci L; Bertini I; Bunce J; Ciofi-Baffoni S; Huffman DL., “Structure of
Human Wilson Protein Domains 5 and 6 and Their Interplay with Domain 4 and the
Copper Chaperone HAH1 in Copper Uptake,” Proceedings of the National Academy
of Sciences, vol. 103, no. 15, pp. 5729–5734, 2006.
[51] Banci, L.; Bertini, I.; Ciofi-Baffoni, S.; Kandias, N. G.; Robinson, N. J.; Spyroulias, G.
A.; Su, X. C.; Tottey, S.; Vanarotti, M., “The Delivery of Copper for Thylakoid Import
Observed by NMR,” Proceedings of the National Academy of Sciences, vol. 103,
no. 22, pp. 8320–8325, 2006.
[52] Singleton, C.; Le Brun, N. E., “Atx1-like Chaperones and Their Cognate P-type AT-
Pases: Copper-Binding and Transfer,” Biometals, vol. 20, no. 3-4, pp. 275–289,
2007.
[53] De Feo, C. J.; Aller, S. G.; Siluvai, G. S.; Blackburn, N. J.; Unger, V. M., “Three-
dimensional Structure of the Human Copper Transporter hCTR1,” Proceedings of
the National Academy of Science USA, vol. 106, no. 11, pp. 4237–4242, 2009.
[54] Ohrvik, H.; Thiele, D. J., “How Copper Traverses Cellular Membranes Through the
Mammalian Copper Transporter 1, Ctr1,” Annals of the New York Academy of Sci-
ences, vol. 1314, pp. 32–41, 2014.
[55] Matson Dzebo, M.; Arioz, C.; Wittung-Stafshede, P., “Extended Functional Reper-
toire for Human Copper Chaperones,” Biomolecular Concepts, 2016.
275
[56] Levy, A. R.; Yarmiayev, V.; Moskovitz, Y.; Ruthstein, S., “Probing the Structural Flexi-
bility of the Human Copper Metallochaperone Atox1 Dimer and its Interaction with the
CTR1 C-terminal Domain,” Journal of Physical Chemistry, vol. 118, no. 22, pp. 5832–
5842, 2014.
[57] Wernimont, A. K.; Huffman, D. L.; Lamb, A. L.; O’Halloran, T. V.; Rosenzweig, A. C.,
“Structural basis for Copper Transfer by the Metallochaperone for the Menkes/Wilson
Disease Proteins,” Nature Structural Biology, vol. 7, no. 9, pp. 766–771, 2000.
[58] Palm-Espling, M. E.; Niemiec, M. S.; Wittung-Stafshede, P., “Role of Metal in Folding
and Stability of Copper Proteins in vitro,” Biochimica et Biophysica Acta, vol. 1823,
no. 9, pp. 1594–1603, 2012.
[59] Wittung-Stafshede, P., “Unresolved Questions in Human Copper Pump Mecha-
nisms,” Quarterly Review of Biophysics, vol. 48, no. 4, pp. 471–478, 2015.
[60] Menkes, J. H.; Alter, M.; Steigleder, G. K.; Weakley, D. R.; Sung, J. H., “A Sex-linked
Recessive Disorder with Retardation of Growth, Peculiar Hair, and Focal Cerebral
and Cerebellar Degeneration,” Pediatrics, vol. 29, pp. 764–779, 1962.
[61] Wilson, S. A. K., “Progressive Lenticular Degeneration: A Familial Nervous Disease
Associated with Cirrhosis of the Liver,” The Lancet, vol. 179, no. 4626, pp. 1115–
1119, 1912.
[62] Wu, X.; Sinani, D.; Kim, H.; Lee, J., “Copper Transport Activity of Yeast Ctr1 is
Down-regulated via its C terminus in Response to Excess Copper,” The Journal of
Biological Chemistry, vol. 284, no. 7, pp. 4112–4122, 2009.
[63] Cobine, P. A.; Ojeda, L. D.; Rigby, K. M.; Winge, D. R., “Yeast Contain a Non-
proteinaceous Pool of Copper in the Mitochondrial Matrix,” Journal of Biological
Chemistry, vol. 279, no. 14, pp. 14447–14455, 2004.
[64] Xiao, Z.; Wedd, A. G., “A C-terminal Domain of the Membrane Copper Pump Ctr1
Exchanges Copper(I) with the Copper Chaperone Atx1,” Chemical Communications,
no. 6, pp. 588–589, 2002.
[65] Jensen, L. T.; Howard, W. R.; Strain, J. J.; Winge, D. R.; Culotta, V. C., “Enhanced
Effectiveness of Copper Ion Buffering by CUP1 Metallothionein Compared with
CRS5 Metallothionein in Saccharomyces Cerevisiae,” Journal of Biological Chem-
istry, vol. 271, no. 31, pp. 18514–18519, 1996.
[66] Huffman, D. L.; O’Halloran, T. V., “Energetics of Copper trafficking Between the Atx1
Metallochaperone and the Intracellular Copper Transporter, Ccc2,” Journal of Bio-
logical Chemistry, vol. 275, no. 25, pp. 18611–18614, 2000.
[67] Banci, L.; Bertini, I.; Cantini, F.; Felli, I. C.; Gonnelli, L.; Hadjiliadis, N.; Pierattelli,
R.; Rosato, A.; Voulgaris, P., “The Atx1-Ccc2 complex is a Metal-Mediated Protein-
Protein Interaction,” Nature Chemical Biology, vol. 2, no. 7, pp. 367–368, 2006.
[68] Banci, L.; Bertini, I.; Chasapis, C. T.; Rosato, A.; Tenori, L., “Interaction of the Two
Soluble Metal-binding Domains of Yeast Ccc2 with Copper(I)-Atx1,” Biochemical and
Biophysical Research Communications, vol. 364, no. 3, pp. 645–649, 2007.
[69] Franke, S.; Grass, G.; Rensing, C.; Nies, D. H., “Molecular Analysis of the Copper-
Transporting Eﬄux System CusCFBA of Escherichia coli,” Journal of Bacteriology,
vol. 185, no. 13, pp. 3804–3812, 2003.
276
[70] Mealman, T. D.; Bagai, I.; Singh, P.; Goodlett, D. R.; Rensing, C.; Zhou, H.; Wysocki,
V. H.; McEvoy, M. M., “Interactions Between CusF and CusB Identified by NMR
Spectroscopy and Chemical Cross-linking Coupled to Mass Spectrometry,” Bio-
chemistry, vol. 50, no. 13, pp. 2559–2566, 2011.
[71] Worrall, J. A.; Vijgenboom, E., “Copper Mining in Streptomyces: Enzymes, Natural
Products and Development,” Natural Product Reports, vol. 27, no. 5, pp. 742–756,
2010.
[72] Keijser, B. J.; van Wezel, G. P.; Canters, G. W.; Kieser, T.; Vijgenboom, E., “The
Ram-dependence of Streptomyces lividans Differentiation is Bypassed by Copper,”
Journal of Molecular Microbiology and Biotechnology, vol. 2, no. 4, pp. 565–574,
2000.
[73] Cruz-Morales, P.; Vijgenboom, E.; Iruegas-Bocardo, F.; Girard, G.; Yanez-Guerra,
L. A.; Ramos-Aboites, H. E.; Pernodet, J. L.; Anne, J.; van Wezel, G. P.; Barona-
Gomez, F., “The Genome Sequence of Streptomyces lividans 66 Reveals a Novel
tRNA-dependent Peptide Biosynthetic System Within a Metal-Related Genomic Is-
land,” Genome Biology and Evolution, vol. 5, no. 6, pp. 1165–1175, 2013.
[74] Chaplin, A. K.; Tan, B. G.; Vijgenboom, E.; Worrall, J. A., “Copper Trafficking in the
CsoR Regulon of Streptomyces lividans,” Metallomics, vol. 7, no. 1, pp. 145–155,
2015.
[75] Kunst, F.; et.al. , “The Complete Genome Sequence of the Gram-positive Bacterium
Bacillus Subtilis,” Nature, vol. 390, no. 6657, pp. 249–256, 1997.
[76] Zweers, J. C.; Barak, I.; Becher, D.; Driessen, A. J.; Hecker, M.; Kontinen, V. P.;
Saller, M. J.; Vavrova, L.; van Dijl, J. M., “Towards the Development of Bacillus Sub-
tilis as a Cell Factory for Membrane Proteins and Protein Complexes,” Microbial Cell
Factories, vol. 7, p. 10, 2008.
[77] Hirooka, K.; Edahiro, T.; Kimura, K.; Fujita, Y., “Direct and Indirect Regulation of
the ycnKJI Operon Involved in Copper Uptake Through Two Transcriptional Repres-
sors, YcnK and CsoR, in Bacillus Subtilis,” Journal of Bacteriology, vol. 194, no. 20,
pp. 5675–5687, 2012.
[78] Gaballa, A.; Helmann, J. D., “Bacillus Subtilis CPx-type ATPases: Characterization
of Cd, Zn, Co and Cu Eﬄux Systems,” Biometals, vol. 16, no. 4, pp. 497–505, 2003.
[79] Smaldone, G. T.; Helmann, J. D., “CsoR Regulates the Copper Eﬄux Operon CopZA
in Bacillus Subtilis,” Microbiology, vol. 153, no. Pt 12, pp. 4123–4128, 2007.
[80] Singleton, C.; Banci, L.; Ciofi-Baffoni, S.; Tenori, L.; Kihlken, M. A.; Boetzel, R. and
Le Brun, N. E., “Structure and Cu(I)-Binding Properties of the N-terminal Soluble
Domains of Bacillus Subtilis CopA,” Biochemical Journal, vol. 411, no. 3, pp. 571–
579, 2008.
[81] Hearnshaw, S.; West, C.; Singleton, C.; Zhou, L.; Kihlken, M. A.; Strange, R. W.; Le
Brun, N. E.; Hemmings, A. M., “A Tetranuclear Cu(I) Cluster in the Metallochaperone
Protein CopZ,” Biochemistry, vol. 48, no. 40, pp. 9324–9326, 2009.
[82] Zhou, L.; Singleton, C. and Le Brun, N. E., “CopAb, the Second N-terminal Sol-
uble Domain of Bacillus Subtilis CopA, Dominates the Cu(I)-binding Properties of
CopAab,” Dalton Transactions, vol. 41, no. 19, pp. 5939–5948, 2012.
277
[83] Zhou, L.; Singleton, C.; Hecht, O.; Moore, G. R.; Le Brun, N. E., “Cu(I)- and Proton-
binding Properties of the First N-terminal Soluble Domain of Bacillus Subtilis CopA,”
FEBS Journal, vol. 279, no. 2, pp. 285–298, 2012.
[84] Zhou, L.; Singleton, C.; Le Brun, N. E., “High Cu(I) and Low Proton Affinities of the
CXXC motif of Bacillus Subtilis CopZ,” Biochemical Journal, vol. 413, no. 3, pp. 459–
465, 2008.
[85] Bertani, G., “Studies on Lysogenesis. The Mode of Phage Liberation by Lysogenic
Escherichia Coli,” Journal of Bacteriology, vol. 62, no. 3, pp. 293–300, 1951.
[86] Birnboim, H. C. and Doly, J., “A Rapid Alkaline Extraction Procedure for Screening
Recombinant Plasmid DNA,” Nucleic Acids Research, vol. 7, no. 6, pp. 1513–1523,
1979.
[87] Hanahan, D., DNA Cloning: A Practical Approach. Oxford, UK: IRL Press, 1985.
[88] Inoue, H.; Nojima, H.; Okayama, H., “High Efficiency Transformation of Escherichia
Coli with Plasmids,” Gene, vol. 96, no. 1, pp. 23–28, 1990.
[89] Kihlken, M. A.; Leech, A. P. and Le Brun, N. E., “Copper-Mediated Dimerization of
CopZ, a Predicted Copper Chaperone from Bacillus Subtilis,” Biochemical Journal,
vol. 368, no. Pt 3, pp. 729–739, 2002.
[90] Porath, J.; Carlsson, J.; Olsson, I. and Belfrage, G., “Metal Chelate Affinity Chro-
matography, a New Approach to Protein Fractionation,” Nature, vol. 258, no. 5536,
pp. 598–599, 1975.
[91] Hochuli, E.; Dobeli, H.; Schacher, A., “New Metal Chelate Adsorbent Selective
for Proteins and Peptides Containing Neighbouring Histidine Residues,” Journal of
Chromatography, vol. 411, pp. 177–184, 1987.
[92] Stellwagen, E., “Gel filtration,” Methods in Enzymology, vol. 463, pp. 373–385, 2009.
[93] O’Fagain, C.; Cummins, P. M.; O’Connor, B. F., “Gel Filtration Chromatography,”
Methods in Molecular Biology, vol. 681, pp. 25–33, 2011.
[94] Burgess, R. R., “Protein Precipitation Techniques,” Methods in Enzymology, vol. 463,
pp. 331–342, 2009.
[95] Schmid, F., Biological Macromolecules: UV-visible Spectrophotometry. John Wiley
and Sons, Ltd, 2001.
[96] Nilapwar, S. M.; Nardelli, M.; Westerhoff, H. V.; Verma, M., “Absorption Spec-
troscopy,” Methods in Enzymology, vol. 500, pp. 59–75, 2011.
[97] Pace, C. N.; Vajdos, F.; Fee, L.; Grimsley, G.; Gray, T., “How to Measure and Pre-
dict the Molar Absorption Coefficient of a Protein,” Protein Science, vol. 4, no. 11,
pp. 2411–2423, 1995.
[98] Sreerama, N.; Woody, R. W., “Computation and Analysis of Protein Circular Dichro-
ism Spectra,” Methods in Enzymology, vol. 383, pp. 318–351, 2004.
[99] Martin, S. R.; Schilstra, M. J., “Circular Dichroism and Its Application to the Study of
Biomolecules,” Methods in Cellular Biology, vol. 84, pp. 263–293, 2008.
[100] Bruker, “MicrOTOF-QII User Manual,” Bremen, Germany, 2008.
278
[101] Banerjee, S.; Mazumdar, S., “Electrospray Ionization Mass Spectrometry: a Tech-
nique to Access the Information Beyond the Molecular Weight of the Analyte,” Inter-
national Journal of Analytical Chemistry, vol. 2012, p. 282574, 2012.
[102] Wilm, M., “Principles of Electrospray Ionization,” Molecular and Cellular Proteomics,
vol. 10, no. 7, p. M111.009407, 2011.
[103] Baldwin, M. A., “Mass Spectrometers for the Analysis of Biomolecules,” Methods in
Enzymology, vol. 402, pp. 3–48, 2005.
[104] Dole, M.; Mack, L. L.; Hines, R. L.; Mobley, R. C.; Ferguson, L. D.; Alice, M. B.,
“Molecular Beams of Macroions,” The Journal of Chemical Physics, vol. 49, no. 5,
pp. 2240–2249, 1968.
[105] Iribarne, J. V.; Thomson, B. A., “On the Evaporation of Small Ions from Charged
Droplets,” The Journal of Chemical Physics, vol. 64, no. 6, pp. 2287–2294, 1976.
[106] Carlton, D. D.; Schug, K.A., “A Review on the Interrogation of Peptide-Metal Inter-
actions Using Electrospray Ionization-Mass Spectrometry,” Analytica Chimica Acta,
vol. 686, no. 1-2, pp. 19–39, 2011.
[107] Kelly, R. T.; Tolmachev, A. V.; Page, J. S.; Tang, K.; Smith, R. D., “The Ion Funnel:
Theory, Implementations, and Applications,” Mass Spectrometry Reviews, vol. 29,
no. 2, pp. 294–312, 2010.
[108] Herbert, C.G. and Johnstone, R., Mass Spectrometry Basics. CRC Press, 2003.
[109] Mathieu, E., “The Vibratory Movement of an Elliptical Membrane,” Journal de Math-
ematiques Pures et Appliquees, vol. 13, pp. 137–203, 1868.
[110] De Hoffmann, E.; Stroobant, V., Mass Spectrometry. Wiley, London, 2007.
[111] Fenn, J. B.; Mann, M.; Meng, C. K.; Wong, S. F.; Whitehouse, C. M., “Electro-
spray Ionization for Mass Spectrometry of Large Biomolecules,” Science, vol. 246,
no. 4926, pp. 64–71, 1989.
[112] Loo, J. A., “Studying Noncovalent Protein Complexes by Electrospray Ionization
Mass Spectrometry,” Mass Spectrometry Reviews, vol. 16, no. 1, pp. 1–23, 1997.
[113] Hopper, J. T.; Robinson, C. V., “Mass Spectrometry Quantifies Protein Interac-
tions - From Molecular Chaperones to Membrane Porins,” Angewandte Chemie-
International Edition in English, vol. 53, no. 51, pp. 14002–14015, 2014.
[114] Kebarle, P.; Tang, L., “From Ions in Solution to Ions in the Gas Phase - the Mech-
anism of Electrospray Mass-Spectrometry,” Analytical Chemistry, vol. 65, no. 22,
pp. A972–A986, 1993.
[115] Warnke, S.; von Helden, G.; Pagel, K., “Protein Structure in the Gas Phase: The
Influence of Side-Chain Microsolvation,” Journal of the American Chemical Society,
vol. 135, no. 4, pp. 1177–1180, 2013.
[116] Rajabi, K.; Ashcroft, A. E.; Radford, S. E., “Mass Spectrometric Methods to Ana-
lyze the Structural Organization of Macromolecular Complexes,” Methods, vol. 89,
pp. 13–21, 2015.
[117] Pan, J.; Xu, K.; Yang, X.; Choy, W. Y.; Konermann, L., “Solution-Phase Chelators
for Suppressing Nonspecific Protein-Metal Interactions in Electrospray Mass Spec-
trometry,” Analytical Chemistry, vol. 81, no. 12, pp. 5008–5015, 2009.
279
[118] Xu, A. S.; Peng, L. L.; Havel, J. A.; Petersen, M. E.; Fiene, J. A.; Hulse, J. D., “De-
termination of Nicotine and Cotinine in Human Plasma by Liquid Chromatography-
Tandem Mass Spectrometry with Atmospheric-Pressure Chemical Ionization inter-
face,” Journal of Chromatography B: Biomedical Sciences and Applications, vol. 682,
no. 2, pp. 249–257, 1996.
[119] Breuker, K.; McLafferty, F. W., “Stepwise Evolution of Protein Native Structure with
Electrospray into the Gas Phase,” Proceedings of the National Academy of Science
USA, vol. 105, no. 47, pp. 18145–18152, 2008.
[120] Peschke, M.; Verkerk, U. H.; Kebarle, P., “Features of the ESI Mechanism That Af-
fect the Observation of Multiply Charged Noncovalent Protein Complexes and the
Determination of the Association constant by the titration method,” Journal of the
American Society of Mass Spectrometry, vol. 15, no. 10, pp. 1424–1434, 2004.
[121] Benesch, J. L.; Ayoub, M.; Robinson, C. V.; Aquilina, J. A., “Small Heat Shock Pro-
tein Activity is Regulated by Variable Oligomeric Substructure,” Journal of Biological
Chemistry, vol. 283, no. 42, pp. 28513–28517, 2008.
[122] Benesch, J. L.; Ruotolo, B. T., “Mass Spectrometry: Come of Age for Structural and
Dynamical Biology,” Current Opinion in Structural Biology, vol. 21, no. 5, pp. 641–
649, 2011.
[123] Seo, J.; Hoffmann, W.; Warnke, S.; Bowers, M. T.; Pagel, K.; von Helden, G., “Reten-
tion of Native Protein Structures in the Absence of Solvent: A Coupled Ion Mobility
and Spectroscopic Study,” Angewandte Chemie International Edition, vol. 55, no. 45,
pp. 14173–14176, 2016.
[124] Heck, A., “Native Mass Spectrometry: a Bridge Between Interactomics and Struc-
tural Biology,” Nature Methods, vol. 5, no. 11, pp. 927–933, 2008.
[125] Potier, N.; Rogniaux, H.; Chevreux, G.; Van Dorsselaer, A., “Ligand-Metal Ion Bind-
ing to Proteins: Investigation by ESI Mass Spectrometry,” Methods in Enzymology,
vol. 402, pp. 361–389, 2005.
[126] Gross, J. H., Mass Spectrometry: a Textbook. Springer Science and Business Me-
dia, 2006.
[127] Reinhold, B. B.; Reinhold, V. N., “Electrospray Ionization Mass Spectrometry - De-
convolution by an Entropy-Based Algorithm ,” Journal of the American Society of
Mass Spectrometry, vol. 3, no. 3, pp. 207–215, 1992.
[128] Ferrige, A. G.; Seddon, M. J.; Jarvis, S., “Maximum Entropy Deconvolution in Elec-
trospray Mass Spectrometry,” Rapid Communications in Mass Spectrometry, vol. 5,
no. 8, pp. 374–377, 1991.
[129] Blindauer, C. A., “Lessons on the Critical Interplay Between Zinc Binding and Protein
Structure and Dynamics,” Journal of Inorganic Biochemistry, vol. 121, pp. 145–155,
2013.
[130] Merrifield, M. E.; Huang, Z.; Kille, P.; Stillman, M. J., “Copper Speciation in the Alpha
and Beta Domains of Recombinant Human Metallothionein by Electrospray Ioniza-
tion Mass Spectrometry,” Journal of Inorganic Biochemistry, vol. 88, no. 2, pp. 153–
172, 2002.
280
[131] Kaltashov, I.A.; Abzalimov, R. R., “Do Ionic Charges in ESI MS Provide Useful In-
formation on Macromolecular Structure?,” Journal of the American Society of Mass
Spectrometry, vol. 19, no. 9, pp. 1239–1246, 2008.
[132] Heck, A. J. R.; van den Heuvel, R. H. H., “Investigation of Intact Protein Complexes
by Mass Spectrometry,” Mass Spectrometry Reviews, vol. 23, no. 5, pp. 368–389,
2004.
[133] Hilton, G. R.; Benesch, J. L. P., “Two Decades of Studying Non-covalent Biomolecu-
lar Assemblies by Means of Electrospray Ionization Mass Spectrometry,” Journal of
the Royal Society Interface, vol. 9, no. 70, pp. 801–816, 2012.
[134] Kaluarachchi, H.; Siebel, J. F.; Kaluarachchi-Duffy, S.; Krecisz, S.; Sutherland, D.
E.; Stillman, M. J.; Zamble, D. B., “Metal Selectivity of the Escherichia coli Nickel
Metallochaperone, SlyD,” Biochemistry, vol. 50, no. 49, pp. 10666–10677, 2011.
[135] Lu, S. C., “Regulation of Hepatic Glutathione Synthesis: Current Concepts and Con-
troversies,” The FASEB Journal, vol. 13, no. 10, pp. 1169–1183, 1999.
[136] Spies, H. S.; Steenkamp, D. J., “Thiols of Intracellular Pathogens. Identification of
Ovothiol A in Leishmania Donovani and Structural Analysis of a Novel Thiol from
Mycobacterium Bovis,” European Journal of Biochemistry, vol. 224, no. 1, pp. 203–
213, 1994.
[137] Fahey, R. C., “Glutathione Analogs in Prokaryotes,” Biochimica et Biophysica Acta,
vol. 1830, no. 5, pp. 3182–3198, 2013.
[138] Xiao, Z.; Brose, J.; Schimo, S.; Ackland, S. M.; La Fontaine, S.; Wedd, A. G., “Unifi-
cation of the Copper(I) Binding Affinities of the Metallochaperones Atx1, Atox1, and
Related Proteins: Detection Probes and Affinity Standards,” Journal of Biological
Chemistry, vol. 286, no. 13, pp. 11047–11055, 2011.
[139] Badarau, A.; Firbank, S. J.; McCarthy, A. A.; Banfield, M. J.; Dennison, C., “Visual-
izing the Metal-binding Versatility of Copper Trafficking Sites,” Biochemistry, vol. 49,
no. 36, pp. 7798–7810, 2010.
[140] Leszczyszyn, O. I.; Blindauer, C. A., “Zinc Transfer from the Embryo-Specific Metal-
lothionein E(C) From Wheat: a Case Study,” Physical Chemistry Chemical Physics,
vol. 12, no. 41, pp. 13408–13418, 2010.
[141] Urvoas, A.; Amekraz, B.; Moulin, C.; Le Clainche, L.; Stocklin, R.; Moutiez, M., “Anal-
ysis of the Metal-binding Selectivity of the Metallochaperone CopZ from Enterococ-
cus Hirae by Electrospray ionization Mass Spectrometry,” Rapid Communications in
Mass Spectrometry, vol. 17, no. 16, pp. 1889–1896, 2003.
[142] Palumaa, P.; Kangur, L.; Voronova, A.; Sillard, R., “Metal-binding Mechanism of
Cox17, a Copper Chaperone for Cytochrome c Oxidase,” Biochemical Journal,
vol. 382, no. Pt 1, pp. 307–314, 2004.
[143] Sharma, S. V.; Jothivasan, V. K.; Newton, G. L.; Upton, H.; Wakabayashi, J. I.;
Kane, M. G.; Roberts, A. A.; Rawat, M.; La Clair, J. J.; Hamilton, C. J., “Chemi-
cal and Chemoenzymatic Syntheses of Bacillithiol: a Unique Low-Molecular-Weight
Thiol Amongst low G + C Gram-positive Bacteria,” Angewandte Chemie-International
Edition in English, vol. 50, no. 31, pp. 7101–7104, 2011.
281
[144] Xiao, Z.; Loughlin, F.; George, G. N.; Howlett, G. J.; Wedd, A. G., “C-terminal Domain
of the Membrane Copper Transporter Ctr1 From Saccharomyces Cerevisiae Binds
Four Cu(I) Ions as a Cuprous-Thiolate Polynuclear Cluster: Sub-femtomolar Cu(I)
Affinity of Three Proteins Involved in Copper trafficking,” Journal of the American
Chemical Society, vol. 126, no. 10, pp. 3081–3090, 2004.
[145] Kamau, P.; Jordan, R. B., “Complex Formation Constants for the Aqueous Copper(I)-
acetonitrile System by a Simple General Method,” Inorganic Chemistry, vol. 40,
no. 16, pp. 3879–3883, 2001.
[146] Dobo, A.; Kaltashov, I. A., “Detection of Multiple Protein Conformational Ensembles
in Solution Via Deconvolution of Charge-State Distributions in ESI MS,” Analytical
Chemistry, vol. 73, no. 20, pp. 4763–4773, 2001.
[147] Singleton, C.; Le Brun, N. E., “The N-terminal Soluble Domains of Bacillus Subtilis
CopA Exhibit a High Affinity and Capacity for Cu(I) Ions,” Dalton Transactions, no. 4,
pp. 688–696, 2009.
[148] Xiao, Z.; Wedd, A. G., “The Challenges of Determining Metal-protein Affinities,” Nat-
ural Product Reports, vol. 27, no. 5, pp. 768–789, 2010.
[149] Hasler, D. W.; Faller, P.; Vasak, M., “Metal-thiolate Clusters in the C-terminal Domain
of Human Neuronal Growth Inhibitory Factor (GIF),” Biochemistry, vol. 37, no. 42,
pp. 14966–14973, 1998.
[150] Pountney, D. L.; Schauwecker, I.; Zarn, J.; Vasak, M., “Formation of Mammalian
Cu8-Metallothionein in vitro: Evidence for the Existence of Two Cu(I)4-thiolate Clus-
ters,” Biochemistry, vol. 33, no. 32, pp. 9699–9705, 1994.
[151] Hussain, F.; Wittung-Stafshede, P., “Impact of Cofactor on Stability of Bacterial
(CopZ) and Human (Atox1) Copper Chaperones,” Biochimica et Biophysica Acta,
vol. 1774, no. 10, pp. 1316–1322, 2007.
[152] Felitsyn, N.; Peschke, M.; Kebarle, P., “Origin and Number of Charges Observed on
Multiply-Protonated Native Proteins Produced by ESI,” International Journal of Mass
Spectrometry, vol. 219, no. 1, pp. 39–62, 2002.
[153] Lee, J. W.; Soonsanga, S.; Helmann, J. D., “A Complex Thiolate Switch Regulates
the Bacillus Subtilis Organic Peroxide Sensor OhrR,” Proceedings of the National
Academy of Science USA, vol. 104, no. 21, pp. 8743–8748, 2007.
[154] Chi, B. K.; Gronau, K.; Mader, U.; Hessling, B.; Becher, D.; Antelmann, H., “S-
bacillithiolation Protects Against Hypochlorite Stress in Bacillus Subtilis as Revealed
by Transcriptomics and Redox Proteomics,” Molecular and Cellular Proteomics,
vol. 10, no. 11, p. M111.009506, 2011.
[155] Arguello, J. M., “Identification of Ion-selectivity Determinants in Heavy-Metal Trans-
port P1B-type ATPases,” Journal of Membrane Biology, vol. 195, no. 2, pp. 93–108,
2003.
[156] Arnesano, F.; Banci, L.; Bertini, I.; Bonvin, A. M., “A Docking Approach to the Study
of Copper Trafficking Proteins; Interaction Between Metallochaperones and Soluble
Domains of Copper ATPases,” Structure, vol. 12, no. 4, pp. 669–676, 2004.
[157] Niemiec, M. S.; Dingeldein, A. P.; Wittung-Stafshede, P., “T versus D in the MTCXXC
motif of Copper Transport Proteins Plays a Role in Directional Metal Transport,” Jour-
nal of Biological Inorganic Chemistry, vol. 19, no. 6, pp. 1037–1047, 2014.
282
[158] Forbes, J. R.; Hsi, G.; Cox, D. W., “Role of the Copper-binding Domain in the Cop-
per Transport Function of ATP7B, the P-type ATPase Defective in Wilson Disease,”
Journal of Biological Chemistry, vol. 274, no. 18, pp. 12408–12413, 1999.
[159] Morin, I.; Gudin, S.; Mintz, E.; Cuillel, M., “Dissecting the Role of the N-terminal
Metal-binding Domains in Activating the Yeast Copper ATPase in vivo,” FEBS Jour-
nal, vol. 276, no. 16, pp. 4483–4495, 2009.
[160] Wu, C. C.; Rice, W. J.; Stokes, D. L., “Structure of a Copper Pump Suggests a
Regulatory Role for its Metal-binding Domain,” Structure, vol. 16, no. 6, pp. 976–
985, 2008.
[161] Tsivkovskii, R.; MacArthur, B. C.; Lutsenko, S., “The Lys1010-Lys1325 Fragment of
the Wilson’s Disease Protein Binds Nucleotides and Interacts with the N-terminal
Domain of this Protein in a Copper-Dependent Manner,” Journal of Biological Chem-
istry, vol. 276, no. 3, pp. 2234–2242, 2001.
[162] Inesi, G.; Pilankatta, R.; Tadini-Buoninsegni, F., “Biochemical Characterization of
P-type Copper ATPases,” Biochemical Journal, vol. 463, no. 2, pp. 167–176, 2014.
[163] Singleton, C.; Hearnshaw, S.; Zhou, L.; Le Brun, N. E.; Hemmings, A. M., “Mech-
anistic Insights Into Cu(I) Cluster Transfer Between the Chaperone CopZ and its
Cognate Cu(I)-Transporting P-type ATPase, CopA,” Biochemical Journal, vol. 424,
no. 3, pp. 347–356, 2009.
[164] Banci, L.; Bertini, I.; Ciofi-Baffoni, S.; Gonnelli, L.; Su, X. C., “Structural Basis for
the Function of the N-terminal Domain of the ATPase CopA from Bacillus Subtilis,”
Journal of Biological Chemistry, vol. 278, no. 50, pp. 50506–50513, 2003.
[165] Maryon, E. B.; Molloy, S. A.; Kaplan, J. H., “Cellular Glutathione plays a Key Role in
Copper Uptake Mediated by Human Copper Transporter 1,” The American Journal
of Physiololgy - Cell Physiology, vol. 304, no. 8, pp. C768–779, 2013.
[166] Fan, B.; Grass, G.; Rensing, C.; Rosen, B. P., “Escherichia coli CopA N-terminal
Cys(X)(2)Cys Motifs are not Required for Copper Resistance or Transport,” Biochem-
ical and Biophysical Research Communications, vol. 286, no. 2, pp. 414–418, 2001.
[167] Hatori, Y.; Hirata, A.; Toyoshima, C.; Lewis, D.; Pilankatta, R.; Inesi, G., “Intermedi-
ate Phosphorylation Reactions in the Mechanism of ATP Utilization by the Copper
ATPase (CopA) of Thermotoga maritima,” Journal of Biological Chemistry, vol. 283,
no. 33, pp. 22541–22549, 2008.
[168] Yatsunyk, L. A.; Rosenzweig, A. C., “Cu(I) binding and transfer by the N terminus
of the Wilson disease protein,” Journal of Biological Chemistry, vol. 282, no. 12,
pp. 8622–8631, 2007.
[169] Changela, A.; Chen, K.; Xue, Y.; Holschen, J.; Outten, C. E.; O’Halloran, T. V.;
Mondragon, A., “Molecular basis of metal-ion selectivity and zeptomolar sensitivity
by CueR,” Science, vol. 301, no. 5638, pp. 1383–1387, 2003.
[170] Ansbacher, T.; Chourasia, M.; Shurki, A., “Copper-chaperones with Dicoordinated
Cu(I)–Unique Protection Mechanism,” Proteins, vol. 81, no. 8, pp. 1411–1419, 2013.
[171] Allen, S.; Badarau, A.; Dennison, C., “The Influence of Protein Folding on the Cop-
per Affinities of Trafficking and Target Sites,” Dalton Transactions, vol. 42, no. 9,
pp. 3233–3239, 2013.
283
[172] Banci, L.; Bertini, I.; Cantini, F.; Rosenzweig, A. C.; Yatsunyk, L. A., “Metal binding
Domains 3 and 4 of the Wilson Disease Protein: Solution Structure and Interaction
with the Copper(I) Chaperone HAH1,” Biochemistry, vol. 47, no. 28, pp. 7423–7429,
2008.
[173] Niemiec, M. S.; Weise, C. F.; Wittung-Stafshede, P., “In Vitro Thermodynamic Dis-
section of Human Copper Transfer from Chaperone to Target Protein,” PLoS One,
vol. 7, no. 5, p. e36102, 2012.
[174] Niemiec, M. S.; Dingeldein, A. P.; Wittung-Stafshede, P., “Enthalpy-entropy Compen-
sation at Play in Human Copper Ion Transfer,” Scientific Reports, vol. 5, p. 10518,
2015.
[175] Wernimont, A. K.; Yatsunyk, L. A.; Rosenzweig, A. C., “Binding of copper(I) by the
Wilson Disease Protein and its Copper Chaperone,” The Journal of Biological Chem-
istry, vol. 279, no. 13, pp. 12269–12276, 2004.
[176] Banci, L.; Bertini, I.; Ciofi-Baffoni, S.; Del Conte, R.; Gonnelli, L., “Understanding
Copper Trafficking in Bacteria: Interaction Between the Copper Transport Protein
CopZ and the N-terminal Domain of the Copper ATPase CopA from Bacillus Subtilis,”
Biochemistry, vol. 42, no. 7, pp. 1939–1949, 2003.
[177] Zhou, L., Studies of Cu(I) Trafficking Proteins from Bacillus subtilis. PhD Thesis,
2009.
[178] Huffman, D. L.; O’Halloran, T. V., “Function, Structure, and Mechanism of Intracel-
lular Copper Trafficking Proteins,” Annual Review of Biochemistry, vol. 70, pp. 677–
701, 2001.
[179] Singleton, C., Studies of Cu(I) Trafficking Proteins from Bacillus subtilis. PhD Thesis,
2008.
[180] Rae, T. D.; Schmidt, P. J.; Pufahl, R. A.; Culotta, V. C.; O’Halloran, T. V., “Unde-
tectable Intracellular Free Copper: the Requirement of a Copper Chaperone for Su-
peroxide Dismutase,” Science, vol. 284, no. 5415, pp. 805–808, 1999.
[181] Shoshan, M. S.; Tshuva, E. Y., “The MXCXXC Class of Metallochaperone Proteins:
Model Studies,” Chemical Society Reviews, vol. 40, no. 11, pp. 5282–5292, 2011.
[182] Banci, L.; Bertini, I.; Ciofi-Baffoni, S.; Su, X. C.; Borrelly, G. P.; Robinson, N. J.,
“Solution Structures of a Cyanobacterial Metallochaperone: Insight into an Atypical
Copper-binding Motif,” Journal of Biological Chemistry, vol. 279, no. 26, pp. 27502–
27510, 2004.
[183] Arnesano, F.; Banci, L.; Bertini, I.; Ciofi-Baffoni, S.; Molteni, E.; Huffman, D. L.;
O’Halloran, T. V., “Metallochaperones and Metal-transporting ATPases: a Compar-
ative Analysis of Sequences and Structures,” Genome Research, vol. 12, no. 2,
pp. 255–271, 2002.
[184] Hussain, F.; Rodriguez-Granillo, A.; Wittung-Stafshede, P., “Lysine-60 in Copper
Chaperone Atox1 Plays an Essential Role in Adduct Formation with a Target Wil-
son Disease Domain,” Journal of the American Chemical Society, vol. 131, no. 45,
pp. 16371–16373, 2009.
[185] Dalosto, S. D., “Computer Simulation of the Interaction of Cu(I) with Cys Residues
at the Binding Site of the Yeast Metallochaperone Cu(I)-Atx1,” Journal of Physical
Chemistry, vol. 111, no. 11, pp. 2932–2940, 2007.
284
[186] Tanchou, V.; Gas, F.; Urvoas, A.; Cougouluegne, F.; Ruat, S.; Averseng, O.;
Quemeneur, E., “Copper-mediated Homo-dimerisation for the HAH1 Metallochaper-
one,” Biochemistry Biophysics Research Communications, vol. 325, no. 2, pp. 388–
394, 2004.
[187] Miras, R.; Morin, I.; Jacquin, O.; Cuillel, M.; Guillain, F.; Mintz, E., “Interplay be-
tween glutathione, Atx1 and copper. 1. Copper(I) glutathionate induced dimerization
of Atx1,” Journal of Biological Inorganic Chemistry, vol. 13, no. 2, pp. 195–205, 2008.
[188] Wimmer, R.; Herrmann, T.; Solioz, M.; Wuthrich, K., “NMR structure and metal in-
teractions of the CopZ copper chaperone,” Journal of Biological Chemistry, vol. 274,
no. 32, pp. 22597–22603, 1999.
[189] Petzoldt, S.; Kahra, D.; Kovermann, M.; Dingeldein, A. P.; Niemiec, M. S.; Aden, J.;
Wittung-Stafshede, P., “Human Cytoplasmic Copper Chaperones Atox1 and CCS
Exchange Copper Ions in vitro,” Biometals, vol. 28, no. 3, pp. 577–585, 2015.
[190] Poger, D.; Fillaux, C.; Miras, R.; Crouzy, S.; Delangle, P.; Mintz, E.; Den Auwer,
C.; Ferrand, M., “Interplay Between Glutathione, Atx1 and Copper: X-ray Absorp-
tion Spectroscopy Determination of Cu(I) Environment in an Atx1 Dimer,” Journal of
Biological Inorganic Chemistry, vol. 13, no. 8, pp. 1239–1248, 2008.
[191] Alvarez, H. M.; Xue, Y.; Robinson, C. D.; Canalizo-Hernandez, M. A.; Marvin, R. G.;
Kelly, R. A.; Mondragon, A.; Penner-Hahn, J. E.; O’Halloran, T. V., “Tetrathiomolyb-
date Inhibits Copper Trafficking Proteins Through Metal Cluster Formation,” Science,
vol. 327, no. 5963, pp. 331–334, 2010.
[192] Chaplin, A.K. , Metalloenzymes Required for Glycan Processing and Morphological
Development in Streptomyces lividans. PhD Thesis, 2016.
[193] Williams, P. A.; Blackburn, N. J.; Sanders, D.; Bellamy, H.; Stura, E. A.; Fee, J. A.;
McRee, D. E., “The CuA Domain of Thermus thermophilus ba3-type Cytochrome c
Oxidase at 1.6 A Resolution,” Nature Structural Biology, vol. 6, no. 6, pp. 509–516,
1999.
[194] Badarau, A.; Dennison, C., “Copper Trafficking Mechanism of CXXC-Containing Do-
mains: Insight from the pH-Dependence of Their Cu(I) Affinities,” Journal of the
American Chemical Society, vol. 133, no. 9, pp. 2983–2988, 2011.
[195] Gonzalez-Guerrero, M.; Eren, E.; Rawat, S.; Stemmler, T. L.; Arguello, J. M., “Struc-
ture of the Two Transmembrane Cu+ Transport Sites of the Cu+ -ATPases,” Journal
of Biological Chemistry, vol. 283, no. 44, pp. 29753–29759, 2008.
[196] Hasan, N. M.; Gupta, A.; Polishchuk, E.; Yu, C. H.; Polishchuk, R.; Dmitriev, O.
Y.; Lutsenko, S., “Molecular Events Initiating Exit of a Copper-transporting ATPase
ATP7B From the Trans-Golgi Network,” Journal of Biological Chemistry, vol. 287,
no. 43, pp. 36041–36050, 2012.
[197] Lin, S. H.; Guidotti, G., “Purification of Membrane Proteins,” Methods in Enzymology,
vol. 463, pp. 619–629, 2009.
[198] Linke, D., “Detergents: an Overview,” Methods in Enzymology, vol. 463, pp. 603–
617, 2009.
[199] Prive, G. G., “Detergents for the Stabilization and Crystallization of Membrane Pro-
teins,” Methods, vol. 41, no. 4, pp. 388–397, 2007.
285
[200] Baginski, E. S.; Foa, P. P.; Zak, B., “Microdetermination of Inorganic Phosphate,
Phospholipids, and Total Phosphate in Biologic Materials,” Clinical Chemistry,
vol. 13, no. 4, pp. 326–332, 1967.
[201] Cariani, L.; Thomas, L.; Brito, J.; del Castillo, J. R., “Bismuth Citrate in the Quantifica-
tion of Inorganic Phosphate and its Utility in the Determination of Membrane-Bound
Phosphatases,” Analytical Biochemistry, vol. 324, no. 1, pp. 79–83, 2004.
[202] Tiehm, A., “Degradation of Polycyclic Aromatic Hydrocarbons in the Presence of
Synthetic Surfactants,” Applied and Environmental Microbiology, vol. 60, no. 1,
pp. 258–263, 1994.
[203] Chae, P. S.; Rasmussen, S. G.; Rana, R. R.; Gotfryd, K.; Chandra, R.; Goren, M.
A.; Kruse, A. C.; Nurva, S.; Loland, C. J.; Pierre, Y.; Drew, D.; Popot, J. L.; Pi-
cot, D.; Fox, B. G.; Guan, L.; Gether, U.; Byrne, B.; Kobilka, B.; Gellman, S. H.,
“Maltose-Neopentyl Glycol (MNG) Amphiphiles for Solubilization, Stabilization and
Crystallization of Membrane Proteins,” Nature Methods, vol. 7, no. 12, pp. 1003–
1008, 2010.
[204] Chintalapati, S.; Al Kurdi, R.; van Scheltinga, A. C.; Kuhlbrandt, W., “Membrane
structure of CtrA3, a Copper-Transporting P-type-ATPase from Aquifex Aeolicus,”
Journal of Molecular Biology, vol. 378, no. 3, pp. 581–595, 2008.
[205] Hung, Y. H.; Layton, M. J.; Voskoboinik, I.; Mercer, J. F.; Camakaris, J., “Purification
and Membrane Reconstitution of Catalytically Active Menkes Copper-Transporting
P-type ATPase (MNK; ATP7A),” The Biochemical Journal, vol. 401, no. 2, pp. 569–
579, 2007.
[206] Torres, C.; Galian, C.; Freiberg, C.; Fantino, J. R.; Jault, J. M., “The YheI/YheH
Heterodimer from Bacillus Subtilis is a Multidrug ABC Transporter,” Biochimica et
Biophysica Acta, vol. 1788, no. 3, pp. 615–622, 2009.
[207] Mandal, A. K.; Cheung, W. D.; Arguello, J. M., “Characterization of a Thermophilic
P-type Ag+/Cu+-ATPase from the Extremophile Archaeoglobus fulgidus,” Journal of
Biological Chemistry, vol. 277, no. 9, pp. 7201–7208, 2002.
[208] Geertsma, E. R.; Nik Mahmood, N. A.; Schuurman-Wolters, G. K.; Poolman, B.,
“Membrane Reconstitution of ABC Transporters and Assays of Translocator Func-
tion,” Nature Protocols, vol. 3, no. 2, pp. 256–266, 2008.
[209] Schurig-Briccio, L. A.; Gennis, R. B., “Characterization of the PIB-Type ATPases
Present in Thermus thermophilus,” Journal of Bacteriology, vol. 194, no. 15,
pp. 4107–4113, 2012.
[210] Gutmann, D. A.; Mizohata, E.; Newstead, S.; Ferrandon, S.; Postis, V.; Xia, X.;
Henderson, P. J.; van Veen, H. W.; Byrne, B., “A high-throughput Method for Mem-
brane Protein Solubility Screening: the Ultracentrifugation Dispersity Sedimentation
Assay,” Protein Science, vol. 16, no. 7, pp. 1422–1428, 2007.
[211] Newton, G. L.; Buchmeier, N.; Fahey, R. C., “Biosynthesis and Functions of My-
cothiol, the Unique Protective Thiol of Actinobacteria,” Microbiology and Molecular
Biology Reviews, vol. 72, no. 3, pp. 471–494, 2008.
[212] Banci, L.; Bertini, I.; Ciofi-Baffoni, S.; D’Onofrio, M.; Gonnelli, L.; Marhuenda-Egea,
F. C.; Ruiz-Duenas, F. J., “Solution Structure of the N-terminal Domain of a Poten-
tial Copper-Translocating P-type ATPase from Bacillus subtilis in the apo and Cu(I)
Loaded States,” Journal of Molecular Biology, vol. 317, no. 3, pp. 415–429, 2002.
286
[213] Rodriguez-Granillo, A.; Crespo, A.; Estrin, D. A.; Wittung-Stafshede, P., “Copper-
transfer Mechanism from the Human Chaperone Atox1 to a Metal-binding Domain
of Wilson Disease Protein,” Journal of Physical Chemistry, vol. 114, no. 10, pp. 3698–
3706, 2010.
[214] Sutherland, D.E.; Summers, K.L.; Stillman, M.J., “Modeling the Zn(2+) and Cd(2+)
Metalation Mechanism in Mammalian Metallothionein 1a,” Biochemical and Biophys-
ical Research Communications, vol. 426, no. 4, pp. 601–607, 2012.
287
Appendix: Summary of ESI-MS
CopZ species observed via ESI-MS The major species observed via ESI-MS
under conditions tested in experimental Chapter 4. These plots illustrate changes
in relative intensities with increasing: A) copper-to-protein ratio or B) thiol-to-
protein ratio for a sample prepared at 1 Cu / protein. At a level of 0 thiol / pro-
tein in (B), the data points are the same as plotted in (A). Plots include the major
species only, additional protein complexes may have been observed via ESI-MS
(see Chapter 4). The filled circles represent data points, with connecting lines
included for ease of interpretation only.
288
CopAab species observed via ESI-MS The major species observed via ESI-
MS under conditions tested in experimental Chapter 5. These plots illustrate
changes in relative intensities with increasing: A) copper-to-protein ratio or B)
thiol-to-protein ratio for a sample prepared at 2 Cu / protein. At a level of 0 thiol
/ protein in (B), the data points are the same as plotted in (A). Plots include the
major species only, additional protein complexes may have been observed via
ESI-MS (see Chapter 5). The filled circles represent data points, with connecting
lines included for ease of interpretation only.
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Atx1 species observed via ESI-MS The major species observed via ESI-MS un-
der conditions tested in experimental Chapter 7. These plots illustrate changes in
relative intensities with increasing: A) copper-to-protein ratio or B) thiol-to-protein
ratio for a sample prepared at 2 Cu / protein. At a level of 0 thiol / protein in (B), the
data points are the same as plotted in (A). Plots include the major species only,
additional protein complexes may have been observed via ESI-MS (see Chapter
7). The filled circles represent data points, with connecting lines included for ease
of interpretation only.
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CopZ-3079 species observed via ESI-MS The major species observed via ESI-
MS under conditions tested in experimental Chapter 7. These plots illustrate
changes in relative intensities with increasing: A) copper-to-protein ratio or B)
thiol-to-protein ratio for a sample prepared at 2 Cu / protein. At a level of 0 thiol
/ protein in (B), the data points are the same as plotted in (A). Plots include the
major species only, additional protein complexes may have been observed via
ESI-MS (see Chapter 7). The filled circles represent data points, with connecting
lines included for ease of interpretation only.
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CopZ-1317 species observed via ESI-MS The major species observed via ESI-
MS under conditions tested in experimental Chapter 7. These plots illustrate
changes in relative intensities with increasing: A) copper-to-protein ratio or B)
thiol-to-protein ratio for a sample prepared at 2 Cu / protein. At a level of 0 thiol
/ protein in (B), the data points are the same as plotted in (A). Plots include the
major species only, additional protein complexes may have been observed via
ESI-MS (see Chapter 7). The filled circles represent data points, with connecting
lines included for ease of interpretation only.
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